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and without gastrointestinal helminth (Ascaris lumbricoides and Trichuris trichura) 
infection. The hypothesis was that concurrent helminth infection adversely affects 
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were recruited from an HIV Support Group and HIV negative individuals residing in the 
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work is limited by the cross sectional design, moderate sample size and practical 
challenges.  
 
The profile of lymphocyte phenotypes, viral loads, eosinophils, activation markers, 
expression of the nuclear proliferation antigen-Ki67 and activation regulator antigen 
CTLA-4 were analysed using flow cytometry in HIV positive and negative subgroups with 
or without helminth infection. The type-1, type-2 and inflammatory cytokines were 
analysed using multiplex cytokine array technology. These were correlated with immune 
responses to HIV.  Non parametric statistics were used to describe differences in the 
variables between the subgroups.  
 
 A major finding of the study was the result of the supplementary use of the serological 
marker, Ascaris lumbricoides-specific IgE in addition to the presence (or absence) of 
helminth eggs in stools to classify intestinal helminth infection status. Two significant 
outcomes of this measure were the enhancement of diagnosis of current or recent 
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helminth infection and, more importantly, the distinction of different phenotypes of 
individuals who displayed different immunological responses to co-infection with HIV and 
helminths. The different helminth infection phenotypes are defined by stool egg positivity 
(egg+) or negativity (egg-) with either high or low Ascaris-specific IgE (IgEhi or IgElo) 
respectively. The four subgroups, egg+IgEhi, egg+IgElo, egg-IgEhi and egg-IgElo showed 
different interactions with regards to immune response to HIV. It should be noted that no 
Trichuris specific IgE tests are commercially available but that there is significant 
antigenic cross-reactivity with Ascaris antigen. 
 
The presence of helminth stool eggs and high Ascaris IgE (egg+IgEhi) was associated 
with the following characteristics: reduction in numbers of all lymphocyte populations, 
frequent eosinophilia, highly activated immune profiles, antigen specific proliferative 
hyporesponsiveness, impaired type 1 cytokine responses in unstimulated and antigen 
stimulated cells and increased TNFα levels.  In HIV infected individuals, the egg+IgEhi 
helminth infection status was associated with lower but not significant CD4+ counts and 
higher viral loads. A strong negative correlation was observed between viral loads, CD4+ 
and CD8+ cells in this subgroup.   
 
Subgroups with high IgE (egg+IgEhi and egg-IgEhi) had elevated Th2 markers with lower 
CD4+ counts and higher viral loads in the HIV+ group. The inverse correlation between 
viral load and CD4+ counts found in all the HIV+ participants was strongest in these two 
subgroups.  
 
Individuals with parasite eggs in stool and low Ascaris IgE (egg+/IgElo) presented a 
modified Th2 profile. This subgroup had high absolute numbers of all lymphocyte subsets 
in both HIV- and HIV+ groups with higher CD4+ counts in the HIV- and lower viral load in 
the HIV+ groups as well as higher interferon gamma, lower IL-4 and higher IL-10.  
 
In conclusion, the results suggest that helminth infections may be associated with 
deleterious effects on the immune responses to HIV in certain groups of susceptible 
individuals. The underlying reasons for the different stool egg/Ascaris IgE combinations 
in settings with high exposure to helminthes is currently not clear but genetic 
predisposition and environmental factors could play a role. Future studies of helminth-
HIV co-infection have to ensure adequate definition of helminth infection status by the 
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use of both stool examination and measurement of helminth-specific IgE as the infection 
phenotype is associated with differential effects on HIV associated immune responses. 
This may also apply to co-infection with other pathogens, including tuberculosis. The 
long-term effect of helminth co-infection in HIV positive people was not assessed in this 





Literature Review: Human immunodeficiency virus (HIV) and helminth co-infection  
1.1 Preamble 
 
Two thirds of the people infected with the Human Immunodeficiency Virus (HIV) 
worldwide reside in sub-Saharan Africa while the majority of the two billion individuals 
infested with helminths are in this same region (UNAIDS/WHO, 2006). In South Africa 
(SA) the estimates for adult (15-49 years) HIV prevalence remained high at 17,5% of  
48,5 million people (the entire population) in 2007 (UNAIDS/WHO, 2008). This makes 
SA one of the countries with the highest HIV prevalence in the world. Although the 
national estimates of helminth prevalence are not known, data from surveys in different 
SA provinces reveal infestation levels ranging between 70.0 -100.0% in school age 
children and preschoolers (Evans et al., 1987; Fincham et al., 1996; Mosala, 2001; 
Mabaso et al., 2004; Saathoff et al., 2005; Wolmarans et al., 2005; Fincham and 
Dhansay, 2006).  
 
Disadvantaged, poor communities who live in densely populated and under serviced 
urban informal settlements as well as in some rural areas carry most of the disease 
burden of the two infections (Bradshaw and Steyn, 2002). Co-infection with HIV and 
intestinal parasites is therefore a major challenge in these settings which comprise a big 
proportion of the country’s population.  
 
Current thinking suggests that chronic infection with helminths exacerbates the HIV 
epidemic in developing countries by increasing susceptibility to the virus, enhancing its 
replication, facilitating faster progression to AIDS and making it more severe compared 
to the disease in the developed world (Bentwich et al., 1995; 1997; 1999; Borkow and 
Bentwich; 2004).  
 
Several aspects of helminthiasis are proposed to contribute to this interaction: Firstly, the 
large extracellular helminths induce a strong humoral response with a Th2 bias, while 
HIV, being an intracellular pathogen initiates a predominantly cell mediated Th1 
response. These two arms of the immune response counter regulate each other such 
that predominance of one arm precludes effective induction of the other (Janeway et al., 
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2001). Secondly, helminth infections persist for protracted periods (life expectancy 
ranges from 1-3 years and 3-5 years for soil transmitted helminths and schistosoma 
adult worms respectively, with rapid reinfection rates (Maizels et al., 1993), thus inducing 
a chronic state of background immune activation; HIV replicates better in activated cells 
(Fauci, 1993; Lawn et al., 2001). Thirdly, helminth infections are documented to result in 
increased expression of CD4 and CCR5 molecules (Secor et al., 2003), both of which 
facilitate virus entry into cells. Lastly, helminths induce generalised immune suppression 
(Borkow and Bentwich, 2004) which increases susceptibility of infested hosts to bacteria 
and viruses. It is partly on this basis then that infection with helminths is suggested to 
create a favorable milieu for HIV to replicate unabated (Clerici et al., 2001; Lawn et al., 
2001; Borkow and Bentwich, 2004). However, some studies elsewhere in the continent 
have found no evidence of improvement of HIV pathogenesis after deworming of co-
infected individuals (Lawn et al. 2000; Elliot et al., 2003; Brown et al., 2004; Modjarrad et 
al., 2005; Hosseinipour et al., 2007) while two have reported a positive impact of worm 
treatment on HIV viral load and CD4+ counts (Wolday et al., 2002; Kallestrup et al., 
2005). A recent systematic review (Walson and John-Stewart, 2007) acknowledges the 
lack of sufficient evidence to confirm the benefits of helminth eradication in co-infected 
hosts. However, these authors indicated that data from one randomized clinical trial 
(RCT) and several observational studies suggest that deworming is of benefit in reducing 
plasma viral load. 
 
Studies analysing immunological interactions between the two infectious agents have 
not been documented in South Africa. An indirect association was drawn from 
deworming of schoolchildren and reduction of eosinophilia (Fincham et al., 2003). The 
present study is thus based on the hypothesis that co-infection with HIV and intestinal 
helminths worsens the pathogenesis of HIV. An attempt is made to investigate some 
aspects of the immune response in the presence and absence of dual infection to 
ascertain if indeed individuals afflicted with both infections are immunologically-




1.2 The Th1 / Th2 Dichotomy 
 
The Th1-Th2 notion defines the ability of the immune response to adapt to antigenic 
challenge and respond with a specific phenotype for different types of antigens, such as 
intracellular or extracellular pathogens. This has significant bearing to the current study 
as it deals with both types of organisms and there is a lot of debate around the role of 
Th1 and Th2 on influencing the pathogenesis of both infections. 
 
In the specific context, CD4+ T lymphocytes differentiate into various functional subsets 
characterized by the profile of the cytokines they produce. Initially the two subsets (Th1 
or Th2) were defined and accepted as central to the Th1/Th2 dichotomy and constitute 
the fundamental immune responses. The regulatory T cells, designated Treg, were also 
described and shown to have immunosuppressive effects (Janeway et al., 2001; 
Fontenot et al., 2003).  Helminths are documented to strongly induce both the Th2 and 
Treg phenotypes (Maizels et al., 2004; Diaz and Allen, 2007). Recently, another distinct 
CD4+ T cell subset has been described, the Th17 cells which produce proinflammatory 
cytokines and play a role in extracellular bacterial infections and autoimmunity (Kurts, 
2007).   Diaz and Allen, (2007) have presented a four dimensional map of the immune 
response profile suggesting that these four cell phenotypes are superimposed and 
coexist in different disease patterns and  counterbalance one another’s effects. 
 
Not all the factors that drive the differentiation of the CD4 T cells into the different 
subtypes are fully understood but several contributors have been indicated such as:  
 
 The type of MHC: peptide complex:  Peptide antigens that interact strongly with 
the T cell receptor and reach high densities on the cell surface induce a Th1 
response, while antigens interacting with a weaker affinity and are presented at low 
concentration induce a Th2 response (Janeway, et al., 2001). Furthermore, since 
antigen presentation occurs in association with MHC molecules, some MHC: 
peptide combinations will favour Th2 while others will have a predilection towards 
Th1 responses. Therefore some individuals with certain MHC alleles will be 
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genetically predisposed to elicit either predominantly Th1 or Th2 responses 
(Janeway et al., 2001).  
 
 The CD4 molecule: The absence of the CD4 molecule on T cells was associated 
with total impairment of Th2 cell development in CD4 deficient mice and in vitro 
transgenic T cells (Brown et al., 1997). This essential role of the interaction 
between CD4 and MHC II molecules in differentiation of Th2 cells was also 
confirmed by Fowell and colleagues (1997).  
 
 The co-stimulatory molecules involved: 
For effective induction of an adaptive immune response against the antigen 
presented to the T cell receptor, ligation of accessory (costimulatory) molecules on 
the same antigen presenting cell to their respective ligands on the T cell is essential.  
In the absence of costimulatory engagement, T cells are partially activated and 
eventually become anergic (Janeway et al., 2001). The influence of costimulatory 
molecules on the type of immune response that develops has been studied in 
various models. For example, in mice, the inducible costimulatory molecule (ICOS) 
was shown to play an important role in the development of Th2 cells (McAdam et al., 
2000).  
 
Ligation of CD40, another costimulatory molecule, reportedly initiates a Th1 response 
through IL-12 and subsequent IFNγ productions (McDonald et al., 2002). CD40 
blockade in human in vitro experiments lead to reduction of the Th1 cytokines, IFNγ 
and IL-12 production (Brodskyn et al., 2001), and its critical role on Th1 cell 
development had also been shown in mice (Campbell et al.,1996; Heinzel et 
al.,1998).  
 
In in vitro and in vivo mouse and rat models, B7-1 (CD80) was shown to favour Th1 
predominance (Kuchroo et al., 1995; Khoury et al., 1996) while CD28 engagement to 
B7-2 (CD86) molecule results in Th2 ascendancy (Ranger et al., 1996; Rulifson et al., 
1997) and this is said to be protective in the control of Th1 mediated autoimmunity 
(Kuchroo et al., 1995; Khoury et al., 1996; Bour-Jordan and Bluestone., 2002). 
 
 5 
Engagement of OX 40 (a costimulatory antigen which is upregulated upon activation 
of T cells) to its ligand is also reported to promote differentiation of Th2 cells (Rogers 
and Croft, 2000). These authors also demonstrated that other accessory antigens 
(the adhesion molecules) also contribute not only to the strength of the activation 
signal but also to the differentiation of the T cells. Binding of Leucocyte Function 
Antigen (LFA) -1 to Intercellular Adhesion Molecules 1 and 2 was shown to 
upregulate Th1 and suppress Th2 differentiation. 
 
While the essence of involvement of costimulatory molecules in immune responses 
lies in ochestrating an effective response that will eliminate the pathogens, it is 
suggested that some organisms have evolved mechanisms of manipulating 
expression of particular costimulatory molecules that will favour their survival in the 
infected host (Brodskyn et al., 2001). The authours demonstrated that Leishmania 
major increased the expression of CD40 and CD80 on macrophages that were co-
cultured with lymphocytes. Their interpretation suggested a strategy by these 
parasites to modulate the immune response to their advantage. 
 
 The cytokine microenvironment that predominates during antigen 
presentation to the T cell: The initial innate response to antigens induces the 
production of the different cytokines, for example, some intracellular bacteria and 
viruses will induce dendritic cells and macrophages to secrete IL-12 (Janeway et 
al., 2001, Rodriguez-Sosa et al., 2002). This cytokine will in turn activate Natural 
Killer (NK) cells to secrete interferon gamma (IFN-γ). IL-12 and IFN-γ will activate 
naïve CD4+ T cells to differentiate into the Th1 phenotype. IFN-γ will inhibit 
differentiation of Th2 cells (Janeway et al., 2001). Extracellular pathogens such as 
helminths will induce expression of CD 1 molecules. These are normally expressed 
by thymocytes, professional antigen presenting cells and intestinal epithelia. CD 1 
molecule expression activates a specialized subset of CD4 T cells known as NK T 
cells because they express the NK 1.1+ marker associated with NK cells. The 
activated NK T cells synthesize and produce IL-4 which induces proliferation of Th2 
cells. IL-4 or IL-10 alone or in combination, will inhibit Th1 cell proliferation 
(Janeway et al., 2001). In another scenario, dendritic cells activate NK1.1+T cells 
via CD1 molecules and lead to production of IL-4 by these. Thus in the presence of 
IL-12, the cell will be stimulated to develop towards the Th1 arm while IL-4 will drive 
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the T  cel l t owards the Th2 profile ( Jordan and Fredrich, 19 87; Janeway et al ., 
2001). Th1 cells produce IFNγ and IL-2, resulting in a predominantly cell-mediated 
response, while Th2 cells produce IL-4, IL-5, IL-10 and IL-13 resulting in a mainly 
humoral response. I ntracellular pathogens i nside m acrophage vesicles will be  
cleared by  m ainly T h1 responses while extracellular pathogens w ill el icit a  
predominantly Th2 response. During the initial interaction with foreign antigens, the 
innate immune cel ls will r ecognise pa thogen associated molecular patterns on 
bacterial surfaces or viral DNA and induce the relevant Th effectors. It is suggested 
that in the absence of these molecular recognition patterns, as occurs in helminth 
infections, dendritic cel ls w ill secrete transforming growth f actor β (TGFβ) which 
upregulates Forkhead box P3 (Fox P3) and induce differentiation of the regulatory 
cells (Fontenot et al., 2003). 
 
The polarised Th1/Th2 arms of immune responses are easily dissected and studied 
in mouse experiments, however, a mixture of the two responses sometimes occurs 
in vi vo in hu mans, especially with some protein an tigens which m ay produce a 
mixture o f pe ptides: so me that i nduce Th1 cells while others induce t he T h2  
phenotype ( Janeway et al ., 20 01). I n that r egard, Picker et al . ( 1995) aptly 
demonstrated that cytokine synthesis networks are more complex in humans than 
the oversimplified distinction of either Th1 or Th2 phenotype. 
 
 Intracellular Factors 
The different intracellular factors that regulate transcription after the antigen-T cell 
receptor interaction has initiated a signal, also play a role in determining the fate of 
differentiating CD4+ T cells.  T he signal t ransducer and activator o f T cell 
transcription factor (STAT) 4 and T-bet together with IL-12  prom ote development 
of Th1 clones while GATA-3, STAT 6 with  IL-4 promote Th2 cell development (Usui 
et al., 2006). Th17 cells are induced by different types transcription factors, namely    
retinoic acid receptor related orphan receptor γt (ROR t), IFN regulatory factor 4    
(IRF-4) and STAT3 (Kurts, 20 07). Differentiation o f Tregs is st imulated by Fo xp 3, 
which in turn is upregulated by expression of TGFβ by de ndritic cel ls d uring the 




 Type of antigen presenting cells 
In mice, antigen presented on B cell surfaces optimally induced proliferation of Th2 
cells while the monocyte macrophage lineages induce Th1 cell clones (Gajewski et 
al., 1991).  
 
 Parasite factors 
Finally, there are suggestions that some helminths manipulate the immune 
response to induce a favourable environment for their continued co-existence in the 
host. These suggestions support the hypothesis that helminth species have 
independently evolved several mechanisms to dampen the inflammatory Th1 
response and thus preferentially induce Th2 biased responses. Maizels et al. (2004) 
in their elaborate review of these mechanisms have demonstrated that several 
helminth species secrete factors that manipulate dendritic cells to produce less IL-
12 and switch to a Th2 phenotype. Similarly alterations in the macrophage 
populations are effected by helminths through induction of alternatively activated 
macrophages, with reduced IL-12 production and increased potential to induce a 
Th2 immune response (Rodriguez-Sosa et al., 2002). 
 
1.3 Overview of the Immune responses to HIV  
1.3.1 Cellular immune responses to HIV 
 
Infection with HIV induces an adaptive immune response like all viruses. However, the 
elicited response rarely eliminates the HI virus, but helps to contain it, particularly during 
the primary and asymptomatic phases of infection. Both CD4+ and CD8+ antigen specific 
T cells directed against various HIV-1 antigens and peptides have been defined in 
different experimental settings (Betts et al., 2001; Imani et al., 2002; Boritz et al., 2004). 
These studies analysed different aspects of the specific responses.The present study is 
based on total quantitation of T cell subsets in unstimulated whole blood and cytokine 
production plus lymphoproliferation in response to HIV p24 and helminth proteins 
(excretory/secretory (E/S) antigen) only and therefore specific responses against 
different HIV or helminth proteins are not discussed in detail. Frequencies of the 
respective cells in relation to HIV are discussed briefly. 
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1.3.1.1 CD4+ lymphocytes 
 
It has been demonstrated that robust HIV-1 specific CD4+ responses, (particularly HIV-1 
gag-specific) in HIV infection are critical in generating and maintaining competent 
cytotoxic T lymphocyte (CTL) functions in viral infections (Matloubian et al., 1994; 
Kalams and Walker, 1998). Paradoxically, the classic immunologic feature of HIV 
infection is depletion of the very CD4+ lymphocytes from the primary stage through to 
AIDS disease.  Several mechanisms have been proposed to be directly or indirectly 
responsible for this phenomenon. These include, among others, direct cytopathic effects 
and virus burden (Connor et al., 1993), functional disorganisation and gradual alteration 
of regenerative capacity of the immune system (Grossman et al., 2006), disruption of 
CD4+ T cell homeostasis and HIV-induced impaired production of T cells by the thymus 
(Douek et al., 2001; Douek, 2003; Gougeon, 2003) and imbalanced cell proliferation and 
cell death rate (Ribeiro et al., 2002). It is probably a combination of all of the events and 
many others taking place simultaneously or consecutively that eventually leads to 
extensive attrition of CD4+ lymphocytes. The common feature of the killing mechanisms 
is the fact that not only HIV-infected cells are affected, but also uninfected bystander 
CD4+ cells are depleted. Some of the prominent hypotheses that are suggested to be 
important contributors to the massive depletion of the CD4+ T cell compartment are 
briefly discussed below. 
 
 Immune activation and associated clonal exhaustion has been strongly implicated 
to contribute to the decline in the CD4+ T cell population. Although the exact 
mechanism by which immune activation depletes CD4 T cells during HIV infection 
remains unclear, this process has been widely cited as a prominent mediator of 
CD4+ T cell depletion, as activation positively associates with disease progression 
(Moanna et al., 1996; Giorgi et al., 1999; Leng et al., 2001; Sousa et al., 2002; 
Hunt, 2007). At basic molecular events, activated CD4+ T cells induce transcription 
factors that are essential for virus replication. The transcription factor NFKβ, that is 
present in all activated cells, binds to both host DNA promoter and viral long 
terminal repeat sequences (LTR) which then initiates viral transcription (Janeway et 
al. 2001). In that way, infected, activated CD4+ T cells can therefore be prone to 
depletion by the viral infection/replication cycle.  
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Leng et al. (2001) and Sousa et al. (2002) showed that CD4+ cell decline is 
significantly and directly linked to immune activation. This association was shown to 
be more significant than that of viral load and CD4+ counts. Bahbouhi and co-
workers (2004) suggested that preferential targeting of Th1 CD4+ by replicating HIV 
could lead to clonal exhaustion of this CD4+ population. The preliminary finding that 
reduction of activation by administration of immunosuppressant cyclosporin A at 
initiation of ART improved CD4+ cell restoration compared to ART regimen initiated 
alone (Rizzardi et al., 2002), strongly supports the notion of immune activation-
induced CD4+ decline. Cyclosporin A inhibits activation of T cells by countering the 
NFAT pathway thereby halting transcription of the IL-2, IL-4 and IL-2 receptor 
genes and thus IL-2 dependent T cell proliferation (Janeway et al., 2001). It was 
also shown that cyclosporin A alters the processing of HIV-Gag proteins (Streblow 
et al., 1998) thus producing non-infective proviruses, therefore the total effects of 
cyclosporin A incorporation into ART reduces viral replication. 
 
The “runaway hypothesis” suggests the vicious cycle wherein the virus induces 
immune activation; immune activation enhances viral replication by increasing cell 
numbers that are susceptible to infection and support replication; as more viral 
particles are produced they in turn infect and activate other cells (Yates et al., 
2007). Using a mathematical model to ascertain if this mechanism can solely 
explain the slow depletion of CD4+ T cells during the chronic phase of infection, the 
authors concluded that other non-mutually exclusive mechanisms are also at play. 
 
Syncytium  formation 
In vitro, HIV infected and uninfected CD4+ T cells have been shown to fuse and form 
syncytia which soon lyse and die (Blanco et al., 2004; Lopez-Balderas et al., 2007). 
This occurs as infected cells express viral Env proteins on their surface. These 
proteins interact with the CD4 molecule and the CXCR4 co-receptor on uninfected 
bystander cells, forming multinucleated giant cells that undergo apoptosis (Castedo 
et al., 2003). Visual proof of the process in vivo has been demonstrated in human 
lymphoid tissue (Orenstein, 2000) and is associated with disease progression. 
Syncytium-inducing (SI) viral strains are known to replicate faster than non-SI strains 
(Callaway et al., 1999) thus both the actual viral turnover and the fusion cytopathy 
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may jointly contribute to the marked decline in CD4+ T cells. This may occur faster 
particularly later in infection as the IL-15 induced transition from non-SI to SI strains 
takes place during the chronic stage of the disease (Callaway et al., 1999).  
 
 Increased apoptosis 
As one of the many strategies of HIV to evade host immune attack, the virus 
produces pro-apoptotic proteins and downregulates anti-apoptotic molecules 
(Badely et al., 2000; Zhang et al., 2001;Yang  et al., 2003; Gougeon,2003; Minami 
et al., 2006; Porichis et al., 2007). Both  the TNF family and the mitochondrial 
apoptotic pathways are induced by the HIV proteins in uninfected and infected cells, 
thus triggering destruction of effective immune control of the virus and contributing 
to CD4+ T cell attrition. The natural host response to increased destruction of T cells 
is manifested by increased turnover (proliferation and differentiation) (Janeway et 
al., 2001). However, the production of several proapoptotic molecules by the 
persistent HIV virus offsets the compensatory T-cell production by destruction of 
progenitors that express the respective receptors and ligands in the thymus, 
periphery and bone marrow (Gougeon, 2003).  
 
In addition to the virus-induced, increased cell death via the extrinsic pathway, the 
intrinsic pathway which is normally induced via the internal sensors in activated 
cells, is also triggered because of the persistent activation by the high virus load in 
the system. Proliferation is also induced on bystander cells with resultant enhanced 
apoptosis (Tough et al., 1996). It has been repeatedly shown that T cells from HIV 
infected individuals are more susceptible to increased apoptosis (Gougeon and 
Montagnier, 1993; Clerici et al., 1996; Gougeon, 2003). 
 
 Excessive viral  protein-induced cytopathic effects  
Persistent viral replication constantly produces viral proteins that accumulate in the 
extracellular compartment and bloodstream. This was shown by investigators in 
early studies of HIV infection: Stevenson and co-workers (1988) demonstrated that 
doubling of gp120 production enhanced cell death after HIV infection. These 
proteins, particularly the envelope glycoprotein complex (gp120/gp41) can act as 
antigens and attach to CD4 molecules on uninfected CD4+ T cells. The antigen-
coated T cells are in turn attacked and killed by the HIV specific cytotoxic T cells 
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(CTL) and antibody-dependent cell mediated cytotoxicity (ADCC) (Gougeon, 2003). 
Cottrezz et al. (1997) also demonstrated that gp 120 on antigen-presenting 
macrophages prime both HIV infected and uninfected T cells to undergo apoptosis. 
 
1.3.1.2 Cytotoxic CD8+ T-lymphocytes  
 
The major histocompatibility (MHC) class-1 restricted cytotoxicT lymphocytes (CTL) 
have been documented to play a pivotal role in the control and sometimes even 
prevention of HIV infection. In many studies, HIV-1 specific CTL responses to single, 
multiple or whole-genome-spanning synthetic peptides and antigens have been well 
characterised. Subsequently, an abundance of evidence suggests that immune control 
of HIV infection is dependent on competent CTL or specific CD8+ responses (McMichael 
et al., 2000; Kiepiela et al., 2004; Addo et al., 2007; Day et al., 2007).  
 
The best direct evidence for the role played by CTL had been repeatedly demonstrated 
in the animal model (macaques) of the HIV simian counterpart. Depletion of CD8+   cells 
in these animals resulted in enhanced viral replication and accelerated disease as 
indicated by increased plasma viraemia (Jin et al., 1999, Metzner et al., 2000). Indirect 
but strongly suggestive evidence for the critical role of CD8+ lymphocytes in humans was 
subsequently derived from several case scenarios: 
 
 During the primary phase of HIV infection, a rapid decline of plasma viral load 
follows the appearance of a CTL response (Borrow et al., 1994; Koup et al., 1994). 
In ex-vivo experiments, Borrow et al.(1994) showed that patients who mounted a 
strong virus specific CTL response effectively controlled viraemia and 
antigenaemia; while waning HIV-specific CTL immunity precedes progression to full 
blown AIDS (Carmichael et al., 1993, Koup et al., 1994; Klein et al.,1995 ). 
 Long term non progressors (LTNP) have been shown to maintain strong, highly 
functional HIV-specific CD8+ cellular responses compared to their progressing 
counterparts (Betts et al., 2006). In another study Valdez et al. (2002) showed that 
LTNP also maintain robust CTL responses to other viruses over and above HIV 
specific immunity. 
 CTL responses are capable of selecting escape mutants which have an increased 
survival potential (Koup, 1994; Borrow et al., 1997; Kiepiela et al., 2004; Leslie et 
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al., 2004). CTL targeting specific viral proteins such as Gag is associated with viral 
control (Masemola et al., 2004). 
 Similarly, HIV seronegative infants born of HIV positive mothers have robust CTL 
responses (Kuhn et al., 2002). 
  Furthermore, a wide variety of populations of exposed but uninfected groups in 
different countries is detailed by different authors. They include HIV negative sexual 
partners in discordant couples (Braganza et al., 2001), highly exposed seronegative 
prostitutes (Rowland-Jones et al., 1998), healthcare workers with occupational 
exposure to HIV infected blood (Pinto et al., 1995) and injection drug users at high 
risk (Beretta et al., 1996). All the groups have been shown to elicit CTL responses 
which are presumably associated with protection against infection. Whether these 
responses are indicators of exposure, or are adjuncts to other yet undefined  
 protective mechanisms or are truly protective on their own, remains to be discerned 
in rigorous studies. So far the argument for the protective role is supported by the 
above cases. 
 
Untreated HIV infected individuals eventually progress to AIDS in the presence of high 
frequencies of CD8+ cells. Recent advances in studies of specific cellular responses 
have provided explanatory evidence for this phenomenon. Essentially, declining 
functional attributes of the CTL response such as proliferation (Boritz et al., 2004; Day et 
al., 2007), lack of fully differentiated memory phenotype (McMichael et al., 2000; Addo et 
al.,2007) and reduced degranulation accompanied by reduced IL-2, IFNγ  and perforin 
production (Betts et al., 2006) have been documented during the chronic phase of 
infection. These explain the eventual loss of the protective role of the CTL response 
despite the presence of CD8+ numbers that remain high during disease progression. 
Therefore, quantitative measurements of CD8+ T cells probably have little prognostic 
value in determining disease progression. 
  
1.3.1.3 Natural Killer (NK) lymphocytes 
 
NK cells are part of the innate arm of the immune response in all viral infections, 
including HIV. Activated by IL-12 and inteferons α and β, they exert their effector 
functions in various manners (Janeway et al., 2001). First they secrete perforin and 
granzymes and induce programmed cell death through Fas ligand and tumour necrosis 
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factor receptors to mediate killing of virally infected cells. Activated NK cells also secrete 
IFN γ which together with IL-12 influence the adaptive immune response towards a Th1 
phenotype for optimum intracellular infection control (Janeway, 2001). NK cells also 
express chemokine receptors CCR5 and CXCR4 which act as chemoattractants to 
recruit more effector NK cells to sites of active replication (Kottilil et al., 2004). In the 
presence of antibodies, through their Fcγ receptors, NK cells also mediate antibody-
dependent cellular cytotoxic (ADCC) killing of antibody coated cells and immune 
complexes (Levy, 1993). This subset therefore plays a critical role in early infection to 
contain viral replication before the adaptive response is invoked and later on act in 
concert with the secondary specific responses. NK cells have been documented to be 
susceptible to HIV infection through their capability to express CD4, CCR5 and CXCR4 
on their surfaces and contribute to the pool of virus reservoir that is poorly accessible 
during antiretroviral therapy (Valentin et al., 2002; Kottilil et al., 2004). 
 
In HIV infection, reports on quantitative assessments of NK cells are inconsistent. In 
1994, Brenner and colleagues indicated that no increases or decreases in NK cell 
numbers had been reported in HIV infection. These authors suggested that those earlier 
studies which reported increases had used a wrong NK cell marker (CD57). However, in 
2000, De Souza and workers found no differences in numbers and function between 
CD16+/CD56+NK cells of HIV seropositive and 3 seronegative patients from Thailand, 
while they reported significant differences between seropositive and seronegative North 
Americans.  Again in 2005 Meier et al. reported reductions in total NK cell numbers and 
function in HIV infected participants. There is therefore a discrepancy regarding the 
numerical changes in this subset in HIV infection.  
 
There is growing evidence however that consistently confirms phenotypic changes which 
are accompanied by functional impairment of NK cells in HIV disease.  A prominent 
finding is a phenotypic switch characterised by decreased numbers of the CD16+/CD56+ 
pool (reportedly the most potent subset) and increased dysfunctional subpopulations. 
Functional defects associated with these changes include reduced cytolytic activity, 
impaired cytokine production, upregulation of expression of inhibitory receptors and 
CCR5 and diminished perforin secretion (Hu et al., 1995; De Souza et al., 2000; Kottilil 
et al., 2004; Mavillo et al., 2005; Meier et al., 2005). These effects were commonly found 
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in most viraemic participants (Kottilil et al., 2004; Mavillo et al., 2005), which were 
reversed to normal by antiretroviral control of virus replication (Kottilil et al., 2004). 
1.3.1.4 B lymphocytes 
 
The role of B cells (and inherently the humoral response) with regards to protection 
against HIV infection and progression to AIDS is still ill defined. Also, to date, it has not 
been shown that HIV directly infects B cells. Most studies indicate that B cell/HIV 
interactions occur on the surface through receptors such as CD21 (Moir et al., 2000) 
and DC-SIGN (Rappocciolo et al., 2006).  
 
Functional and phenotypic disturbances of these cells had been well described from 
early after the discovery of HIV/AIDS (Lane et al., 1983; Schnittman, et al., 1986). The B 
cell changes associated with HIV/AIDS include polyclonal activation associated with 
hypergammaglobulinaemia and impaired specific antibody production (Moir et al., 2001; 
De Milito et al., 2004), decreased expression of CD21 (Moir et al., 2001), increased 
susceptibility to apoptosis (Ho et al., 2006), loss of memory cell pool (Viau et al., 2007, 
Hart et al., 2007), impaired proliferation in response to B cell stimulants (Moir et al., 
2001). A common characteristic of B cell dysfunction manifests as autoimmunity in AIDS 
(Levy, 1993). 
 
The less defined protective role of B cell immunity in HIV is juxtaposed with evidence for 
its ability to promote infection of CD4+ cells and their contribution to the uninfected 
reservoir (Moir et al., 2000). Through their CD21 receptor, B cells isolated from tonsils 
and peripheral blood were found to be equally capable of transferring HIV to activated, 
HIV negative PBMC’s as CD4 + cells ( Moir et al., 2000). Similarly, Rappocciolo et al. 
(2006) demonstrated that a proportion of B cells from peripheral blood and tonsils of HIV 
infected and uninfected patients, expressing DC-SIGN were able to transfect CD4+ cells 
via this receptor. The authors noted that through their migratory pattern in blood and 
intimate interaction with T cells, this B cell subset may have a significant role in 
transferring the virus to CD4+ cells.    
 
Increased turnover of B cells, which is marked in advanced disease, has been 
demonstrated in the macaque-SIV model (De Boer et al., 2003). Increased expression 
of the CD5 molecules occurs on B cells as disease progresses. This phenotype has 
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increased susceptibility to apoptosis (De Milito, 2004) which may explain in part the 
finding of decreased numbers and percentages of B cells in advanced HIV infection 
(Grunewald et al., 1999). 
  
1. 3.2 Humoral Responses to HIV 
 
1.3.2.1 Antibody responses 
 
Within 4-8 weeks after infection, neutralising antibody responses against the envelope 
glycoprotein gp 120, the exposed portion of gp 41, and the core proteins p24/p17 are 
elicited (Levy,1993). The protective ability of these neutralising antibodies (nAbs) is a 
contentious issue. Earlier work suggested a protective role, particularly as demonstrated 
in HIV-1 infected long-term non-progressors. Pilgrim et al. (1997) in their comparative 
study, concluded that neutralising antibodies from LTNPs were more likely to neutralise 
heterologous and autologous strains than sera obtained from fast progressors. Likewise 
Zhang and colleagues (1997) reported lower viral load, controlled viral replication and a 
broader, higher neutralising activity of LTNPs sera compared to sera from fast 
progressing counterparts. In an animal model, Ciurea et al. (2000) showed that 
neutralising antibodies were capable of suppressing viral replication and clearance in 
transgenetic mice infected with lymphocytic choriomeningitis virus in the absence of 
CTL.  Further studies attributing antibody responses to long term non-progression were 
still reported in recent times (Montefiori et al., 2001; Burastero et al., 2006). 
 
Around the same early period (1997), other studies associated a negative contribution of 
humoral response to HIV immunity. ADCC killing mediated by gp120 immune complex-
NK cell interaction was strongly correlated with rapid CD4+ decline and high virus load 
(Skowron et al., 1997). A deleterious effect of antibody response was also shown by 
Homsy and colleagues (1989) who revealed that AIDS patients elicit antibodies that 
enhance viral replication through complement receptor interactions rather than 
neutralising ones.  
 
The generation of escape mutants by neutralising antibodies has been well documented 
(Tremblay and Wainberg, 1990; Skrabal et al., 2005). These antibodies then become 
irrelevant to autologous strains within the same host, and within contemporary strains, 
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thereby casting doubt on the protective role of these antibodies. Recently, Bailey et al. 
(2006) found lower titers of neutralising antibody in sera from LTNPs and HAART 
exposed patients compared to treatment naïve, viraemic patients. They concluded that 
neutralising antibodies are not essential for viral suppression in long term non 
progressors, particularly at low virus levels, suggesting that low copies probable do not 
reach the stimulation threshold to induce and maintain effective neutralising antibody 
responses. 
 
In 2004, Chien et al. reported that patients with high levels of antibodies directed against 
the CD4 binding domain (CD4bd) of the HIV-1 gp 120 protein progressed faster than 
those with lower anti-CD4bd antibodies. The explainatory mechanism is that binding of 
anti- CD4bd inhibits gp 120 presentation to HIV-1 specific CD4+ cells, with a resultant 
attenuation of the envelope-specific lymphoproliferation responses. 
 
The above studies indicate that the role of antibody responses in controlling and possibly 
preventing HIV infection so far remains limited. 
 
1.3. 2. 2 Cytokine responses 
 
The dearth of information on cytokine responses in HIV infection is updating rapidly, thus 
an exhaustive review would be beyond the scope of this work. A brief overview of key 
influences of the main ones is therefore outlined below. 
 
Intracellular (viral) infections, including HIV-1, typically induce Th1 cytokine responses 
such as IL-12, IL-2, IFNγ and TNFα (Lawn et al., 2001). During the innate immune 
response, virally-infected cells produce interferons (IFN) α and β, which activate and 
stimulate NK cells which in turn secrete IFNγ, among other functions (Janeway et al., 
2001). During the primary stage of HIV-1 infection, the expansion of CD8+ cells is 
accompanied by a rise in IFNγ (McMichael et al., 2000; Addo et al., 2007) and the HIV-1 
gp120 glycoprotein directly induces the proinflamatory cytokine TNF α production by 
mononuclear cells (Clouse et al., 1991). A host of other cytokine networks are induced 
during the primary phase of HIV infection, some of which are listed in Table 1 and their 
effects on HIV replication are summarised therein. 
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Table 1 The different cytokines, their sources of production and effects on HIV replication 
in T-cells, PBMC, macrophages and CD4+ cells. Some data was adapted from other studies 
listed in the original source. Reproduced with permission of JA Levy (Levy, 1993 and the 
Copyright Clearence Center, Licence Number 2265850206530) 
 
 
bData on acute HIV-1 infection of the cells listed are presented. The number of arrows indicates an increase (↑) or 
decrease (↓) in virus production. A line through the arrow indicates a slight effect. In limited studies, macrophage-colony-
stimulating factor (M-CSF) increased HIV replication in primary macrophages and granulocyte-colony-stimulating factor 
(G-CSF) enhanced HIV production in CD4+cells. cHigh concentration only. d NT not tested.  
(Source: Levy JA. 1993. Pathogenesis of Human Immunodeficiency Virus infection. Microbiological Reviews. 57(1)183-
289). 
 
It is suggested that as HIV infection progresses, a switch from Th1 to Th2 predominance 
ensues (Clerici and Shearer, 1993; Klein et al., 1997). Using flow cytometry and 
intracellular cytokine staining, Klein et al. (1997) demonstrated this shift at single-cell 
level. These changes have several negative implications with regards to containing the 
HIV infection: (i) Th2 cytokines IL-4 and IL-10 downregulate Th1 cell proliferation and 
differentiation (Janeway et al., 2001). As alluded to in the preceding section, Th1 (CTL) 
responses are critical for virus control (ii) IL-2, (a Th1 cytokine) is a potent inducer of 
CD4+ proliferation (Janeway et al., 2001; Valdez et al., 2003). Its reduction or elimination 
thus exacerbates attrition of this lymphocyte pool. Increased production of IL-4 has been 
demonstrated in HIV infected individuals (Waldrop et al., 1997; Klein et al.,1997) and  
was also shown to induce phenotypic changes from non-syncytia to syncytia inducing 
viral strains that are known to be associated with disease progression and poor 
prognosis (Valentin et al.,1998) (iii) Th1 cytokines (IFNγ and IL-2) were shown to inhibit T 
cell apoptosis, while IL-4 and IL-10 either enhanced or had no effect on programmed cell 
death (Clerici et al., 1994).  In summary, these studies concur with earlier assertions that 
the Th1 to Th2 ascendancy is associated with poor prognosis, or that a balanced Th1/Th2 
response is associated with better control of viral replication (Imami et al., 2002).  
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It has to be noted, however, that some Th1 cytokines are documented to favour HIV 
replication, for instance the proinflammatory cytokine, TNFα (Poli et al., 1990; Lawn et 
al., 2001). On the other hand, some scientists express caution about oversimplifying the 
Th1/Th2 dichotomy in humans (Allen and Maizels, 1997). It has been suggested that a 
mixture of the two phenotypes is likely to occur, when some peptides induce Th1 and 
others Th2 responses during the same infection (Janeway et al., 2001).  
 
Others have not found a Th1 to Th2 shift in HIV disease progression: In early studies, 
peripheral blood mononuclear cells (PBMCs) and lymph node mononuclear cells from 
HIV infected individuals were analysed for constitutive cytokine production. Both IFNγ 
(Th1) and IL-10 (Th2) were expressed at high concentrations at all stages of infection 
while IL-2 (Th1) and IL-4 (Th2) were undetected. No evidence of Th1-Th2 switch was 
demonstrable in this study (Graziosi et al., 1994). In that same year, Maggi et al. (1994) 
demonstrated that HIV does not induce a definite Th1/Th2 shift, but rather a shift to Th0 
clones producing both types of cytokines. Later, Tanaka and colleagues (1999) reported 
a decline in IL-2 producing cells without changes in other cytokines and no shift in the 
Th1/Th2 response in HIV infected donors.  
 
In 2000, Sabbaj et al. evaluated vaccine induced cytokine production in PBMC of healthy 
HIV seronegative donors at mRNA and protein levels. All prime-boost candidates 
secreted both IFNγ and IL-10,   > 80% had detectable levels of IL-2, IL-5 and IL-6 while 
>70% secreted IL-4. Again this study revealed a mixed (Th1/Th2) cytokine response in 
these vaccinated individuals. Recently, Bahbouhi et al. (2004) delineated productively 
infected and bystander (HIV exposed but p24 negative) cells to study the effects of virus 
replication on cytokine profiles and activation/apoptosis. Their findings suggested that 
HIV either preferentially replicates in Th1 rather than Th0 or Th2 cells or upregulates Th1 
cytokines. They further suggested that this may result in the depletion of the Th1 clones.  
Their findings suggest that later as disease pogresses and when the Th1 clones are 
depleted, Th0 and Th2 would predominate, a notion that would superficially concur with a 
Th1- Th2 switch.  
 
It is thus clear that the issue of HIV Th1/Th2 or Th0 is more complex and dynamic than 
previously thought. Therefore as with most aspects of HIV immunology, there is 
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conflicting evidence regarding the Th1/Th2 differentiation during HIV infection and 
progression to AIDS.  
 
Maek-A-Nantawat (2007) reported that HIV infection is associated with significantly 
increased IL-17 in CD4 positive and negative  cells , and most recently, the TH17 
phenotype was shown to be selectively lost in the gut mucosa of HIV infected individuals 
(Brenchley et al., 2008). This finding partly explains the recurrent gastrointestinal 
pathology associated with AIDS disease because the Th17 cells play a critical role in 
immune responses to extracellular bacteria. More research on the role of these cells in 
the pathogenesis of HIV was still ongoing when these findings were published.  
1.4 Helminthiasis and overview of their immune responses 
 
1.4.0 Epidemiology of helminths 
 
 Distribution and prevalence   
 
Approximately two billion people worldwide are infested by soil transmitted helminths 
that include the geohelminths, schistosomes and filarial worms, the vast majority of 
whom are in developing countries (World Health Assembly, 2001) and individuals who 
are affected, frequently harbour more than one species of worm (Bundy et al., 2000).  
School-age children and preschoolers are documented to carry the heaviest burden of 
helminths, hence morbidity and mortality of sTH infections have always been associated 
with children (Drake et al. 2002). The age dependent distribution of helminths has been 
cited by some to be a result of the development of immunity over time from repetitive 
exposures (Maizels et al., 1993). 
 
The majority of these infections vary from light to moderate, while 80% of the heavy 
infections are carried by 20% of the infected population (Maizels et al., 1993). Among 
others, genetic predisposition to high worm burdens has been reported to be responsible 
for the overdispersed distribution of these infections (Quintell, 2003). 
It is noted that some local studies-Western Cape (Adams et al., 2006) KwaZulu Natal 
(Kwitshana et al., 2008)  have revealed high prevalence of helminth infections in adults, 
 20 
suggesting that under conditions of poverty, overcrowding and poor sanitation, these 
infections are just as high in adults as in children.  
 Life  expectancy and transmission 
These vary from species to species, for example adult schistosome worms can live for 
up to five years in the host in the absence of chemotherapy. Onchocecaria volvulus has 
a life expectancy of up to 8-10 years while Ascaris lumbricoides is one year.  Those with 
a short life cycle have a faster re-infection rate after chemotherapy and are highly 
fecund, for example an adult Ascaris female can produce 200 000 eggs per day (Maizels 
et al., 1993). 
Geohelminths cycle via pollution of the soil (earth) by human faeces. In the case of 
schistosomes, water is polluted by urine and/or faeces. These epidemiological cycles 
have been exacerbated because large numbers of people are living in densely 
populated slums (informal settlements) without adequate sanitation or clean water, 
owing to rapid urbanisation and migration (Bundy et al., 2000). In developed countries, 
the general availability of clean water and effective sanitation has eliminated most of 
these parasites. Climate, soil and other geographical parameters determine the optimum 
transmission of different parasites (Mabaso et al; 2004). In addition, other factors such 
as personal hygiene, occupational behaviour and level of exposure also determine 
infection and transmission. 
 
Lastly, the key features of gastrointestinal nematode infections that are intriguing were 
aptly described by Maizels et al., (1993) and include: 
 
 The persistent nature of these infections despite evidence of host immune responses 
which implies that the parasites have evolved effective immune evasion 
mechanisms. 
 The size and complex life cycles of these parasites means that the host is 
challenged by many and varied parasite antigens for protracted periods of time. 
 The non-specific immunosuppression which is a universal feature of helminth 
infections. This may largely explain the increased susceptibility to bacterial and viral 
infections in parasite-infested individuals.  
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1.4.1 Humoral immune responses to helminth infections 
 
1.4.1. 1 Cytokine responses to helminth infections 
 
Classically, the immune response to intestinal nematodes (helminths) displays Th2 type 
cytokine predominance, characterized by elevated total and parasite-specific 
immunoglobulin (Ig) E and IgG, eosinophilia and increased mast cells (Rothenberg, 
1998; Faulkner et al.,2002; Geiger et al.,2002). This predominance of Th2 cytokines has 
been suggested by some to be closely associated with a protective immune response in 
both animals (Else and Finkelman, 1998, Roitt et al., 1990) and humans (Maizels et al., 
1993; Turner et al., 2003; Jackson et al., 2004; Lertanekawattana et al., 2005). 
 
Typical cytokines involved in parasite immunity include IL-4, IL-5, IL-9, IL-10 and IL-13 
(Gopinath et al., 2000;Turner et al., 2003; Borkow and Bentwich 2004; Jackson et al., 
2004; Maizels et al., 2004 ; Lertanekawattana et al., 2005). It is not clear what the key 
role of this Th2 dominance is. One school of thought holds that it is to protect the host 
from re-infection (Else and Finkelman, 1998; Turner et al., 2003; Jackson et al., 2004; 
Lertanekawattana et al., 2005), while others suggest that it is a parasite-induced 
mechanism of escaping inflammatory Th1 attack or a combination of host-parasite 
induced survival strategies (Yazdanbakhsh et al., 2001;Maizels and Yazdanbakhsh 
2003).  
 
1.4.1.2 IgE antibody 
 
IgE is the classic humoral component of host protective immune response against the 
helminthic parasites (Roitt et al., 1990; Rihet et al., 1991; Dunne et al., 1992). Proteases 
released by helminth parasites for tissue invasion promote Th2 responses and hence IgE 
production (Janeway et al. 2001), therefore levels of this antibody are markedly 
increased in parasitic infestation. The mechanism of parasite killing involves eosinophils 
and mast cells. Parasite specific IgE coats parasites and renders them susceptible to 
killing by eosinophils as described in 1.4.2.2 below. Mast cells degranulate after their 
receptors are cross-linked by IgE. Release of substances such as eosinophil 
chemotactic factor (ECF), prostaglandins and mucus-inducing agents ensues. IgE is 
widely documented to be associated with protection against helminth reinfection (Rihet 
et al., 1991; Dunne et al., 1992; Faulkner et al., 2002; Geiger et al., 2002; Brake, 2003; 
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Maizels and Yazdanbakhsk, 2003; Turner et al., 2003; Jackson et al., 2004; 
Lertanekawattana et al., 2005) 
 
Two mechanisms involved in IgE production include the induction of Th2 responses and 
initiation of isotype switch to IgE. Both are derived from activated CD4+ Th2 cells. The 
DNA rearrangements that occur during isotype switching from μ+δ+ to ε+ are influenced 
by the cytokines secreted by CD4+ Th2 cells, particularly IL-4 (Janeway et al. 2001).  
Production of IgE is thus dependent on IL-4. Mutations in the α chain of IL-4 as well as 
gain in function, are associated with excessive IgE production. 
 
Other antibodies play a role in helminth parasite immunology and these include the IgG 
subclasses, IgM and IgA (Janeway et al., 2001). 
 
1.4.2 Cellular immune responses to helminth infections 
 
In principle, several cells interact in orchestrating the overall response and their roles 
during helminth infections are briefly described below. 
 
1.4.2.1 CD4+ T cells 
 
CD4+ T cells play a critical role in the control of intestinal helminth infection. Upon 
stimulation by helminth antigens, T lymphocytes are generated early in infection and 
elicit a secretory response (Osborne and Devaney, 1998; Betts et al., 2000; Brake, 
2003). The eosinophil stimulation promoter (ESP) is secreted by the activated T cells, 
which in turn stimulate eosinophil proliferation. Similarly, the lymphocyte chemoattractant 
factor (IL-16), which is produced by activated CD4+ lymphocytes, binds eosinophils via 
CD4 and induces their migration (Rand et al., 1991; Ferland et al., 2004). Furthermore, 
the activated T cells act on mucus-secreting goblet cells to facilitate helminth expulsion 
from the gut (Roitt et al., 1990, Brake, 2003). 
 
Several animal models of helminth infections have revealed the pivotal role of CD4+ T 
cells during intestinal helminth infections. In nude athymic mice, no IgM, IgG and IgE 
antibodies were detected and helminth expulsion was delayed in these T cell-deficient 
mice (Vos et al., 1983). Similarly, it was shown that recruitment and development of 
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other cells such as intestinal mast cells and goblet cells are dependent on T cells (Vos et 
al., 1983; McDermott et al., 2001). Furthermore, CD4+ cells alone were shown to effect 
helminth expulsion and confer resistance to Trichuris muris in complete absence of 
antibody (Else and Grencis, 1996).  Additionally, deletion of CD4+ T cells resulted in 
abrogation of protective immunity in BALB/c mice infected with the helminth 
Heligmosomoides polygyrus (Urban et al., 1991). These authors concluded that CD4+T 
cells regulate host protective immunity, helminth fecundity and IgE levels. Prowse et al. 
(1978) also illustrated that nude (hypothymic) mice failed to clear Nematospiroides 
dubious helminths and injection of T cells into the nude mice positively correlated with 
increased antibody levels. In mice, schistosomiasis antigens invoked a CD4+ T cell- 
driven response towards Th1 with more severe pathology or towards a Th2 with milder 
form of pathology (Stadecker et al., 2004). These studies show that a full complement of 
T cells is essential for development of resistance to the infective stages of the helminths. 
 
Although the plethora of information on the important role played by T cells in intestinal 
helminth infections has been derived from laboratory animal models (Prowse et al., 
1978; Vos et al., 1983; Urban et al., 1991; Else and Grencis, 1996; Else and Finkelman, 
1998), human studies have also confirmed these findings. In 2003, Turner and co-
workers undertook a cross-sectional community study in which they showed that Th2 
cytokines were associated with reduced helminth burdens with increasing age. 
Furthermore, in their review of the role of IL-13 (a Th2 cytokine) Grencis and Bancroft 
(2004) re-affirmed that CD4+ Th2 cells play a central role in generating protection in both 
laboratory systems and humans in intestinal nematode infections. Evidence of 
decreased CD4+ T cells was reported in humans chronically infested with intestinal 
helminth parasites (Kalinkovinch et al., 1998).  
 
 
1.4.2.2. The role of eosinophils 
 
Eosinophils comprise 2-5% of the total leucocyte pool in healthy, non-atopic individuals. 
These cells are key effector cells which play a specialized role in immunity to helminths 
(Janeway et al., 2001). Although they are capable of phagocytosing and killing ingested 
microorganisms, this does not appear to be their primary function (Roitt et al., 1990). 
Their ability to degranulate and release their cytotoxic granule contents (mainly the Major 
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Basic Protein-MBP) and kill their targets, is best suited for the large targets such as 
helminths which cannot be phagocytosed (Roitt et al., 1990).    
 
Eosinophil differentiation from the pluripotent stem cell is induced by IL-5, and their 
attraction to tissues is controlled specifically by eotaxin-1 and eotaxin-2 
(Rothenberg,1998) and IL-16 (Ferland et al.,2004)  although other non-specific cytokines 
such as the platelet activation factor, leukotriene B-4 and granulocyte-monocyte colony 
stimulating factor are also chemotactic for eosinophils (Roitt et al., 1990). Parasite killing 
by eosinophils is effected by antibody dependent cytotoxicity through release of toxic 
granule contents (Brake, 2003). Eosinophils can adhere to schistosome helminths, 
degranulate and release cytotoxic granules thereby killing the schistosomules (Roitt et 
al., 1990).    
  
Eosinophils interact with a variety of cells and IgE to mount the effective responses to 
helminths. Macrophages, being the first cell line of defense, interact with parasite 
antigens and present them to T cells (Rodriguez-Sosa et al., 2002). Parasite-activated T 
cells produce the stimulatory cytokines such as IL-5, which induces differentiation of 
eosinophils from the pluripotent stem cells (Maizels and Yazdanbakhsk, 2003). The 
eosinophil stimulation promoter (ESP) which induces eosinophil proliferation is also 
produced by parasite-antigen specific T cells. Mast cells that are sensitized by anti-
parasite-IgE degranulate and secrete eosinophil-chemotactic factors (Brake, 2003; 
Maizels and Yazdanbakhsk, 2003). 
 
 
1.4.2.3 The role of B cells  
 
Many parasite antigens act as B cell mitogens, resulting in polyclonal B cell stimulation 
and proliferation. Subsequently, in addition to high levels of parasite-specific IgE, non-
specific hypergammaglobulinaemia occurs in parasite infections (Hagel et al., 2003) 
Characteristically, total IgE (as well as IgM and IgG) rise above normal levels. Such 
polyclonal stimulation can result in diminished levels of specific IgE antibody. This is 
viewed as a means of evading the host’s response by the parasites (Lynch et al., 1998). 
The continuous antigen exposure and polyclonal stimulation of B cells is believed to lead 
to impairment of B cell function, progressive depletion of antigen-reactive B lymphocytes 
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1.4.2.4 Natural Killer (NK cells) 
 
NK cells form part of the large granular lymphocytes and are phenotyped by expression 
of the CD16/CD56 molecules on their surfaces. Their role in helminth infections is not 
well defined. However, a few studies have reported associations between NK cells and 
helminthiasis. Enhanced NK cell activity was demonstrated in murine trichinellosis 
(Niederkorn et al., 1988), while a marked concentration of these cells in pleural cavities 
of mice with filariasis was observed (Korten et al., 2002). The same study suggested a 
potential cytotoxic function of the NK cells due to their direct adherence to adult 
helminths. In humans, a case of NK cell lymphocytosis associated with chronic 
strongyloides infection was reported by Myers and co-workers (2000).  
 
In human schistosomiasis, different correlations between NK cell activity and infection 
were reported. While Feldmeier et al. (1985) reported decreased NK cell function with 
increasing helminth burden among infected children in Sudan, Barsoum and colleagues 
(1984), however did not find changes in circulating NK cell activity in two parallel studies 
in Egypt and Brazil. On the other hand, upon reviewing relevant literature Wynn and 
Cheever (1995) concluded that NK cells play a critical role in controlling granuloma 
formation by schistosome eggs. The suggested mechanism is through early production 
of interferon gamma by these cells with a resultant down regulation of Th2 cytokines. 
  
These inconsistent reports warrant further investigation of the role played by this 
population of cells in helminth infections. 
1.5. Other host factors that affect the host immune response 
  
 Nutritional status  
Malnutrition is recognised as the most common cause of immunodeficiency 
(Bachou et al.,2006)). The most common forms being protein-energy and 
micronutrient deficiencies are associated with impairement of all the critical 
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functions of the immune system such as antibody and cytokine production, cell 
mediated responses, phagocytosis, complement system, and secretory IgA 
(Cunningham-Rundles et al.,2005).  
 
 Immunosenescence 
The natural  decline of immune competence brought about by aging is associated 
with prolonged exposure to various antigenic challenge, DNA oxidative stress, 
thymic atrophy, impaired haematopoiesis, alterations in T and B quantity and 
function, changes in both innate and acquired immunity which all result in the 
impaired capacity to respond to infection by the elderly (Carusa et al., 2009). 
 
 Microbial translocation  
The migration of the gut flora to other organs has been implicated as a cause of 
systemic immune activation. Disruption of the intestinal mucosal barrier as occurs 
in haemorragic shock, thermal injury, malnutrition, antibiotic administration, 
cytotoxic drugs and total parenteral nutrional supplementation facilitate the 
translocation of the gut microorganisms to other sterile sites and cause 
generalised immune activation and inflammatory processes.  (Ancuta et al., 
2008). The mechanism was earlier confirmed by Brenchely and colleagues 
(2006) in both animal model of Simian immunodeficiency infection of macaques 
and chronically HIVinfected humans.The overall outcome is compromised 
responses to infections and septicaemia that can sometimes be fatal. 
 
 Genetic predisposition  
The association of some diseases with possession of certain HLA antigens (such 
as ankylosing spondylitis and HLA-B7) is an example of the immunologic genetic 
predisposition phenomenon that has been described to explain differences in 
susceptibility to various infections in different individuals (Roitt et al., 1990). 
 
 Other pathophysiologic factors such as chronic stress, which persistently 
stimulates the pituitary-hypothalamic-adrenal-axis and increased glucocorticoid 
circulation (Reiche et al., 2004), prolonged alcohol abuse and pregnancy also 
result in an impaired immune system of the host.  
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1.6. Proposed mechanisms by which helminths influence HIV pathogenesis 
 
The central events in helminth infections that are proposed to be co-factors in HIV 
pathogenesis and transmission are: 
 Persistent exposure of the host immune system to parasite antigens resulting in 
chronic activation 
 Generation of a strong humoral (Th2 biased) response 
 Induction of generalised and specific immunosuppression and increased 
apoptosis 
Such a milieu of background immune activation and dysregulation is suggested to 
contribute in various ways to HIV entry, replication and dissemination, and some of 
the underlying mechanisms as documented are discussed briefly. 
 
Chronic immune activation resulting from prolonged exposure to helminths is widely 
described by the Israeli workers who extensively studied the immune profile of the 
thousands of Ethiopian immigrants, the majority of whom were infested by helminths 
upon their arrival in Israel. Their work, which originated in the ninenties (Bentwich et al., 
1995, 1996, 1997, 1999, 2000; Shapira-Nahor et al., 1998; Borkow et al., 2000; 
Kalinkovinch et al., 2001; Leng, et al., 2001) and a review by Borkow and Bentwich, 
2004 propose evidence for an adverse impact of helminthiasis on HIV pathogenesis. In 
these studies, evidence for helminth infection-induced activation was shown by 
increased expression of activation markers HLA-DR on CD3, CD4+ and CD8+, and 
increased levels of CD38 on CD8+ cells and CTLA-4 on T cells as well as neopterin and 
β2 microglobin. A strong association between chronic activation by helminths and 
dramatic spread of HIV has also been suggested in other settings as well (Burkina Faso, 
Ghana, Guyana, Uganda, Nigeria, Sierra Leone, Kenya, Italy and North American 
residents (Rizzardini et al., 1998; Clerici et al., 2000, 2001; Gopinath et al., 2000; Secor 
et al., 2003).  
 
Simultaneous initiation of antiretroviral therapy (ART) and administration of cyclosporin A 
improved CD4 counts restitution in HIV infected individuals compared to their ART-only 
counterparts (Rizzardi et al., 2002). This finding strongly supports the negative 
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relationship between immune activation and HIV pathogenesis, and implications thereof 
for helminthiasis-induced HIV aggravation. 
 
The activated state in immune cells is postulated to enhance viral replication, 
transmission and disease progression by various mechanisms. Examples include altered 
cytokine environment, increased HIV receptors (chemokine receptors and CD4 
molecules), increased cell anergy and increased apoptosis resulting in decreased 
antiviral activity (impaired CTL and chemokines). Indeed immune activation was 
demonstrated to be a determinant of HIV progression (Mahalingam et al., 1993; Giorgi et 
al., 1999) while also, immune activation was shown to correlate better with disease 
progression (as measured by CD4 decline), than viral load (Leng et al., 2001). Kassu et 
al., 2003 showed that treatment of intestinal parasites in Ethiopians resulted in reduction 
of the activation, thus providing strong suggestive evidence for the link between helminth 
infection and predisposition to HIV, and severe pathogenesis after such infection. 
 
1.6.1 Virus entry 
 
HIV uses the CD4 molecule and the β chemokine receptor CCR5 for entry into cells to 
initiate infection. Upon receiving stimulatory signals, CD4 molecules are increased on 
the cell surface and remain high on activated cells (Fauci, 1993, Janeway et al., 2001).  
 
Increased expression of CCR5 associated with immune activation in areas of high 
parasitic endemicity has been reported. Clerici et al. (2000) compared expression of this 
receptor on PBMC’s of Africans and Italians living in rural Uganda to levels of expression 
on similar population groups living in Italy. Immunophenotyping and mRNA PCR of 
CCR5 showed elevated CCR5 levels in Africans and Italians living in Africa but not in 
Africans living in Italy. The authors concluded that the increased CCR5 expression was 
not genetic but environmentally-driven, and is a determinant of the prevalent R5 virus 
strains in sub-Saharan Africa. Likewise,  Kalinkovinch and colleagues (1999, 2001) 
ascribed increased CCR5 expression to activation associated with chronic helminth 
infection as well as a possibility of a genetic trait among immigrant Ethiopians moving to 
Israel from an area of high parasite prevalence. Secor et al. (2003) also reported 
increased expression of both CCR5 and CXCR4 on CD4+T and mononuclear cells 
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among schistosomiasis-infected Kenyan car washers compared to those who had been 
treated.  
 
Under conditions of abnormal immune activation, CCR5 may also be increased on 
uninfected cells, thereby increasing their susceptibility to HIV infection (Wahl et al., 
1999).  Sozzani and colleagues (1998) also confirmed by an in vitro study that IL-10 
increases the expression of CCR5 on monocytes and also enhanced the productive 
infection of these cells by the macrophage-tropic HIV Bal strain. Furthermore, an animal 
model of helminth infection showed that these parasites induce a subset of alternatively-
activated macrophages which are characterised by (inter-alia), increased expression of 
CCR5 during the chronic phase of infection (Rodriguez-Sosa et al., 2002). 
 
Eosinophils are the most prominent cellular component of parasite immunity, hence 
helminth infections are the main cause of eosinophilia in developing countries 
(Rothenberg, 1998). Earlier studies had shown that eosinophils express CD4, bind the 
HIV gp120 protein and are indeed infectable by HIV (Lucey et al., 1989; Freedman et al., 
1991). This is in keeping with the finding that HIV-1 infected eosinophils transiently 
expressed the viral core protein p24 and the subsequent conclusion that these cells may 
act as host cells for HIV-1 (Conway et al., 1992). IL-16, a CD4+ cell chemoattractant, 
was shown to increase surface expression of the CD4 molecules on eosinophils while 
also promoting their migration (Ferland et al., 2004).  It is therefore possible that during 
chronic helminth infection, recruitment of activated eosinophils to the genital and rectal 
tracts may provide an additional entry portal for HIV during hetero-and homosexual 
contact respectively. 
 
Thus it is clear that helminth-induced increased expression of the CCR5 co-receptor on 
lymphocytes, macrophages, and eosinophils, (all of which are known to be host cells for 
HIV) combined with increased expression of CD4 molecules on lymphocytes, monocytes 
and eosinophils may enhance virus entry and transmission. 
 
Furthermore, immune responses to Schistosoma haematobium are suggested to 
enhance HIV transmission and pathogenesis. The pathological sequelae of 
schistosomiasis by egg sequestration in the genital tracts are hypothesised to increase 
virus shedding to semen  through increased inflammation (Leutscher et al., 2000) and in 
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female genital schistosomiasis syndrome (Poggensee and Feldmeir, 2001; Mosunjac et 
al., 2003).   
 
Based on these reported studies, and the findings that (i) CCR5 is preferentially 
expressed more on CD45RO+ (memory) than CD45RA (naïve) T lymphocytes (Bleul et 
al., 1997; Kalinkovinch et al., 2001), (ii) HIV replicates better on memory than on naïve 
lymphocytes (Fauci, 1993; Spina et al., 1997),  (iii) marked increase in the proportion of 
CD4+ CD45RO+ occur during chronic helminth infections (Kalinkovinch et al., 1998) 
support the proposition that chronic immune activation in persons living in regions of high 
helminth prevalence may be responsible for increased CCR5 expression that 
subsequently enhances virus spread.  However, findings by Patterson and colleagues 
(1998, 1999), which correlate immune activation with downregulation of CCR5 
expression, (downregulated by IL-10) is by our inference contradictory. Whether the fact 
that these authors were using PBMC’s isolated from individuals residing in areas of low / 
no helminth infections is relevant in the context of helminth-induced upregulation of 
CCR5 is debatable. Sozzani et al. (1998) acknowledged the divergent role of IL-10 in 
enhancing or downregulating expression of chemokine receptors under different 
conditions. 
 
1.6.2 HIV replication 
 
HIV relies on the host cell transcription processes to complete its life cycle and produce 
new virus particles (Janeway et al., 2001). The cellular nuclear factor (NF–Kβ) is present 
in all activated cells and induces transcription of HIV upon binding to its promoter long 
terminal repeat (LTR) region (Janeway et al., 2001). Also, the nuclear factor of activated 
T cells (NF-AT) stabilizes the postfusion HIV complex and facilitates reverse 
transcription of the virus (Lawn et al., 2001). Proinflammatory cytokine signaling 
pathways, particularly TNFα, IL-1 and IL-2 induce these transcriptional factors (Janeway 
et al., 2001).  IL-6 also synergises with TNFα in monocytes to enhance HIV replication 
(Gopinath et al., 2000; Lawn et al., 2001).  Increased levels of proinflammatory cytokines 
such as TNFα and IL -2 are well documented in chronic helminthiasis (Bentwich et al., 
1995, Henri et al., 2002).  
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The influence of Th2 cytokines on HIV replication is supported by evidence 
demonstrating that HIV replicates better in Th2/Th0 than Th1 cells (Maggi et al., 1994). In 
addition, potentiation of Th2 cytokines during helminth infection has negative 
consequences with regards to enhancing viral replication:  Th1/Th2 reciprocal cross-
regulation would promote viral replication as predominance of Th2 cytokines (IL-10 and 
IL-4) which, alone or in combination inhibit Th1 cell proliferation, thereby impairing potent 
innate and CTL responses that are well documented to be critical in control of HIV 
replication. Furthermore, increased levels of regulatory T cells (Tregs) are reported in 
helminth infections (Borkow and Bentwich, 2004; Mckee and Pearce, 2004). These cells 
secrete high levels of IL-10 and transforming growth factor β (TGF β).The latter cytokine 
was shown by Chen et al. (2005) to enhance virus entry by increasing expression of 
CXCR4 in macrophages. Likewise, Sozzani and colleagues (1998) showed that IL-10 
increases expression of CCR5 and infection by HIV in human monocytes. 
 
However, it is noted that the role of Th2 cytokines (IL-4 and IL-10) on HIV replication is 
contentious. While by virtue of decreasing CCR5 expression on CD4+ cells (Patterson et 
al., 1999), IL-10 would thus impact negatively on virus entry and replication. On the other 
hand Weissman and co-workers (1995) demonstrated that IL-10, in synergy with other 
cytokines enhances HIV production on PBMC’s. Furthermore, IL-10 also inhibits pro-
inflammatory processes initiated via the NFk-β transcription (Schottelius et al., 1999), 
and could thus inhibit viral replication. IL-4 was also demonstrated to increase CXCR4 
and decreasing CCR5 expression on human CD4 T cells and induce a switch from non-
sincytium (NSI), to SI inducing (rapidly-replicating) strains (Valentin et al., 1998) and this 
was interpreted to exacerbate HIV progression. 
 
For the reason that HIV uses the host’s transcription machinery to complete its cyle, it is 
thus clear why the virus replicates more effeciently in activated than in naïve cells (Fauci, 
1993). The finding that CCR5 expression is increased in activated cells (Kalinkovinch et 
al. 2001), and that helminth infections induce both cellular activation (Kalinkovinch et al. 
1998; Borkow and Bentwich, 2004) and upregulation of CCR5 (Bleul et al., 1997; 
Kalinkovinch et al., 2001) is in support of the augmentive interaction between helminth 
infection and HIV transmission.  
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1.6.3 Impaired immune control 
 
Chronic helminthiasis is associated with generalised and antigen specific attenuation of 
effective immune responses (Borkow et al, 2000; Borkow and Bentwich, 2004). Several 
cellular and molecular mechanisms have been described. 
 
Effective T cell activation requires appropriate antigen presentation to the T cell receptor 
together with ligation of the costimulatory molecule, CD28 on T cells to B7-1 (CD80) or 
B7-2 (CD86) on the same antigen-presenting cell (Janeway et al., 2001).  CD28 
enhances IL-2 mRNA stabilisation and IL-2 R expression  by T cells. IL-2 then acts in an 
autocrine mode to induce T cell proliferation during activation.  T cell receptor 
engagement in the absence of CD28 results in impaired T cell proliferation, activation 
and permanent anergy (Janeway et al., 2001).  Major decrease in the number of 
CD8+CD28+ T cells during helminth infection has been documented, as well as low 
CD80 expression on antigen presenting cells (Kalinkovinch et al., 1998; Borkow and 
Bentwich, 2004).  
 
Another downmodulatory feature associated with helminthiasis is upregulation of the 
counter-stimulatory molecule, cytotoxic T-lymphocyte associated antigen-4 (CTLA-4). 
CTLA-4 increases the threshold at which T cells are stimulated by reducing IL-2 
production (Janeway et al., 2001). This is a natural process to dampen immune 
activation to prevent pathological consequences of uncontrolled activation. CTLA-4 
binds to B7 ligands with higher affinity compared to CD28 (Janeway et al., 2001). Levels 
of CTLA-4 are documented to be elevated during helminth infections (Borkow et al., 
2000; Steel and Nutman, 2003).  
 
Binding of CTLA-4 also induces production of transforming growth factor β (TGF β) 
(Borkow and Bentwich, 2004). This downregulatory cytokine, together with IL-10 is also 
produced by T suppressor (CD25+ CD4+) T-regulatory cells, which are known to be also 
increased during helminthiasis (Mckee and Pearce, 2004; Borkow and Bentwich 2004). 
Chen et al., (2005) demonstrated how TGF β enhances HIV replication by increasing 
CXCR4 expression, increasing macrophage responsiveness to stromal-derived factor-α 
(SDF-α) and enhancing virus entry. Increased C1b-1, which is an intracellular negative 
regulator of activation, also occurs in helminth infection (Borkow and Bentwich, 2004). 
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Chronic T cell hyperactivation also results in functional anergy, thus preventing the host 
to respond to cognate antigens (Giorgi et al., 1999) to the advantage of HIV replication.  
 
In addition, completion of T cell activation also involves phosphorylation and 
dephosphorylation of kinases to facilitate translocation of transcription factors to the 
nucleus for transcription of relevant genes (Janeway et al., 2001). Helminth infection was 
associated with a markedly aberrant process of phosphorylation/dephosphorylation of 
tyrosine kinases, defective degradation of IκBα, and total impaired signal transduction 
(Borkow et al., 2000). Partial activation of T cells induces anergy (Janeway, 2001). HIV 
replicating in an anergic, activated immune environment increases viral burden, while 
competent antiviral CTL responses are attenuated. 
 
Furthermore, the β–chemokines (natural ligands of the chemokine receptor, CCR5), 
macrophage inflammatory protein 1α (MIP) 1-α, MIP1- β and RANTES have been 
repeatedly shown to have suppressive anti-HIV activity by different mechanisms (Cocchi 
et al., 1995; Amella et al., 2005). Decreased expression of these β–chemokines as a 
result of chronic infection with helminths, is documented (Kalinkovinch et al., 1999; 
Borkow et al., 2000; Gopinath et al., 2000).  
 
From the above data, it is clear that HIV replication is more likely to be enhanced by 
helminth-induced anergy, attenuated control of replication and decreased antigen-
specific CTL and antiviral activity. All these mechanisms create a conducive environment 
for HIV replication by attenuating innate and CTL responses against HIV. 
 
1.6.4 Modulation of non-parasite responses by helminth infection. 
 
As pointed out in the previous section above, helmiths induce anergy. The anergic 
responses initially are antigen–specific (Clerici and Shearer, 1993), downmodulating 
responses to the infecting parasite. However dysregulation of effective responses later 
extends to bystander cells, resulting in generalised reduction of responsiveness to 
mitogens, recall and other non-parasite antigens (Maizels and Yazdanbakhsh, 2003). 




Additionally, the Th2 predominance induced by helminthiasis also extends to uninfected 
cells such that naïve T cells expressing different repertoires of receptors are primed to 
differentiate to a Th2 phenotype (Liu et al., 2002). Accordingly, suppression of Th1 
responses by helminth infection is well documented in both animals (Elias et al., 2005) 
and humans (Cooper et al, 1998; 2000; 2001).  For public health implications, several 
human studies have reported altered Th1 responses to vaccines, which was attributed to 
immune modulation by helminth parasites. Albendazole pre-treatment of Ascaris 
infection improved antibody responses to cholera toxin in children infested by this 
parasite (Cooper et al., 2000). In young adults, the Albendazole-treated group had 
significant post-treatment increases in IFNγ responses to a recombinant cholera toxin 
and significantly higher IL-2 responses compared to the placebo group (Cooper et al., 
2001). Similar trends of impaired Th1 immune responses (IFNγ production) to tetanus 
toxoid-specific response in humans infected with Schistosoma (Sabin et al., 1996) and 
Onchocerca volvulus (Cooper et al., 1998) were demonstrated.  Likewise, elimination of 
helminths by Albendazole treatment improved T cell proliferation and IFNγ production by 
PBMC’s as well as PPD-specific responses in BCG-vaccinated individuals (Elias et al., 
2001). 
 
Furthermore, an extensive prospective study monitoring BCG vaccine efficacy from birth 
to 14 years of age in infants and children born of schistosomiasis- and filariasis- infected 
mothers was undertaken in Kenya where both parasites are endemic (Malhotra et al., 
1999). This study showed that in utero- sensitized infants acquire parasite immunity 
which lasts for up to 10-14 months after birth. IFNγ production in response to BCG 
vaccination by T cells of these sensitized infants was 26-fold lower than for children not 
sentitised to filariasis and schistosomiasis during gestation. Moreover, T cells from 2-to 
10- year old children of mothers without parasite infection produced 10 fold more IFNγ in 
response to mycobacterial purified protein derivative (Malhotra et al., 1999). In 2005 
Elias and co-workers also demonstrated an attenuated response to BCG in mice with 
schistosomiasis. Higher colony-forming units of TB bacilli, reduction in lung air exchange 
area and significantly less IFNγ production by splenocytes was found in these mice 
relative to their uninfected counterparts.  
 
These attenuated responses to vaccines have serious complications for HIV vaccine 
development in areas where helminth infections are prolific. 
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1.7 Regulatory T cells in HIV and in helminth infections 
 
The role of regulatory T cells ( Treg) in both parasitic helminth  and HIV infections  has 
been reviewed in detail and  in both infections, their expression follows the  activation of  
the immune system as a downmodulatory mechanism to control possible 
immunopathological sequelae of uncontrolled activation (Borkow and Bentwich, 2004).  
Their induction and activity in one infection may create either a favourable or an inimical 
environment for the establishment and development of the other. For example it is 
suggested that the decrease in Treg during the chronic stages of HIV may disrupt the 
balance between activation and suppression of the immune system that is required for a 
synergistic co-existence of nematode parasites within the host (Brown et al, 2006). On 
the other hand, upregulation of these cells by helminths may counter the 
proinflammatory processes that are essential for the transcription and replication of the 
retroviruses including HIV. The role of regulatory cells is still a subject of debate 
regarding the interaction between HIV and other diseases including parasites (Brown et 
al, 2006). 
 
1.8 Human studies evaluating direct helminth-HIV immunological interactions 
 
Data explored above is mainly hypothetical, although they form a strong supportive basis 
upon which helminth infections are implicated as co-factors in HIV pathogenesis. It 
would be difficult to directly evaluate this interaction in humans, therefore in vitro and ex 
vivo models have been used in studies that attempt to assess this interaction. 
 
PBMCs from filaria-infected individuals were shown to be more susceptible to HIV 
infection (Gopinath et al., 2000). In this study viral replication as measured by reverse 
transcriptase (RT) values were higher but not statistically significant among the infected 
compared to the uninfected group. Of importance was the finding that 1-2 years post 
treatment RT values were significantly lower than the baseline pre-treatment levels of 
the same individuals, implying that elimination of filariasis decreased the susceptibility to 
rapid HIV replication. A similar study by Shapira-Nahor et al. (1998) revealed similar 
findings of increased susceptibility to HIV infection by PBMCs of helminth infected, 
activated individuals.  
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These in vitro studies, together with the findings (cited above) that helminth-infected 
animals and humans had impaired responses to vaccines plus the reports that 
deworming reversed the immune dysregulation observed in the immigrant Ethiopians 
(Bentwich et al., 1996; 1997; Kalinkovinch et al., 1998) lend strong support for a 
negative impact of helminth infections in HIV susceptibility. Nevertheless, human studies 
addressing the effect of eradication of helminth infections on HIV disease progression in 
different geographic localities have yielded inconsistent results, and sometimes 
suggesting a beneficial response of co-infection.  
 
For example, Wolday et al., 2002 investigated the effect of helminth treatment on HIV 
progression through measurement of baseline and 6-month post treatment follow up of 
CD4+counts and viral load among helminth-HIV coinfected Ethiopian participants. Stool 
examination of the 56 participants revealed 45% Trichuris trichiura, 41% Ascaris 
lumbricoides, 12% Schistosoma and 6% Strongyloides prevalence. In their findings, 
baseline viral loads and CD4 counts were similar between 31 helminth infected and 25 
uninfected participants, however, a strong statistical difference between helminth 
intensity and viral load was found, with the heavier egg load associated with higher virus 
load. After 6 months follow up, there was a mean decrease of -0,36 log10 in HIV load 
among 13 successfully-treated participants compared to six who were persistently 
infected after treatment and nine who had been negative throughout the study period. In 
both the persistently infected and persistently negative participants, an increase in viral 
load was observed.  
 
In Kenya, Lawn et al. (2000) compared viral loads before and 1-15 months after 
treatment of schistosomiasis among 30 male car washers. Stools and circulating anodic 
antigen (CAA) ELISA were used to confirm schistosomiasis. These authors did not find a 
correlation between eradication of schistosoma infection and reduction in HIV load. 
Instead, a post treatment-interval-dependent increase in viral load was found.  
 
However, in another eport, Kallestrup and coworkers (2005) reported a positive impact of 
treatment of schistosomiasis among HIV-schistosomiasis co-infected Zimbabweans. 
Their controlled cohort was randomised into early (baseline, n=64) or delayed (3 month, 
n=66) praziquantel intervention groups with or without (n=97) HIV-1 co-infection. Stool, 
urine and CAA were used in the diagnosis of schistosoma infection. Early treatment of 
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schistosomiasis was associated with a significant increase in CD4 counts, and arrested 
increase in viral load, while there was an increase in HIV RNA load in the delayed-
treatment group. No changes were observed in CD4 counts among the HIV negative 
controls. An important finding of this study was an association between schistosomiasis 
co-infection and amplified HIV replication.   
 
In Zambia (Modjarrad et al., 2005) no significant association between treatment of 
helminths and reduction of viral load was found. At baseline, the viral load was lower 
among the helminth infected participants and a higher median CD4 count was observed 
throughout the study period in this group. In both helminth co-infected (n=54) and 
uninfected (n=57) groups, a slight increase in viral load and slight decreases in CD4 
counts were noted  four months after treatment for helminths which were predominantly 
roundworm (48%),hookworm (33%),schistosomiasis (9%) and other nematodes were 
less than 5%. 
 
In Uganda, Elliot et al. (2003) compared 34 helminth-infected and 34 uninfected HIV-1 
positive, ART-naive individuals to evaluate the effects of co-infection. The most common 
helminths found in this cohort were schistosoma and hookworm species, diagnosed by 
eggs in stools. At baseline, helminth-infected individuals had slightly lower viral load, 
significantly higher CD4 counts and CD4:CD8 ratio. Among the helminth uninfected 
group there was a progressive decline in CD4+ counts from baseline to five weeks and 
four months follow up while no significant change in CD4+ was found in those who were 
treated for helminthiasis. No significant change was found in viral load between baseline 
and four months post treatment in both groups. However, five weeks after treatment for 
helminths, a transient increase in viral load was observed in all groups, which was 
followed by a significant decline at four months among schistosomiasis-treated 
individuals. These authors concluded that their data does not support the notion that 
helminth infection worsens HIV infection, instead they suggest a possibility that 
helminthiasis may hinder HIV replication. 
 
Again in Uganda, Brown et al. (2004) studied the association between helminthiasis and 
HIV-1 progression in a larger cohort (163 participants). Schistosoma and hookworm 
infections were the most common. They complemented stool screening with serological 
assays for schistosomiasis CAA ELISA; charcoal culture for strongyloides and Knotts 
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concentration method for microfilaria. Similarly, they reported no association between 
helminth infection and lower CD4 counts, higher viral load and faster decline in CD4+ 
counts. In fact helminth infected participants were reported to have higher CD4 counts 
than their non infected counterparts, and a significantly higher median CD4+ count was 
found in participants with hookworm infection. There were no significant changes in the 
viral load after treatment (except in Mansonella perstans infected participants in whom 
failure to clear the infection was associated with a decrease in viral load). The authors 
concluded that treatment of helminth infections may not be beneficial in slowing HIV 
replication (Brown et al., 2004). 
 
In Malawi, neither helminth parasitic infection nor treatment thereof had an impact on 
HIV viral load in a cohort of 389 participants with prevalence of 43% helminths and 68% 
HIV (Hosseinipour et al., 2007). 
 
 As can be noted, two of the seven cited studies reported a beneficial effect of 
deworming in HIV–helminth co-infected participants (Wolday et al., 2002; Kallestrup et 
al., 2005). The rest did not find this effect, instead some even reported an increase in 
viral load after treatment (Lawn et al., 2000; Elliot et al., 2003; Brown et al., 2004; 
Modjarrad et al., 2005). There may be several possible factors contributing to these 
different findings: 
 
 In both studies in Uganda (Elliot et al., 2003; Brown et al., 2004), Schistosoma 
mansoni was most prevalent; whereas in the Ethiopian (Wolday et al., 2002) and 
Zambian studies (Modjarrad et al., 2005) the other intestinal parasites were more 
common. This would concur with the suggestion by Modjarrad and colleagues 
(2005) that immunological influences exerted by the tissue-resident schistosoma 
may differ from those of surface dwelling intestinal nematodes. However, both 
Lawn et al. (2003) and Kallestrup et al. (2005) investigated schistosomiasis and 
HIV co-infections and found inconsistent results. Furthermore, Modjarrad and 
colleagues’ (2005) findings differed from those reported by Wolday et al. (2002) 
despite the predominance of intestinal parasites in both studies.  
  
 In some of the studies efforts were made to increase the sensitivity of parasite 
diagnosis, such as serology for schistosomiasis, special concentration for 
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microfilaria and charcoal culture for strongyloides. However, diagnosis of the 
intestinal nematodes, particularly the most common (Ascaris lumbricoides and 
Trichuris trichuria) depended solely on detection of eggs from stools in all the 
studies (some on single collection). This method is known to have limited 
diagnostic value and therefore the error of misclassifying these infections as a 
result of false negatives would invariably be high. Wolday et al., 2002 collected 
two samples 4 hours apart within the same day, but the day-to-day variation in 
egg excretion would still not be overcome.  
 
 Differences in study designs may also be a contributing factor. Some were 
double blind placebo controlled, and others were not blinded, while some 
compared the effect of treatment by comparing the impact of successful 
treatment versus persistent infection after treatment.  Some of these studies 
lacked appropriate HIV uninfected comparison groups (Modjarrad et al., 2005). 
 
 The cohort sizes were markedly varied. 
 
 Types of helminths and intensity of infestation may be another important factor. 
Wolday et al. (2002) and Modjarrad et al. (2005) reported significant association 
between helminth load and viral load, with the higher helminth load 
corresponding to higher viral RNA. Therefore differences in study outcomes 
might have been influenced by differences in intensities and types of helmiths in 
the different studies.  
 
 The time interval between treatment and follow up may possibly have influenced 
some of these differences. It has been suggested that the immunological 
influence exhibited by schistosomiasis may be different from the superficial 
intestinal nematodes, and the time interval to have noticeable immunological 
effects may subsequently differ (Modjarrad et al., 2005).  
 
 
Other sources of bias: 
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1. Inter-individual variation in the primary outcomes (viral load and CD4 counts). 
These parameters vary greatly from individual to individual. Some studies 
compared changes in these two factors between groups who were and were not 
infected by helminths, or between those who were successfully treated and those 
persistently infected at follow up, or between early and delayed intervention 
groups, undermining the possible confounding by inter-individual variation. Four 
of the studies (Wolday et al.,2002; Brown et al.,2004; Elliot et al.,2003; Modjarrad 
et al.,2005) compared data of the same individuals at baseline and at follow up 
after treatment. These were the strenthgs of these studies. 
   
2. The possible immunomodulatory effect of anthelminthic treatment was not 
considered in some of the studies. In only two of the studies (Wolday et al., 2002; 
Brown et al., 2004) were all the participants treated, including those who were not 
found to be infected by helminths. The rest of the authors reported treatment of 
those found to be infected by helminths only. 
 
3. The lack of blinding to intervention. Kallestrup et al.(2005) assigned 
schistosoma infected individuals to early and delayed treatment arms Hence in 
this study there was no blinding.  
 
4. Measurement of successful treatment by clearance of stool eggs could be 
another source of confounding, where false negatives coul be classified as 
successfully treated participants who were then compared to persistently-infected 
individuals.   
The strengths and weaknesses identified in the studies: 
The strengths of the study by Kallestrup et al. (2005) was the randomised, 
controlled trial design, however the weakness was the unblinded assignment to 
early and delayed treatment arms. 
Modjarrad et al.,(2005) matched the 54 HIV and helminth infected participants for 
age and sex, and this was a strength of the study, however, not all participants 
received anthelminth treatment, which weakened the investigation. 
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In summary, the significant reduction of activated CD4+ and CD8+ T cells in HIV-1 
negative Ethiopian adults following treatment of helminth infection (Kassu et al., 
2003), the reduction of immune activation by the immunosuppressant cylosporin A 
during ART initiation which is associated with improved CD4+ counts (Rizzardi et 
al., 2002) and the in vitro studies cited above in section 4 all lend strong support for 
the notion of increased susceptibility to HIV infection by concurrent helminth 
infection. However, there have been conflicting results from other studies and the 
effect of helminth infection severity, helminth types or other confounding and as yet 
unexplained mechanisms on HIV pathogenesis and HIV infection outcome remain 
to be elucidated. Human in vivo studies that attempt to determine the effect of 
infection by and treatment of parasites need to be standardised, be undertaken in 
different geographic locations in order to provide comparable and compelling 
evidence for the role played by helminths on HIV pathogenesis. 
 
     1.9 Study hypothesis 
 
Individuals co-infected with HIV and intestinal helminths have impaired immune      
responses to HIV.  
 
Some of the key aspects that are proposed to play a role in this interaction will be       
evaluated in the current work. These include the suggestions that: 
 Helminth infections result in altered composition of peripheral blood 
lymphocyte populations.   
 Helminth infections induce chronic immune activation.  
 Chronic immune activation by helminths will increase viral load. 
 Helminthiasis results in a predominance of Th2 cytokines which down 
modulate Th1 cytokines that are essential for control of viral infections.  





1.10 Study aim 
 
The study intends to characterize the immune profiles of South African HIV-1 sero-
positive and sero-negative individuals living in a helminth-endemic area and correlate 
these with HIV immune responses. 
1.11. Objectives  
1. To characterise the peripheral blood lymphocyte phenotypes of HIV infected 
and uninfected individuals with or without intestinal helminth co-infection. 
2. To determine the activation status of lymphocytes in the participant 
subgroups with single or dual infections. 
3. To assess functional characteristics (cytokine and lymphoproliferative 
responses) of lymphocytes in participants with and without HIV / intestinal 
helminths co-infection. 




1.12 Outline of the thesis 
 
In Chapter 1 the literature was reviewed and Chapter 2 describes the study design, the 
preliminary tests that were done mainly by the supporting laboratories and the baseline 
characteristics of the participants. Chapter 3 defines the lymphocyte phenotyes of all 
suitable participants with complete data sets. In the subsequent Chapters 4-5, a subset 
of the participants was selected for analysis of immune activation, cytokine and 
lymphoproliferative responses to stimulation. Owing to the costs of analytic tests, 
selection requirements for the tests and budgetary constraints, only a limited number of 
samples could be investigated. The selected samples had to have enough cells (at least 
5.5 x 106 cells/ml) in order to analyse the various immune components. Furthermore, 
participants with infections other than HIV and helminths had to be excluded. Therefore, 
for these analyses, a subgroup of sixty two participants (40 HIV+ and 22 HIV -) who did 
not have TB or sexually transmitted infections (STI) was selected. Their PBMC’s were 
examined for activation, proliferation and cytokine production in response to antigen 
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stimulation.  Chapter 6 summarises the study challenges and limitations that had been 
described in each relevant chapter. Chapter 7 discusses all the results and draws 
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Study Design, Specimen Collection and Preliminary Tests 
The overall aim of the present work was to investigate immunological interactions 
between the HIV and helminth infections through analysis of cells obtained from singly 
and dually infected individuals. Collaboration with supporting laboratories and fieldwork 
was undertaken to obtain baseline information prior to embarking on the immunology 
work which constitutes the essence of the thesis. 
 
The current chapter thus describes the study area, the participants’ profile and 
preliminary tests that were done to categorise the participants including helminth 
infection versus non-infection status, serum IgE levels and HIV status. The section 
outlines the tests that were done by other support laboratories therefore it does not 
include detailed descriptive techniques.  Full details of methodologies that were 
undertaken by the author are given in subsequent chapters.  
 
2.1 Study’s ethical clearance 
This work was part of the project titled: Prospective, placebo-controlled trial of 
deworming of HIV infected individuals. Project: N04/02/045.The study’s ethical clearance 
was obtained from the South African Medical Research Council’s and the University of 
Stellenbosch’s Ethics Committees in 2002 and 2004 respectively. A waiver of University 
of KwaZulu-Natal ethics approval was granted by the chair of the Biomedical Research 
Ethics Committee, Prof Wassenaar (Appendices 9, 10 and 11). Permission to conduct 
the study was granted by the Matthew Goniwe Clinic’s management team, consisting of 
the director of City Health, City of Cape Town (at the time the late Dr Ivan Toms), Dr De 
Villiers, directly in charge the Matthew Goniwe clinic as well the sister in-charge, Sister 
X. Mandindi. 
 
During the study, the core foundations of research ethics pertaining to human 




2.2 Study setting and population  
 
The study was undertaken in an informal settlement, Khayelitsha in the Western Cape 
Province (South Africa). Although over 90% of the participants were originally from the 
Eastern Cape Province, the majority had resided in Khayelitsha for a substantial number 
of years, with a mean stay of 10 and 14 years in the HIV positive and negative groups 
respectively (Adams et al., 2006). Study participants were recruited between May 2002 
and November 2003 for the main clinical trial till the final follow up visit and the present 
study analyses commenced in 2004 to 2005.  
 
In 2004 the Khayelitsha population was estimated at 500 000 with 80% of the residents 
living in shacks, with a population density ranging between 2 250 and 33 786 per km2 
(mean 15 653 per km2). In 2006, more than 14 000 households did not have access to 
clean water and there was almost a 30 000 sanitation backlog and an average of 105 
people per toilet in sites B and C Khayelitsha (Thom, 2006). A survey of 12 primary 
schools in this area showed that more than 90.0% of the school children were infected 
by helminths (The Khayelitsha Task Team 2001), while a pilot study of helminthiasis in 
adults who live around Matthew Goniwe clinic (Khayelitsha) suggested levels exceeding 
40% (unpublished) and a recall study on the history of helminth infection among the 
same group showed that more than 70.0% had been infested by helminths previously 
(Adams et al., 2006). Within the Western Cape Province, the prevalence of HIV in 
Khayelitsha (22.0%) is higher than the 9,1% provincial  level  (Shaikh et al., 2006). 
 
 
2.3 Study design 
 
This was a cross sectional study aimed at examining immunological interactions 
between intestinal helminth and HIV infections. Data for this study was collected at 
baseline of the deworming trial. Ideally, a randomly selected sample of a substantial 
magnitude to allow statistical power for making inferences to the entire population should 
have been made. However there were budgetary and some technical constraints in the 
face of the costs of some of the molecular tests which prevented such an approach. The 
study was thus designed as a pilot study for hypothesis testing within the available 
financial resources.   
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As a result, sample size for statistical power could not be taken into account while 
selection bias could not be optimally minimised. This is then an exploratory study and no  
population inferences can be made.  Essentially, one of the expected outcomes is to test 
the hypothesis for immunological interactions between HIV and helminths and provide 
data that could guide the design of future similar studies. 
 
The sampling strategy determined by the primary deworming trial. The study target 
population was HIV-1 positive individuals and HIV negative controls who live in an area 
of high helminth endemicity and limited infrastructural resources in Khayelitsha. Some 
sampling bias could have been introduced for the HIV positive individuals who  were 
recruited from an HIV support group, while the HIV negative were mainly community 
members who were accompanying clinic attendees.  The inclusion criteria for the main 
study group (HIV positive individuals) were the following: 
 HIV sero-positivity 
 Age above 18 years  
 attending the HIV AIDS support group in the local Matthew Goniwe clinic 
 consenting to a repeat HIV test. 
The exclusion criteria were determined for both the main trial as well as for the 
immunology work of this thesis as some of the exclusion criteria have significant 
influence on the immune system activation and hence would confound the present 
study. The first two criteria were for the respect of patient autonomy and prevention of 
harm.  
: 
 Unwillingness to undergo an HIV test or retesting 
 Known sensitivity to mebendazole 
 Presence of known systemic diseases that cause immune suppression (except 
HIV) such as diabetes mellitus, cancer chemotherapy, prior organ transplatation, 
congestive heart failure, advanced chronic obstructive pulmonary disease, known 
liver disease or alcoholism, use of corticosteroids in excess of 10mg per day 
 Known presence of other infectious diseases such as tuberculosis and sexually-
transmitted infections 
 Use of multivitamin supplements and prophylactic medication including 
immunomodulators 
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 Pregnancy in the last 6 months (some of the participants were on the Infant 
Feeding Choice programme that was in progress at the time)  
 Recreational use of illicit drugs and excessive consumption of alcohol 
After recruitment efforts were made to ensure optimum participation.  All participants 
were anti-retroviral therapy-naïve at the time of study commencement as such treatment 
was not available then in public health institutions. The HIV-1 negative controls were 
recruited from the same clinic, most of whom were accompanying patients to the clinic. 
They were recruited for comparison purposes only, since the objective of the study was 
to analyse immune responses to HIV in the presence and absence of helminth co-
infection. To maintain group similarity, only Khayelitsha residents were enrolled to 
participate. 
 
After obtaining informed consent, 170 HIV-1 sero-positive and 65 HIV-1 sero-negative 
adult Khayelitsha residents were recruited into the study. Case record files and 
questionnaire screening were used to exclude participants who had other infectious 
diseases including those who were treated for active tuberculosis, sexually-transmitted 
infections, those who were on Bactrim prophylaxis as well as those who were taking 
vitamin supplements. 
 
Thus of the 170 HIV-1 seropositive participants enrolled, 151 were eligible for analysis 
and donated approximately 30ml blood and/or stool samples while 45 of the 65 HIV-1 
seronegatives recruited submitted these specimens. All these participants were 
screened for helminth infection and their peripheral blood lymphocyte profiles were 
phenotyped.  After stratification according to HIV and helminth serology and faecal egg 
positivity, only samples from those participants with complete datasets were investigated 
further. The stratification resulted in four subgroups based on presence or absence of 
faecal eggs with or without elevated Ascaris-specifif IgE. For further immunological 
testing, only a limited number of samples could be analysed owing to the costs of some 
of the analytical tests and the budgetary limitations.  From the 124 HIV+ participants with 
complete data, sequential sampling was undertaken by selecting every second 
participant (using study identification numbers) until there were 10 participants in each of 
the 4 subgroups. Twenty-two HIV-negative individuals had complete data sets and were 
all included in subsequent analysis. Stool analysis was aimed at the identification of 
eggs from either Ascaris lumbricoides and/or Trichuris trichuria. As pointed out in 
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Chapter 1 there is significant cross-reactivity between antibodies against Ascaris and 
Trichuris and as there is no commercial Trichuris trichuria assay available the Ascaris-
specific IgE test was used as proxy for infection by any one of these two pathogens. 
Stratification resulted in the following groups: 
(i) faecal egg positivity and high Ascaris–specific IgE (egg+IgEhi)  
(ii) faecal egg positivity and low Ascaris IgE (egg+IgElo)    
(iii) no eggs and elevated Ascaris–specific IgE(egg-IgEhi)   
(iv)  no eggs and low Ascaris–specific IgE(egg-IgElo).  
 
The last subgroup is presumably free of current and recent helminth infection while the 
other three subgroups have evidence of exposure to these infections. Use of serum IgE 
aimed at increasing the Figure 2.1 outlines the numbers of participants that were 
included or excluded for each selection criteria. The limitations of this selection strategy 







   
Figure 2. 1. Selection strategy for inclusion of participants for immunological analyses.  
The numbers and exclusion criteria for HIV positive and negative subjects that were initially recruited into the study is 
illustrated. Of those consenting to participate, a proportion was excluded because they had other infectious diseases, 
were on Bactrim prophylaxis or vitamin supplements. Those eligible donated blood and stool samples. Helminth status 
was determined by both colproscopy and serology and lymphocyte immunophenotypes done. Those with incomplete data 
for helminth status classification were further excluded. A subset of the eligible participants was sequentially selected 
(every second individual) using study identification numbers for further immunological analysis. *Among the HIV- eligible 
participants, 23 did not submit the complete set of samples thus the remaining 22 were included by default.    
                 Eligible:  
Helminth status (serology and colposcopy) 
determined and immunophenotype 
analysis 
HIV+    HIV- 
N=151    N=45 
 
Eligible for further immunological tests: 
Complete datasets for immunophenotypes and 
helminth serology + faecal eggs and complete 
sample set 
HIV+    HIV- 
N=124    N=22 
 
Sequential selection of 10 participants per 
subgroup 
 
HIV+   HIV- 
N=40   *N=22 
Excluded: Incomplete data for 
helminthiasis status 
 
HIV+            HIV- 
N=27            N=23 
 





                               Number of subjects recruited  
 
HIV+ N=170              HIV- N=65 
     
 Excluded: Other infectious diseases, 
Bactrim prophylaxis and Vitamin 
supplementation, illicit drugs or excessive 
alcohol use. 
 
HIV+    HIV- 
N=19    N=20 
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It should be noted that although efforts were made to include all the recruited HIV 
negative controls (n=45) for comparisons, the numbers of participants suitable for 
stratification of helminth infection were lower as six of the 45 paricipants did not submit 
stool samples. Although the samples for lymphocyte phenotypic analyses (n=38) were 
adequate, further immunological tests could only be conducted on a smaller subset 
(n=22) due to insufficient cell mumbers or poor cell viablity of less than 90%.  
Stratification into subgroups was therefore not possible in the HIV negative groups as 
one subgroup only had three participants. Thus in Chapter 3 analyses, thirty eight 
subjects were included while in Chapters 4-5 only twenty-two suitable participants 
remained. However, as the essence of this work is to assess the effect of helminth 
infections on immune responses to HIV, the HIV uninfected participants become less 
relevant in this context. 
 
2.4 Questionnaire administration and case record file data collection 
 
Data on health status (history of other infectious diseases), vitamin supplementation and 
prophylaxis treatment, demography and social habits were collected. The history of 
helminth infection as a child or as an adult was recorded upon interviewing the study 
participants. The first date of HIV testing was documented from the case record files. 
 
2.5 Specimen collection  
 
Blood and faecal samples were collected from each consenting individual.  During each 
collection period, faecal samples were collected on two consecutive days to detect the 
presence of parasite eggs and ova. After HIV counselling was offered, blood samples 
were collected by standard phlebotomy and the following blood tubes were collected for 
the tests indicated: 
 Ethylenediaminetetraacetic acid (EDTA) tube for full blood counts and 
lymphocyte phenotypes (5ml). 
 Cell Preparation Tubes (CPT) for peripheral blood mononuclear cell (PBMC’s) 
isolation for cryopreservation and subsequent culture experiments, determination 
of activation markers, proliferation and cytokines production (2 x 8ml). 
 Serum Separator Tubes (SST) tubes for confirmation of HIV status, total and 
Ascaris lumbricoides-specific IgE (2x 5ml). 
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 EDTA tubes for plasma viral loads (5ml). 
The specimens were sent to the laboratories within two hours of collection. Processing of 
all the samples was according to good laboratory practice and recommended laboratory 
protocols. 
 
2.6 Preliminary tests 
 
2.6 1. Detection of faecal helminth eggs and/or ova  
 
Microscopy was performed on two stool samples collected on 2 consecutive days by two 
independent microscopists using formol-ether concentration and the Kato Katz methods 
respectively. 
2.6 2. HIV tests and viral loads 
  
Although the HIV positive participants had been tested previously before enrolling in the 
HIV Support group, for the purposes of this study their HIV infection status was 
confirmed.  A rapid test for HIV (InstantScreen® Rapid HIV-1/2 Assay GAIFAR GmbH, 
Germany) was done at the clinic. Serum was re-tested at Tygerberg Academic Hospital, 
Department of Virology using the Abbott Axsym ® Microparticle Enzyme Immunoassay 
(MEIA) for the detection of antibodies to HIV-1 (subtypes M and O) and/or HIV-2. 
Confirmation of MEIA positive tests was done by PCR sequencing of viral DNA. HIV-1 
viral load was determined by the Abbot LCx® HIV RNA Quantitative assay (Abbott 
Q1Laboratories, IL) in the same Virology department.     
 
2.6.3 Full blood counts and IgE tests 
 
Total and Ascaris lumbricoides specific IgE levels were determined at Pathcare 
Laboratories using CAP total IgE and ImmunoCAP® Specific IgE (RAST), respectively.  
Full blood counts (H2 Technicon) and differential counts were done by the Tygerberg 






2.7.1 General characteristics of the participants 
 
Of the 170 HIV-1 seropositive participants enrolled into the study, 151 donated either 
blood and/or faecal samples while 45 of the 65 HIV-1 seronegatives recruited submitted 
these specimens. Among these 196 successfully recruited participants 28 were males 
(their mean age was 41 years) and 170 were females (with a mean age of 32 years).  
The participants were classified into 2 groups according to their HIV-1 status. The 
general characteristics of participants are shown in Table 2.1. Fewer HIV-1 seronegative 
participants were recruited as clinic attendees were reluctant to undergo HIV testing as 
antiretroviral therapy was not available at public health institutions at the time.The HIV 
positive participants were already aware of their HIV status and recruitment was largely 
successful amongst the attendees of a HIV support group.  
 
The HIV positive participants could not be categorised according to duration of HIV 
infection. Although the date of diagnosis of HIV status was retrieved from the clinic’s 
case record files, this was found unreliable for accurate estimation of the date of 
seroconversion. 
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Table 2.1 Summary of baseline characteristics of study participants by HIV status who 
submitted blood and faecal samples. 
The prevalence of helminth infection was estimated by microscopical screening of stools for 
eggs/ova as well as the levels of serum Ascaris lumbricoides specific IgE. Data includes sex, 
median ages and total serum IgE levels within the two groups. 
 
 
Characteristic HIV-1 positive HIV-1 negative 
Sex, number of participants 
                                Males 
                                Females 







































Mean Ascaris-specific IgE (Ref. range below 





Mean Ascaris Worm Burden (SD) 
Mean Trichuris Worm Burden ( SD) 
 
 











*Evidence of helminth exposure as indicated by faecal egg excretion and/or elevated Ascaris lumbricoides 
specific IgE. Ascaris specific IgE cross-reacts significantly with Trichris trichura. 
 a Twenty seven of 151 (HIV+) and b six of 45 ( HIV-) participants did not submit faecal samples. Mean worm 
burdens were done as egg counts per gram of stool in each person and the mean was calculated for each 
HIV group among the infested persons. SD= standard deviation.epg=eggs per gram of stool.
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2.7.2 Prevalence of helminth infections in the Khayelitsha adult study individuals. 
 
In both HIV groups the prevalence of helminths exceeded 40.0% when assessed by the 
presence of faecal eggs only and was 66.0% and 71.1% for HIV-1 positive and negative 
respectively, when evidence of exposure to parasites is defined by both egg excretion 
and elevated Ascaris lumbricoides-specific IgE. Some participants excreted intestinal 
helminth eggs with or without elevated Ascaris lumbricoides IgE while others had high 
serum Ascaris lumbricoides IgE but did not excrete helminth eggs in their faeces. The 
most common intestinal helminths in this adult population were Ascaris lumbricoides (44 
of the 51 HIV+egg positive and 14 of 18 HIV- egg positive participants), followed by 
Trichuris trichiura (30 of 51 HIV+ and 8 of 18 HIV- participants).  Other parasites included 
the Taenia species (5 of 51 and 3 of 18 HIV+and HIV- individuals respectively), Fasciola 
(one in each of the two HIV-1 groups) and Schistosoma mansoni (one of the 18 HIV-1 
negatives). Among the HIV-1+, 21 of 51 (41%) were dually infected by Ascaris 
lumbricoides and Trichuris and 5 of the 18 (28%) HIV- negative group harboured both 
these parasites.  The mean Ascaris worm burdens were not significantly different in the 
two HIV groups while mean Trichuris burden was significantly lower in the HIV positive 
group (p=0.04). 
 
Treatment with Mebendazole (and Praziquantel where necessary) was given to all 
participants with faecal helminth eggs. Since the faecal egg results were available earlier 
than IgE results which were done by another laboratory (Pathcare), Mebendazole was 
given to those diagnosed with fecal eggs only during the trial. However at the end of the 
study all participants were treated, owing to the high prevalence of helminths and 
unsanitary living conditions in Khayelitsha.   
 
2.7.3 Other infectious diseases 
 
Some of the participants had other additional infections. Of the 170 HIV seropositive 
individuals recruited, nineteen (11.0%), and six of 65 (9.0%) HIV seronegative 
participants initially recruited had tuberculosis (TB) at the time of study commencement. 
One HIV negative (2.0%) and 11 (7.0%) HIV + reported having sexually transmitted 
infections (STI) during the recruitment period.  
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2.7.4 Full blood counts, serum Total IgE and Ascaris lumbricoides specific IgE 
 
Total IgE levels were 6-fold above the method reference range among the HIV-1 sero 
positive people and 9-fold higher in the HIV-1 uninfected group (Table 2.1).  
Ascaris lumbricoides-specific IgE levels were considered low if the levels were below the 
method detection limit of 0.175 (class 0). These are based on European reference 
ranges for the methods. The results of Ascaris lumbricoides IgE are used in the following 
chapters together with faecal egg results to classify the individuals’ helminth infection 
status.  
  
The full blood count results were used for the calculation of absolute lymphocyte subset 





Data on the prevalence of helminth infections among adults is infrequent in South Africa 
as most of the available survey reports are obtained from studies done on children. The 
present study confirms for the first time, evidence of exposure to and infection with 
intestinal parasites in the adult Khayelitsha residents by both faecal egg excretion and 
elevated Ascaris lumbricoides-specific IgE data.  Ascaris-specific IgE was used as a 
reliable additional, serological marker of helminth exposure because there is extensive 
cross-reactivity between antigenic epitopes of helminths infecting humans 
(Bhattacharyya et al., 2001) and as it is known to share antigens with Trichuris trichiura 
(Lilly-white et al., 1991).  At the time of conducting the study there was no crude antigen 
for the Trichuris trichiura serology. High levels of Ascaris-specific anti IgE would thus 
provide a representative serodiagnostic marker that reflects exposure to other related 
intestinal parasites in the population. Parasite specific IgE response was documented to 
appear within seven days of infection and unbound serum IgE has a short half life of two 
to five days while the bound antibody persists for several weeks to months in healthy 
nourished individuals. (Lynch et al., 1998;Nagaraj  et al., 2004). Ten days following 
treatment, the levels were documented to remain high in malnourished adult males 
(Nagaraj  et al., 2004).  Both Ascaris lumbricoides and Trichuris trichiura were shown to 
be the most prevalent helminths in this population (Adams et al, 2006). 
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The present study established that the level of exposure to helminths ranged between 
66,0% and 71,1% when measured by both faecal eggs and elevated Ascaris 
lumbricoides-specific IgE among this adult Xhosa population residing in a resource-poor 
area. Helminth egg excretion revealed a prevalence of 41.1% and 46.1 % for HIV-1 
positive and negative individuals respectively in this setting. This discrepancy highlights 
the point that use of egg excretion alone as an indicator of helminth infection can be 
misleading, particularly for studies whose aim is to analyse co-infection by helminths and 
other infectious agents. The mean worm burdens were slightly higher in the HIV negative 
groups, and Trichuris burden was significantly higher in the HIV negative group (p=0.04). 
This finding could corroborate the suggestion that egg excretion may be impaired by a 
compromised immune system. 
 
Upon analysis of data on stool egg positivity and serum Ascaris-specific IgE, four groups 
emerged, assuming that the sensitivity of faecal egg detection was uniformly improved 
by use of two methods and two independent microscopists on faecal samples collected 
on two consecutive days. Some participants had intestinal helminth faecal eggs and high 
serum Ascaris lumbricoides IgE. This first group reflected typical, fecund helminth 
infection and will be subsequently referred to as egg+IgEhi.  
 
A second group comprised of individuals who excreted helminth eggs in stool but 
Ascaris IgE levels were lower than or equalled the method detection limit (egg+/IgElo). 
There would be two possible explanations for this combination of results: the first would 
be newly-acquired infection before detectable levels of antibodies are reached at the 
time of sample collection. Secondly, this group could represent a predominantly Th1 
phenotype, who inherently secrete lower levels of IgE and therefore are more 
susceptible to intestinal parasite infection (hence egg excretion). This type of distinction 
was more clearly defined in mice, where animals with a Th1 phenotype were more 
susceptible to Trichuris reinfection compared to their Th2 counterparts (Else et al., 1994). 
Whether this phenomenon occurs in humans is yet to be elucidated. Maizels and 
Yazdanbakhsk (2003) described three types of phenotype outcomes that follow exposure 
to some helminth parasites. One of these are helminth-infected individuals who secrete 
lower anti-parasite IgE and higher IgG4 levels, and have strong regulatory cell activity 
accompanied by high IL-10. These individuals are referred to as modified Th2 phenotype 
and are susceptible to persistent, asymptomatic, usually heavy infection by parasites 
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and they constitute the reservoir for parasite transmission. In the present work, the 
egg+/IgElo participants in the second group befit this phenotype although no data is 
available on IgG4 levels for these participants.  
 
The third study group comprised of individuals with high serum Ascaris specific IgE but 
absent faecal eggs (egg-/IgEhi). This group could be representing individuals with 
residual antibodies who had recently been exposed to the parasites and had cleared the 
infection; or alternatively people with a predominantly Th2 immune phenotype with an 
increased potential to clear the helminth infection. According to the model presented by 
Maizels and Yazdanbakhsk (2003) this group represent a balanced Th1/Th2/Th3 
phenotype. The individuals in this group are apparently resistant to infections and these 
authors suggest that the balanced Th1/Th2 immune system is sufficient to eliminate 
invading parasites. 
 
The last group had neither faecal eggs nor high Ascaris specific IgE (egg-/IgElo).  Again 
this group could reflect a naturally resistant subgroup (considering their living conditions 
that are conducive to high levels of exposure to helminth infection) or they could have 
been uninfected at the time of sample collection. Another possibility exists that these 
individuals are severely immunocompromised and fail to mount humoral (IgE) 
responses. Egg production by parasites (worm fecundity) is suggested to be dependent 
on a competent immune system (Karanja et al., 1997; Viney, 2002); therefore in the 
proposed scenario egg and antibody production would be impaired resulting in the egg-
/IgElo status. The worm burden was generally lower in the HIV negative group compared 
to the HIV positive individuals, and this difference was significant for Trichuris trichiuria. 
This finding could corroborate the suggestion that egg excretion may be impaired by a 
compromised immune system. 
 
Parallel to this evidence for a high level of exposure to helminth infections are the 
elevated serum total IgE levels (Table 2.1) in this population. Notably, although still high, 
the median total IgE level was lower in the HIV positive compared to the HIV negative 
group, probably reflecting a function of immunodeficiency. The observed hyper-IgE 
globulinaemia in this population concurs with the suggestion that Africans represent a 
genetically high IgE responder phenotype (Haus et al., 1988). These workers reported 
highest median cord blood IgE values from African (Xhosa) neonates compared to their 
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White and Coloured counterparts, irrespective of maternal ascariasis or atopic family 
history. It is suggested that the high IgE level among the Africans is environmentally as 
well as genetically driven (Orren et al., 1975; Gerrard, 1985). This finding could be of 
significance to the study hypothesis as high IgE is associated with Th2  bias. 
 
Finally, the immunological assays discussed in the subsequent chapters thus depended 
on the availability of all the relevant sample results and also on the costs of tests. For 
proper classification of helminth infection or non-infection, data on both egg and serology 
status was required in order to interpret immunological data. In addition, results of full 
blood counts as well as of flow cytometry were required for determination of absolute 
CD4+and CD8+ counts using the two-platform analysis. Results of immunophenotypes in 
Chapter 3 were only obtained from participants with complete full blood count, 
immunophenotyping, Ascaris-specific IgE and faecal microscopy results, hence the 
numbers declined. Further expensive assays on cryopreserved PBMCs (Chapters 4 and 
5) were done on 40 HIV+ and 22 HIV- participants where suitable samples were available 
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Ex-vivo peripheral blood lymphocyte phenotyping, eosinophil counts and their 
relationship to viral load  
3.1 Introduction 
 
The present chapter analyses and compares cellular phenotypes (and viral load) among 
subgroups of HIV-1 positive and negative individuals with or without helminth co-
infection. A brief overview of outcomes of both infections on cellular proportions and 
phenotypes is re-contextualised below.  
3.1.1 Lymphocyte subsets and viral load in HIV infection 
 
3.1.1.1 CD4+ lymphocytes:  
 
As described in Chapter 1,  HIV infection is classically characterized by marked 
reduction and eventual depletion of CD4+ and a gradual rise in CD8+ lymphocytes with 
disease progression while total CD3+ counts remain constant (Giorgi, 1993). On this 
basis, guidelines for initiation and monitoring of HIV therapy are founded on CD4+ 
lymphocyte thresholds (Center for Diseases Control (CDC), 1997). Lymphocyte immuno-
phenotyping thus plays a pivotal role in defining the rate of cellular immune dysfunction.  
  
3.1.1.2 CD8+ cells:  
 
Cytotoxic or suppressor T lymphocytes (CD8+) play a key role in the control of viral 
infections. Likewise a significant increase of these cells occurs within the first few 
months of HIV infection and remains elevated during the asymptomatic phase (Koup et 
al., 1994). At the onset of AIDS, absolute numbers of total, CD4+, CD8+ lymphocytes 
decrease, but the percentage of CD8+ increases (Giorgi, 1993). At the end stage of the 
disease all T lymphocytes are CD8+ (Giorgi, 1993). Different ratios of viral load to CD8+ 
lymphocyte numbers have been reported (Jin et al., 1999; Metzner et al., 2000; Betts et 




3.1.1.3 NK Cells:  
 
Changes in NK cell numbers occur within the functional phenotypes, as alluded to in 
Chapter 1. The number of CD56+CD16+ NK cells (the most potent cytolytic phenotype) 
decreases dramatically. The expression of CD16 also drops with a subsequent 
expansion of CD16 dim CD56- cells. This results in impaired NK cell functional activity in 
AIDS disease (Hu et al., 1995; De Souza et al., 2000; Kotttilil et al., 2004; Mavillo et al., 
2005; Meier et al., 2005). With regard to NK cell numbers, literature reports discrepant 
results during HIV infection. It is therefore not clear whether their numbers increase or 
decrease with disease progression. 
 3.1.1.4 B cells:  
 
B cell numbers can be increased by polyclonal stimulation by HIV proteins. The 
significance of enumeration of this lymphocyte pool during HIV infection has not been 
well established (Kunkl, 1997).  
3.1.1.5 Viral Load:  
 
Molecular level data indicates that from primary infection through the asymptomatic 
phase to disease onset, there is continuous change in the mean viral activity (Bagnarelli 
et al.1994). On average, viral load quantification enables a relative measure of virus 
replication and cell killing (Wei et al., 1995). Consequently, despite the wide individual 
(intra-host) variability, viral loads are strongly associated with and widely used to assess 
disease progression (Nolte, 1999). It is noteworthy however that findings of a recent 
report suggest that viral load is not always an accurate predictor of CD4+ cell decline 
(and disease progression) at the individual level (Nelson, 2006).  
 
While there are several studies suggesting that ethnic variation in viral load occurs, 
mainly indicating that Black Africans generally have lower levels compared to other 
ethnic groups (Rizzardini et al., 1998, Anastos et al., 2000; Saul et al., 2001, Swindells 
et al., 2002; Smith et al., 2003), some workers however have not observed these race 
differences. In a US study assessing racial differences in viral load among White, Black 
and Hispanic military members, Brown and colleagues (1997) did not observe race 
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dependent variations in their study participants. It is not known whether the antiretroviral 
treatment contributed to this finding because the participants were receiving antiretroviral 
treatment. Nonetheless, the ethnicity and virus threshold level issues should probably be 
considered in interpreting viral load studies and still warrant further verification. 
 
3.1.2 Helminths and peripheral blood cellular distributions: 
 
The hallmark of cellular response to helminth infection is eosinophilia and mastocytosis. 
In addition, however disruptions to T cell populations similar to those occurring in HIV 
infection (decreased CD4+ and increased CD8+ lymphocytes) have been demonstrated 
in animal experimental helminthiasis (Else and Grencis, 1991, 1996; Soltys et al.,1999) 
and in humans: Pollack and colleagues (1993) described low CD4+ counts in HIV 
seronegative Ethiopian Jews who had immigrated to Israel from Ethiopia. The high 
prevalence of helminth infection in this group was suggested to be associated with the 
CD4+ lymphocytopaenia. Many studies were carried out particularly in this immigrant 
population of Ethiopians to Israel. Kalinkovich et al. (1998) ascribed decreased CD4+ 
and increased CD8+ lymphocyte counts in helminth infected HIV uninfected Ethiopian 
groups. These authors confirmed this association when eradication of helminths resulted 
in reversal of the immune alteration.  
 
With the suggested role of helminth-induced immune dysregulation in African 
populations, other studies followed. A study in Tanzania determining the reference 
values of lymphocyte subsets in HIV seronegative adult Tanzanians reported low 
percentages of CD3+ and CD4+  and CD4+ CD8+ ratios compared to the levels reported 
for European adults (Urassa et al., 2003).  Similarly, Smith and colleagues (2003) 
reported lower CD4+ counts among Black Africans compared to Caucasians in an 
observational study of 537 antiretroviral naïve HIV-1 positive individuals attending two 
East London (Britain) clinics. All these studies speculatively suggested that a general 
tendency towards low CD4+ mostly accompanied by elevated CD8+ lymphocytes is 
found among African populations, owing to chronic exposure to infectious agents, 
predominated by helminths. However, some immunological studies undertaken in other 
African studies have not found these alterations in T cell subsets: These include Nigeria 
(Aina et al., 2005), Zimbabwe (Katzenstein et al., 1990), Senegal (Le Guenno et al., 
1991), Cote d’ Ivore (Kestens et al., 1992) and the Gambia (Whittle et al., 1993). 
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Rizzardini et al., (1998) compared lymphocyte profiles, among others, of HIV infected 
Ugandans and Italians with those of HIV uninfected Ugandan and Italian controls and 
found  similar percentages of CD3+CD8+ and CD3+CD4+ and CD4+ CD8+ ratios  between 
the controls and HIV infected groups.  
 
Contrary to the studies citing a trend towards low levels of CD4+ counts among Africans, 
in West Africa, higher levels were reported among 380 HIV infected adults compared to 
370 French participants. Approximate equivalencies of absolute CD4+ counts based on 
adjusted percent values were about a third higher in the West Africans than in French 
adults (Anglaret et al., 1997). Furthermore, healthy Ugandan adults (Tugume et al., 
1995; Lugada et al., 2004) and uninfected Tanzanian individuals (Levin et al., 1996) had 
mean CD4+ counts that are markedly higher than those found in healthy Ethiopians. 
 
These studies confirm evidence of significant geographic and ethnic variations that are 
postulated to play a role in the different haematologic and immunologic parameters, 
further endorsing a recommendation that local standardization of reference values and 
threshold decision levels should be undertaken (Anglaret et al., 1997). 
3.1.3 Flow Cytometry 
 
“Flow cytometry is a unique, powerful and technologically sophisticated methodology 
that utilizes principles of physics, biology, chemistry, engineering, digital electronics, 
optics, analog devices and laser technology to measure the light scattering and 
fluorescent characteristics of particles” (Walker, 1998). As a result of these features, flow 
cytometry has wide applications in various fields. 
 
In immunology, flow cytometry combines the specificity and stable binding of monoclonal 
antibodies with the unique properties of laser and flourescent light to quantify, 
characterise/identify target molecules and monitor function in cells. 
 
Basically, laser light illuminates single particles (within cells) in liquid suspension (in a 
fluidic system). As they pass through the light path, they scatter the laser beam. The size 
and texture of the particles will determine the amount of light scattered to the sides (side 
scatter (SSC) and forwards (forward scatter (FSC). The laser will simulteneously excite 
flourescence in antibodies conjugated to fluorochromes, the intensity of fluorescence 
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being directly proportional to the amount of target molecule bound by the antibodies. The 
specific fluorescent light from fluorochrome-labelled monoclonal antibodies and 
scattered laser light is collected in different channels for each stained particle/cell. The 
FSC, SSC and flourescent light is collected via a series of lenses, specific filters and 
beam splitters and directed to photomultiplier tubes (photodiode for FSC). These 
photodetector tubes then relay the signals and convert the light to electrical signals 
which are finally digitalized by the Analog to Digital Converter (ADC), placed into specific 
channels corresponding to the level of fluorescence and stored in the computer system. 
This allows for graphic analysis and interpretation of stored data after acquisition. The 
data may be displayed in a linear or logarithmic scale depending on its distribution 
(Davey and Kell, 1996). Earlier, flow cytometers used a single laser for the light source 
(Neon, Argon), and the technology advanced to the use of dual lasers in most 
instruments (BD Biosciences, 2004).   
 
Flow cytometry allows qualitative and quantitative analysis of multi-fluorochrome-labeled 
molecules on cell surfaces as well as intracellular molecules such as cytokines, 
hormones, DNA, proliferation antigens as well as functional aspects such as membrane 
potential determination (Walker, 1998). These can be determined at single cell level. 
Simultaneous multicolour staining and use of dual laser technology allows up to five 
parameter analysis within a single cell, thus results in generation of enormous amounts 
of quantitative and qualitative data from small quantities of sample. These unique 
features make flow cytometry highly reliable, cost effective, specific, dynamic and 
reproducible. 
 
To obtain optimum benefits from the numerous advantages of flow cytometry, the 
investigator needs to gain adept insight to use the sophisticated technique. This includes 
appropriate experiment planning and design, proper instrument settings including 
accurate compensation for spectral overlap and attention to detail during acquisition.  
 
In the present work, flow cytometry was used to differentiate lymphocyte populations 
(immunophenotypes), to assess the level of expression of activation markers on cell 
surfaces and functional (proliferation) aspects in lymphocytes.  
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3.1.4 Objectives of the chapter 
 
In view of the fact that helminths have been documented by others to be associated with 
a similar pattern of low CD4+ and increased CD8+ counts as in HIV infection, the 
assumption is that dual infection by both infectious agents would have an additive 
aberrant effect on the lymphocyte population distribution and proportions. In line with the 
study hypothesis, disease progression (as determined by viral load and absolute CD4+ 
counts in this section) would be enhanced by co-infection with helminths and HIV. The 
current section aimed to determine whether infection by helminths could be associated 
with alterations in peripheral blood lymphocyte subsets and eosinophils (and 
subsequently impair effective responses to HIV infection). Total lymphocytes and their 
subpopulations (T, B, NK, CD4+ and CD8+), eosinophil counts and viral load among 
groups of HIV infected and uninfected participants with or without helminth co infection 
were described in a South African setting. The secondary objectives were to elucidate 
whether if present, these immune alterations affected the HIV disease progression in 
terms of correlations between viral load, CD4+ and CD8+ counts in singly- and dually-
infected individuals.                    
 
3.2 Methods 
3.2.1 Participants and samples 
 
All participants with other infectious diseases (TB and STI’s) were excluded for this and 
all subsequent analyses. Clinical examinations by the study clinician, questionnaire 
responses and case-record files were used to screen for these infections. At the time of 
study the clinic was using an empirical (syndromic) approach to management and 
treatment of STIs, hence the prescribed treatments as appearing on patient files was 
also used as additional screening information (provided by the collaborating clinic  
clinician) for the presence of STIs.  Similarly TB treatment data was used as additional 
screening information. Thus immunophenotype data from EDTA anticoagulated whole 
blood of 149 HIV-1 positive participants and 45 HIV-1 negative controls were analysed in 
combination with the full blood counts that were done at the Tygerberg Hospital 
Haematology department.  
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3.2.1.1 Methodology description 
 
This description is adapted from the Becton & Dickenson Biociences (BD) Product 
Catalog Techical Resources (2003)a. The MultiTest  four- colour, two-tubes panel 
method employing direct immunofluorescence to determine the percentages of T 
lymphocyte (CD3+) subsets  (CD3+CD4+) and (CD3+CD8+) as well as non-T lymphocytes 
(CD16+/56+ NK cells and CD16+ B cells) was used. The two panels of monoclonal 
antibodies (mAbs) to human lymphocyte surface antigens already labeled with 
fluorochromes as listed in Table 3.1 were purchased from BD.  Panel 1 MultiTESTTM 
includes monoclonal antibodies to CD3/CD4/CD8/CD45 and panel 2 MultiTESTTM 
monoclonal antibodies to CD3/CD19/ CD16 and CD56/ CD45. 
 
Table 3.1 List of monoclonal antibodies and fluorochromes. 
The monoclonal antibodies to lymphocyte surface antigens (their clones in brackets) and the 
fluorochromes with which they are labelled are tabulated. The abbreviations of the fluorochromes 
are given and will be used in all subsequent text. The respective channels on the flow cytometer 
(FL1-FL4) where each fluorochrome is measured are shown in brackets. 
Cell Surface Marker(clone) Fluorochromes Full Name 
CD3 (SK7) FITC (FL1) Flourescein Isothiocyanate 
CD4 ( SK3) APC (FL4) Allophycocyanin 
CD8 (SK1) PE (FL2) Phyco-erythrin 
CD16+56B (73,1 & NCAM16,2) PE (FL2) Phyco-erythrin 
CD19(SJ25C1) APC (FL4) Allophycocyanin 




The BD/ Pharmingen staining procedure for labeling cell surface markers on whole blood  
was optimized to determine if microtiter plates could be substituted for the tubes without 
compromising the efficacy of the assay.  Five samples were stained in tubes, v-bottom 
and u-bottom microtiter plates. The results of all the 5 samples were highly reproducible. 
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An illustration of one of the samples is depicted in Table 3.2. Thereafter all subsequent 
staining procedures were done on v-bottom tubes. 
 
Table 3.2 Reproducible results obtained from staining in different containers.  
Typical reproducible results obtained from the same sample that was stained using different 
methods. All tests were performed in duplicate. Cells were stained with a cocktail of 
fluorochrome-conjugared monoclonal antibodies to CD45, CD3, CD4, CD8, CD 16/56 and CD19. 
The sample was stained in tubes, V-bottom and U-bottom microtiter plates.  The values are 
expressed as percentages of positive cells as determined by flow cytometry. The table represents 
data from one sample. 
 
Lymphocytes  (%) Tubes U-bottom V-bottom 
CD3 85 85 85 
CD4 25 25 25 
CD8 54 52 54 
NK 1 2 2 
B 5 6 4 
T h/s ratio 0.45 0.46 0.45 
Lymphosum 96.3 95.7 96.5 
CD3  difference* 1 2 0 
NK: natural killer lymphocytes; T h/s: T helper/suppressor ratio; B lymphocytes. *CD3              
lymphocyte difference.  
 
3.2.1.3 Procedure for Staining 
 
All reagents were equilibrated to room temperature.  (NB: Cold lysing solution would not 
lyse the cells adequately). Excess glove powder was removed by rinsing gloved hands in 
tap water to avoid particulate interference with flow cytometry analysis. Monoclonal 
antibodies were diluted 1:3 in sterile Phosphate Buffered Saline (PBS) pH 7.2 (Sigma) 
prior to each experiment. Each specimen was assigned to appropriate wells of a V 
bottomed 96-well microtiter plate (Costar Corning) for each of the antibody panels 1 and 
2. Twenty microliters of Panel 1 mAbs and 20L of Panel 2 mAbs were added to 
appropriately designated wells of the microtiter plate, ensuring that the mAbs solutions 
were added to the bottom of the well. The EDTA blood was mixed thoroughly by gently 
inverting the tubes five times. Fifty microliters of the well-mixed blood was pipetted into 
the designated wells containing antibody solutions. The antibody solutions were 
thoroughly mixed with blood by using a pipette.  The plate was covered and incubated in 
the dark at room temperature for 15 minutes.  After incubation, the plate was centrifuged 
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at 4°C at 300 ±30g for 3 minutes.  The excess supernatant was carefully aspirated by 
low pressure vacuum and discarded.  Using the multi-dispensing pipettor, 180 μl of 1x 
FACS lysing solution (BD) diluted in sterile distilled water, was added to all wells and 
mixed by gently shaking the plate in the IKA MTS Multiwell plate shaker (Sigma) at 
1000rpm for 30 seconds.  The plate was covered and re-incubated in the dark at room 
temperature for 10 minutes after which it was centrifuged for 3 minutes at 4°C at 300 
±30g to pellet the cells.  Diluted haemoglobin was removed from each well by aspiration 
as above. The cell pellets were resuspended by addition of 180L of filtered PBS to 
each well and by gentle mixing. The plate was covered and centrifuged for 3 minutes at 
4°C at 300 ±30g. The supernatants were aspirated and discarded. The 
wash/centrifugation steps were repeated one more time. The stained cells were then 
resuspended in 180μl of fixative (4% v/v formaldehyde (Sigma) in filtered PBS). The 
samples were transferred to disposable, polystyrene 12x75mm BD FACS tubes 
containing 450μl of 4% v/v formaldehyde in filtered PBS. These could be kept at 4ºC in 
the dark for up to 24 hours or analysed immediately on the FACS CaliburTM (BD) Neon-
Argon dual laser flow cytometer, using the MultiSET software program. Where 
necessary, the Cell Quest software was used to reanalyze discordant results. 
 
3.2.1.4 Flow cytometry analysis 
 
The flow cytometer was calibrated using the CalibriteTM  APC Beads Target Card (BD) 
and the 3 colour CalibriteTM  beads (BD) using the FACSCompTM software to set the 
Photomultiplier tube (PMT) voltage gain, detectors amplification  and spectral overlap 
compensation. The threshold was adjusted to minimise debris just before running the 
samples. Acquisition of samples then followed and for each sample the two sets of 
panels of antibodies were analysed in two tubes that were vortexed beforehand. 
 
The MultiSET TM software then determined the percentages of lymphocytes in each 
sample: Firstly a leucocyte gate was established on the side scatter versus CD45+ 
PerCP region wherein lymphocytes were identified as CD45 bright cells with low side 
scatter. From this region all T lymphocytes were gated on the basis of CD3 expression 
(CD3+). T helper/ inducer (CD3+ CD4+) and T suppressor/ cytotoxic (CD3+ CD8+) were 
then determined from these gates (Figure 3.1). Similar gating was established for the 
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second tube. From the leucocyte gate in the side scatter versus CD45+ PerCP  and side 
scatter versus CD3 plots, all CD3 negative lymphocytes, NK cells (CD3- CD16+CD56+) 
and B lymphocytes (CD3- CD19+) were computed. A double-platform method was then 
used to calculate the absolute counts of each lymphocyte subset from the total 
lymphocyte counts (from Haematology counts) and the lymphocyte percentages 





Figure 3.1 Gating strategy for identification of lymphocyte subsets.  
The gating strategy for identifying CD4+ and CD8+ lymphocytes from the combined regions is 
illustrated.  Whole EDTA blood was stained with fluorochrome-conjugated monoclonal antibodies 
to CD45, CD3, CD4, CD8, CD19, CD16 and CD56 and analysed with MultiTest software in the 
FacsCalibur flow cytometer. Leucocytes are gated and identified as CD45 bright cells with low 
side scatter (SC) on the SC versus CD45 dot plot (A) and lymphocytes then gated by CD3 
staining (B & D). T helper/ inducer (CD3+ CD4+), panel D and T suppressor/ cytotoxic (CD3+ 
CD8+) panel B were determined (upper right quadrants) from these gates. Panel C would indicate 
the proportion of double positive (CD4+ CD8+) lymphocytes (upper right quadrant). Similarly NK 
and B lymphocytes were gated as CD3- CD16+ plus CD56+ and (CD3-CD19+ respectively (not 




3.2.1.5 Quality control 
 
 To check that almost all the lymphocytes were included in the gate, the total 
lymphocyte sum (total T, B and NK) (lymphosum) accepted was as close as possible 
to 100 (the acceptable lymphosum is between 90 and 110%). 
 To establish minimal tube to tube variation, the accepted percentage CD3+ 
lymphocyte difference between the two tubes was less than 3%. 
 
3.2.1.6 Statistical analysis 
 
Statistica 7.0 and NCSS 2004 software were used for the statistical analyses. The 
median was used as a measure of central tendency for descriptive statistics. The normal 
distribution was tested by the Shapiro Wilks tests and variables with skewed data were 
log-transformed. As some of the variables remained skewed after this transformation 
non-parametric tests were used. Kruskal Wallis ANOVA was used to test the medians 
and for multiple comparisons of all measured variables between the HIV positive and the 
HIV negative subgroups. Findings were considered significant at the level of p≤0.05. 
 
3. 3 Results 
 
3.3.1 Summary characteristics of the HIV-1 positive and the HIV-1 negative 
participants.  
 
The results of this section are divided into two, the first part relates to all the participants 
whose EDTA blood samples were analysed for both full blood counts and phenotyping of 
lymphocyte subsets (Table 3.3). In the second part the results are analysed for those 
participants with complete data for helminth status stratification as well as lymphocyte 
phenotypes. 
  
Of the 151 HIV-1 positive participants who submitted blood samples, a total of 149 EDTA 
bloods were analysed for phenotypes and 124 had complete data for stratification, while 
45 of the 65 HIV-1 negative participants submitted bloods for phenotyping and 39 were 
suitable for stratified analysis. The demographic, viral and immunologic profile of all the 
participants are summarized in Table 3.3 and highlight the important immunologic 
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indices such as CD4+ and CD8+ counts for the 2 groups in this population. Expectedly, 
the HIV positive group medians were mostly lower than the HIV negative values (except 
indeed for higher CD8+ values in HIV+ group). 
 
In subsequent sections, median absolute numbers of lymphocyte subsets, eosinophil 
counts and viral load are compared within HIV-1 positive and negative subgroups 
stratified according to stool egg positivity and Ascaris lumbricoides-specific IgE (Ascaris 
IgE) as in section 3.2.2. The parameters are analysed to determine if helminth exposure 
results in anomalies that can be associated with impaired immune responses to HIV.  
 
Table 3.3 Characteristics and immunological indices for HIV-1 and HIV-1 negative groups.  
Demographic characteristics and immunological indices for HIV-1 positive and HIV-1 negative 
groups are shown. EDTA blood was used for full blood counts using H2 Technikon 
haemocytometer and flow cytometric analysis of lymphocyte phenotypes after staining with 
monoclonal antibody cocktails conjugated to fluorochromes. Separate samples were used to 
determine viral loads. Where applicable reference values are shown in brackets and these have 
been established within the local community served by the Tygerberg Academic Hospital 
(Tygerberg Hospital Haematology Dept). 
 
CHARACTERISTICS HIV-1 POSITIVE HIV-1 NEGATIVE 
Males 15 11 
Females 134 34 
Total 149 45 
 Median      25%       75% Median           25%     75% 
Age  ( years) 29.4           25.7          35.5 41.2                30.0       48.5 
Eosinophils (0.2- 0.6 x109/L) 0.14           0.07         0.27 0.24                 0.11      0.39 
Total lymphocytes ( 1.0-4.0 
x109/L) 
1.98           1.41         2.48  2.22                 1.91      2.81  
T lymphocytes (1.1-1.7cells/ml) 1.49           1.06        1.86  1.71                1.33       1.97 
CD8+(0.5-0.9 x109/L) 0.78           0.56        1.01 0.47                0.29       0.58 
CD4+ (0.7-1.1 x109/L) 0.32           0.29        0.47  0.74                0.59       0.86 
CD4:CD8 ratio 1-1,5 0.38            0.25       0.58  1.58                1.34       2.36 
NK cells (0.2-0.4 x109/L) 0.11            0.06        0.19 0.18                0.11       0.25 
B lymphocytes(0.2-0.4 x109/L) 0.11            0.07        0.17 0.25                0.21      0.35 
Viral load (copies/ml) 33317        170      120288       
25%, 75%= 25th and 75th percentiles respectively. The reference values as established for the local 
population at Tygerberg Hospital in brackets. NB: The local lower limits differ from those of the CDC 





3.3.2 Characterisation of subgroups by helminth infection and HIV status 
Excretion of parasite eggs by infested hosts is intermittent and stool microscopy has 
limited diagnostic sensitivity, examination of a single stool specimen can result in false 
results and misclassification of ihelminth infection (van Gooi et al., 2003). Furthermore, 
egg excretion is also a function of a competent immune system (Karanja et al., 1997) 
and worm burden (May and Anderson, 1979).The intensity of infection is documented to 
peak in children between the ages of five and fifteen years and is lower in adults (Bundy, 
1990), a phenomenon associated with the development and maturation of immune 
responses following prolonged exposure. In addition, hosts that harbour non-fecund and 
male species may not excrete eggs. For these reasons we proposed that sole reliance 
on the presence of parasite eggs in stool to diagnose helminthiasis can be misleading, 
particularly in adults and result in serious misinterpretation of co-infection studies 
(Adams et al., 2006). Furthermore, Maizels and Yazdanbakhsh (2003) presented three 
phenotypic outcomes of helminth infection that are determined by T helper cell and 
antibody isotype (IgG4 and IgE) profiles.  Each phenotype is characterised by specific 
immune responses to helminths. Stool egg detection was therefore supplemented with 
serum Ascaris lumbricoides –specific IgE measurement to increase diagnostic sensitivity 
of micrposcopy and delineate the serological phenotypes. 
 
Based on Ascaris-specific IgE levels and stool helminth-egg excretion, the two main 
groups of participants (HIV-1+ and HIV-1- ) were then further stratified into different 
categories depending on their evidence of exposure to helminth infection (egg excretion 
with or without elevated serum Ascaris -specific IgE) as follows: 
 Group 1 (egg+/IgEhi): Trichuris and/or Ascaris egg positive stool and elevated 
Ascaris IgE  (n =21)    
 Group 2 (egg+/IgElo): Trichuris and/or Ascaris egg positive stool without elevated 
Ascaris IgE (n=35)    
 Group 3 (egg-/IgEhi):  Trichuris and Ascaris egg negative stool but elevated 
Ascaris IgE (n =21) 
 Group 4 (egg-/IgElo): Trichuris and Ascaris egg negative stool and without 
elevated Ascaris IgE (n=47) 
Among the HIV-1 - the groups were: 
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Group 5 (egg+/IgEhi): n=9; Group 6 (egg+/IgElo): n=9; Group 7 (egg-/IgEhi): n=11; Group 8 
(egg-/IgElo): (n=10). 
Use of egg excretion alone as an indicator of helminth infection can be misleading, 
particularly in adults for several reasons. Firstly the sensitivity of stool microscopy is low 
and because excretion of intestinal parasite eggs is intermittent (van Gooi, 2003) studies 
whose aim is to analyse co-infection by helminths and other infectious agents.  
 
 
3.3.3 Immunophenotype profiles of subgroups in HIV+ and HIV- groups 
 
To evaluate any differences between groups with HIV-helminths co-infection and those 
without, the median values for the various variables were desribed within the subgroups 
as tabulated in Tables 3.4 and 3.5 for HIV positive and negative groups respectively.  
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Table 3.4 Median values for eosinophils, viral load and lymphocyte subsets in HIV-1+ subgroups.  
Median, minimum and maximum values of lymphocytes, eosinophils and viral loads in HIV+ groups classified as either 
excreting/not excreting helminth eggs- with or without elevated Ascaris IgE. Data represent results of full blood counts, 
viral load determination and ex vivo phenotyping of whole blood obtained from these HIV+subgroups. Whole EDTA blood 
was stained with fluorochrome-conjugated monoclonal antibodies to CD45, CD3, CD4, CD8, CD19, CD16 &CD56 and 
percentages of cells expressing these surface markers determined by flow cytometry. Absolute CD4+, CD8+, numbers 
were obtained by multiplying the absolute counts by percentages per total counts. Cells are expressed in count x 109/L. 
and viral load in mRNA copies /ml. 
 EOSIN 
TOT 
LY T LY CD8 CD4 
CD4:
CD8 NK LY B LY V-LOAD 
Group 1 egg+/IgEhi   n = 21  
Median 0.32a 1.72 1.30 0.66 0.28a 0.38a 0.11 0.09a 70878 
25% 0.1 1.56 1.1 0.58 0.15 0.28 0.09 0.06 41 449 
75% 0.79 1.9 1.58 0.93 0.43 0.44 0.18 0.11 120 288 
Group 2 egg+/IgElo    n = 35  
Median 0.15b 2.1 1.75 0.84 0.41b 0.48b 0.12 0.15b* 25666 
25% 0.07 1.61 1.21 0.58 0.27 0.37 0.06 0.09 1886 
75% 0.25 2.8 2.25 1.02 0.66 0.8 0.19 0.22 70 615 
Group 3 egg-/IgEhi   n = 21  
Median 0.18b 1.89 1.39 0.78 0.32b 0.37a 0.10 0.12b 87813 
25% 0.1 1.54 1.24 0.57 0.16 0.27 0.06 0.08 4929 
75% 0.3 2.06 1.73 0.99 0.46 0.69 0.21 0.16 165 421 
Group 4 egg-/IgElo  n =47   
Median 0.10b 1.98 1.25 0.66 0.23a 0.34a 0.11 0,10b 28258 
25% 0.06 1.15 0.83 0.43 0.12 0.17 0.06 0.05 4178 
75% 0.23 2.3 1.8 1.1 0.39 0.55 0.18 0.14 199 859 
*All HIV+  n=149    
Median 0,14 1.98 1,49 0,78 0,32 0,4 0,1 0,1 33317 
Legend: 25%, 75%= 25th and 75th percentiles respectively.Eosin: eosinophils;Tot Ly Total lymphocytes; T ly T-
lymphocytes; CD4:CD8  ratio. *All HIV+ are the overall median values obtained from all the 45 HIV negative participants 
inTable 3.2; CDC reference ranges- CD4+: 0,475-1,616 x109 cells/L; CD8+:0,209- 0,924x109 cells/L (NHANES).The 
CD4+ and CD8+ ranges for the HIV negative group 8 without evidence of helminth exposure (presumably representing 
healthy controls for this population) fall below the CDC reference ranges, albeit the small number of individuals in this 
group (N=10). Subgroups with significant interactions shown in red while similar groups are indicated with similar letters. 
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Table 3.5 Median values for eosinophils and lymphocyte subsets in HIV-1- subgroups. Median, 
minimum and maximum values of lymphocytes subsets and eosinophils in HIV- groups stratified by stool 
helminth eggs (microscopy) with or without elevated Ascaris IgE.Data represent results of full blood counts 
determination and from ex vivo phenotyping of whole blood obtained from these HIV-subgroups. Whole 
EDTA blood was stained with fluorochrome-conjugated monoclonal antibodies to CD45, CD3, CD4, CD8, 
and CD19, CD16 and CD56 and percentages of cells expressing these surface markers determined by flow 
cytometry. Absolute lymphocyte numbers were derived from multiplying the percentages by total counts 
from full blood counts. Cells expressed in count x109 /L 
 Eosin *Tot ly *T ly CD8 CD4 
CD4:
CD8 NK ly B ly 
Group 5 egg+/IgEhi   n = 9 
Median 0.37a 1.95a 1.40 0.36 0.67 1.86 0.08 0.22 
25% 0.24 1.67 1.29 0.20 0.55 1.52 0.08 0.2 
75% 0.45 2.18 1.71 0.56 0.72 2.2 0.18 0.23 
Group 6 egg+/IgElo   n=9 
Median 0.12b 2.65b 1.91 0.49 0.75 1.54 0.17 0.29 
25% 0.08 2.17 1.52 0.38 0.66 1.26 0.16 0.27 
75% 0.2 2.81 2.0 0.59 0.79 2.19 0.22 0.37 
Group 7  egg-/IgEhi   n =11 
Median 0.31a 2.87b 1.73 0.47 0.68 1.37 0.23 0.25 
25% 0.15 2.01 1.63 0.29 0.58 0.98 0.17 0.14 
75% 0.56 2.97 2.22 0.77 0.93 2.36 0.27 0.34 
Group 8 egg-/IgElo   n =10 
Median 0.22b 2. 79b 1.83 0.41 0.76 1.85 0.16 0.24 
25% 0.10 1.8 1.33 0.29 0.68 1.5 0.09 0.21 
75%` 0.29 2.79 2.0 0.54 0.89 2.36 0.28 0.44 
All HIV - n=45 
Median 0,2 2,22 1,71 0,47 0,74 1,58 0,18 0,24 
Legend: 25%, 75%= 25th and 75th percentiles respectively. Eosin: eosinophils;Tot Ly Total lymphocytes; T ly 
T-lymphocytes; H/S  helper/suppressor ratio. *All HIV- are the overall median values obtained from all the 45 HIV negative 
participants inTable 3.2; CDC reference ranges- CD4+: 0,475-1,616 x109 cells/L; CD8+:0,209- 0,924x109 cells/L 
(NHANES).The CD4+ and CD8+ ranges for the HIV negative group 8 without evidence of helminth exposure (presumably 
representing healthy controls for this population) fall below the CDC reference ranges, albeit the small number of 
individuals in this group (N=10). Subgroups with significant interactions shown in red while similar groups are indicated 





3.3.4 Interactions between variables in subroups 
3.3.4.1. The HIV-singly-infected (egg-gElo) group does not differ from the HIV and 
typical helminth co-infected (egg+IgEhi) and all dually infected subgroups. 
According to the study hypothesis, the HIV-1+, egg-/IgElo group should have a relatively 
competent immune profile as the group is singly-infected by HIV while the other three 
subgroups have evidence of dual infection. Contrary to expectation, it is noteworthy that 
the egg-/IgElo group had the lowest median absolute CD4+ cell and lymphocyte counts. 
Additionally, when comparing the egg+/IgEhi group with the egg-/IgElo group, there were 
no significant differences in median values for all  the measured variables except for 
eosinophils which were significantly higher in the dually infected individuals (Table 3.4 
and Figure 3.2  in page 109) In contrast, the helminth uninfected group had lower T 
lymphocytes, CD4+ counts, CD4:CD8 ratio and similar levels of CD8+  and NK 
lymphocyte counts when compared to the group with typical helminthiasis (egg+/IgEhi).  
 
The HIV negative, helminth uninfected (egg-IgElo) and the typical helminth infected 
(egg+IgEhi) subgroups: 
Higher median absolute counts for all T and non-T lymphocyte subsets and similar 
CD4:CD8 ratios were observed when the egg-gElo was compared to the typical helminth 
infected subgroup (egg+/IgEhi), Total lymphocyte counts were significantly higher 
(p=0.05) in the egg-gElo group and a lower trend (p=0.09) in eosinophils was present. 
In both HIV positive and negative groups, the egg-/IgElo typically had lowest eosinophil 
counts as eosinophilia is mainly associated with helminth infection. 
 
 
3.3.4.2. The HIV positive, egg+/IgEhi group shows a tendency to lymphocytopaenia 
and significant eosinophilia.  
 
Amongst the subgroups with evidence of dual infection, in the HIV+, helminth eggs+ and 
high Ascaris IgE (egg+/IgEhi) group, the median absolute values were lower for all 
lymphocyte populations, compared to the overall absolute count medians for the entire 
HIV positive group and also lower compared to the egg+/IgElo and the egg-/IgEhi groups 
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(Table 3.4 page 103).  The lower values reached significance for B lymphocytes 
(p=0.02) between this egg+/IgEhi and the egg+/IgElo groups (Figure. 3.2 Panel H). 
 
The egg+/IgEhi status was also associated with more frequent eosinophilia compared to 
the other three subgroups and this difference was statistically highly significant (p=0.01) 
between this egg+/IgEhi group and the egg-/IgElo group (no evidence of worm exposure) 
Figure. 3.2 panel A.   
 
The median viral load for the egg+/IgEhi group appeared to be more than 2-fold higher 
than that of the entire HIV+ group and nearly 3-fold higher than those of the egg+/IgElo 
and egg-/IgElosubgroups (Table 3.4). These were however not statistically significant 
(p=0.12). It is noted that the egg-IgEhi subgroup had the highest viral load. 
 
The HIV negative, Egg+IgEhi group displays lymphocytopaenia and eosinophilia.  
 
As in the HIV positives, among the dually infected subgroups, the HIV uninfected, 
egg+/IgEhi participants had lower median values for all lymphocyte subsets except the 
CD4:CD8 ratio that was highest (Table 3.5). Total lymphocytes were significantly lower 
in the egg+/IgEhi compared to the egg-/IgEhi group (p=0.05) (Figure 3.3 in Appendix 1). 
 
Furthermore, the egg+/IgEhi group had marked eosinophilia (Table 3.5) compared to the 
rest of the HIV-1 negative subgroups. Absolute eosinophil counts also showed a higher 
trend in the egg+/IgEhi group compared to the group without evidence of helminth 
infection (egg-/IgElo group (p=0.09) (Figure 3.3).  
 
3.3.4.3 Low IgE and presence of stool eggs is associated with higher CD4+ counts, 
lower viral load and a tendency towards an increase in all lymphocyte 
populations. 
 
The HIV+, Egg+ IgElo group 
The egg+/IgElo participants had highest median values for all measured variables (Table 
3.4. Differences in CD4+, and CD4:CD8 ratio medians were highly significant (p=0.01, 
and p=0.03 respectively) between the egg+/IgElo and the egg-/IgElo groups (Figure 3.2 
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panels E and  F).  B lymphocyte median values also differed significantly between this 
egg+/IgElo and the egg+/IgEhi  subgroups (p=0.02) (Table 2b). 
 
 
Additionally, the median absolute numbers of all the lymphocyte subsets were even 
higher than the overall values for the entire HIV positive group (Table 3.4). 
 
Finally, the egg+/IgElo group also had the lowest median viral load (Table 3.4) although 
this was not statistically significant (p=0.12).  
 
The HIV- , Egg+ IgElo group: 
In the HIV negative group, among the helminth infected subgroups, the egg+/IgElo 
participants appeared to have the highest median T-,CD4+, CD8+  and B  lymphocyte 
counts. The median CD4+ was similar to the values for the egg-/IgElo group (without 
evidence of helminth infection) (Table 3.5 page 104). However, no statistical significance 
was reached for these observations. 
 
Other observations in this section included the findings that low IgE also typically is 
accompanied by low eosinophil counts, particularly in the HIV uninfected groups.  
 
3.3.4.4 High IgE was associated with higher viral loads in the HIV positive group 
 
Among the HIV infected participants, both groups with elevated IgE (the egg+/IgEhi and 
egg-/IgEhi groups)  had highest median viral loads (70 878 copies per ml (cpml) and 87 
813 cpml respectively) compared to the two groups with low Ascaris IgE -egg+/IgElo and 
egg-/IgElo (25 666 cpml & 28 257 cpml respectively Table 3.4). Although these 
differences in viral load were not statistically significant, the two groups with high IgE had 
almost three-fold higher median values.  
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High IgE and eosinophilia were associated with lower CD4+ counts in the HIV 
negative group 
Likewise, among the HIV uninfected individuals, both groups with high IgE                                                                       
(egg+/IgEhi and egg-/IgEhi) had marked eosinophilia and lower median CD4+ counts 
(Table 3.5). 
In summary,: 
 The egg-/IgElo and the egg+IgEhi subgroups did not differ in the HIV infected 
group except for significantly lower eosinophil counts, while in the HIV negative 
group all measured variables except the CD4:CD8 ratio, were lower in the 
egg+IgEhi,compared to the egg-/IgElo subgroup. 
 The egg+/IgEhi helminth infection was associated with generalised reduction of all 
lymphocyte populations irrespective of HIV status, amongst the helminth infected 
subgroups.  
 High IgE was accompanied by higher viral load in the HIV positive group; while it 
was related to eosinophila and lower CD4+ counts in HIV uninfected individuals. 
 The stool egg positive group with low IgE had higher median T- and non-T 
lymphocytes and lowest median viral load in the HIV positive group while this 
was true for T lymphocytes, CD8+ and B lymphocytes in the HIV negative group. 
Median CD4+ count was similar to that of the helminth-uninfected subgroup.  
 
With the exception of significant reduction in B cells in HIV+/egg+/IgEhi group, no marked 
differences were observed in NK and B cell populations in the other subgroups (Tables 































































































































Figure 3.2 Kruskal Wallis Box and Whisker Plots for lymphocyte phenotypes in HIV+ 
groups.    
Whole EDTA blood was stained with fluorochrome-conjugated monoclonal antibodies to CD45, 
CD3, CD4, CD8, CD19, CD16 and CD56 and percentages of cells expressing these surface 
markers determined by FacsCalibur flow cytometry using the MultiTest software. Full blood 
counts were done for eosinophil counts and dual platform calculation of absolute lymphocyte 
counts. Viral load was determined by PCR.  
Egg+ IgEhi group (n = 17) stool egg positive and elevated serum Ascaris lumbricoides-specific 
IgE; Egg+ IgElo group  (n=35) stool helminth egg positive  and low  Ascaris lumbricoides IgE;  
Egg- IgEhi  group  (n=21) No stool egg excretion and high Ascaris lumbricoides IgE; Egg- IgElo  
group  (n=47) No stool  egg excretion and low Ascaris lumbricoides IgE. Significantly different group 
/s shown in deep blue. The Y axis shows the absolute cell counts per milliliter of blood, and viral 









Table 3.6 Kruskal Wallis ANOVA, Median tests and multiple comparisons of eosinophils 
and lymphocytes in HIV+ groups.  
Lymphocyte phenotypes were determined using flow cytometry. Percentage medians of each cell 
population were compared by Kruskal Wallis ANOVA for significant differences in each of four 
HIV+ subgroups. Two tailed comparative p values are shown for all significant interactions.  
 
Variable N KruskalWallis 
ANOVA by rank 
p values 
Median 








the significant p 
values 
Eosinophils 124 0.009 0,014 0,013 *1 & 4 
Total Lymphs 124 0,506 0,619 0,512  
T-lymphocytes 124 0,240 0,909 0,167  
CD8+ 124 0,661 0,178 0,561  
CD4+ 124 0,012 0.026 0,011 *2 & 4 
H/S ratio 124 0.030 0.032 0,035 *2 & 4 
NK cells 124 0,826 0.673 0,712  
B  Lymphs 124 0.030 0.112 0.095 1 & 2 
Viral load 119** 0,041 0.008 0.056 *2 & 3 
*Group 1 – Egg+IgEhi ; *Group 2- Egg+IgElo  *Group 3- Egg-IgEhi *Group 4- Egg-IgElo . Egg- faecal 
helminth eggs. IgEhi - high serum Ascaris lumbricoides-specific IgE; IgElo – low serum Ascaris 
lumbricoides-specific IgE NB.** If extreme values for viral load are excluded from analysis the 





3.3.5 Maximum Viral loads and Correlates of immunodeficiency among HIV 
positive participants  
 
To determine the interaction of exposure to helminths and the parameters of advanced 
HIV disease in this population, the level of immunodeficiency was compared between 
the four subgroups of participants with and/or without HIV-helminth co-infections. The 
recognised indicators of immunodeficiency in HIV disease, namely level of CD4+ 
depletion and viral loads were used to grade disease severity because there is no follow 
up data in this cross-sectional study to assess progression of disease.  The international 
thresholds (CDC, 1993) of onset of immunodeficiency (<0,5 cells x109/L) and 
advanced/severe immunodeficiency, (<0,2 cells x109/L) were used to categorise the 
groups for level of disease progression. The overall group median (0,32 cells x109/L) is 
similar to the CDC threshold of 0,35 x109/L identified as a level below which functional 
immune deficiency is present in resource-poor settings (World Health Organization 
(WHO), 2005; AIDS Education and Training Centers (AETC), 2006), thus this cut-off 
level was also used to grade the immunodeficiency (as moderate) in the subgroups of 
the study population. For viral loads, the first level of grading was based on the overall 
median for the group (33 000 copies/ml) and the cutoff levels of  100 000 and 1x106 
copies/ml were used in Table 3.7 to further characterise the  immunodeficiency. 
 
The proportions of individuals with viral loads exceeding 100 000 in each subgroup 
were: 33% (Egg+IgEhi); 17% (egg+IgElo); 48% (egg-IgEhi) and 29% (egg-IgElo). In the 
latter, three individuals had virus burden exceeding 1 000 000 cpm. The egg+IgElo group 
had the highest proportion of participants (19 of  35) with less than 33 000 copies/ml and 
none of the group individuals had virus concentrations exceeding  1000 000 copies/ml ( 
Table 3.7).  
 
Grading by CD4+ counts showed that the  the percentages of individuals with severe and 
moderate immunodeficiency were 62% (egg+IgEhi); 31% (egg+IgElo); 56% (egg-IgEhi) and 
70% (egg-IgElo).The egg+IgElo group had the lowest proportion of individuals with severe  
immunodeficiency  (14%  versus  33% and 38% in the other three groups) and the group 
had the highest number of individuals  with CD4+ counts >0.5 cells x109/L than the other 
three subgroups ( Table 3.7).Figure 3.3a 
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In dual infection, low CD4+ counts frequently associated with high virus burden. In all 
three subgroups with evidence of dual infection, almost all individuals with < 0.2 cells 
x109 /L had viral loads exceeding 100 000 copies per millilitre. However, in the egg-IgElo 
subgroup, 13 of 18 individuals with < 0.2 cells/L had viral load less than 100 000cpm.  
(Results not shown). 
 
 
Figure 3.3a Grading immunodeficiency by CD4 + count levels. Percentages of individuals in subgroups 
of HIV+ with di fferent grades o f immunodeficiency m easured by  CD4+ counts c ategories fourHIV a nd 
helminth infection subgroups. The Y axis shows the percentages of individuals in each subgroup while the X 






Figure 3.3b Grading of viral load levels in the four subgroups of HIVand helminth 
infection. .Percentages o f H IV+ individuals i n co-infected s ubgroups w ith d ifferent categories of  v irus 
burden. The Y axis shows the percentages of individuals in each subgroup while the X axis represents the 
levels of virus burden in copies per ml.  
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In summary, grading of immunodeficiency by CD4+ counts and viral load did not reveal 
significant  differences between the egg+/IgEhi and the egg-IgElo groups. However, there 
were relatively higher numbers of individuals with CD4+ above 0.5 cells/ml and more 
individual with virus burden below 33 000 cpm in the egg-IgElo subgroup ( figures 3.3a 
and 3.3b) . The egg+/IgElo group participants consistently had lower proportions of 
individuals with advanced immunodeficiency in terms of both CD4+ counts and viral 
loads. None of the egg+/IgElo group participants had virus concentrations equal to or 
greater than 106 copies/ml, while the maximum load was lowest in this group and highest 
in the egg-/IgElo group, without evidence of helminth infection (Table 3.7). 
 
Both groups with high IgE (the egg+/IgEhi and egg-/IgEhi groups) had the higher 
percentages of individuals with viral load exceeding 100 000 cpml (33% and 48% versus 
17% and 29% in the two low IgE groups). No differences in proportions of individuals 
with immunodeficiency were noted between egg+/IgEhi group and the group without 
evidence of exposure to helminths (egg-/IgElo). 
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Table 3. 7 Proportions of HIV+ participants grouped by helminth infection and their HIV 
disease stage surrogate markers. 
Whole EDTA blood was stained with monoclonal antibodies conjugated to fluorochromes and 
analysed by flow cytometry. Full blood count results were used to derive absolute lymphocyte 
counts. Viral load was determined by PCR. CD4+ absolute counts and viral load threshold data 
were then established and used to define the level of HIV disease in each of the 4 subgroups. 













<0.2 7 (33%) 5    (14%) 7 (33%) 18 (38%) 
0.2-0.34 6 (29%) 6    (17%) 5 (23%) 15 (32%) 
0.35-0.5 6 (29%) 13   (37%) 4 (19%) 6   (13%) 





    
>1  000 000 1 (4.7%) 0  2 ( 9.5%) 3    (6.4%) 
101 000-1 000 000 6  (28%) 6 (17%)  8 (38%) 11 (23%) 
 34 000-100 000 9 (43%) 10 (28%) 3   (14%) 9   (19%) 
≤ 33 000 5 (23%) 19 (54%) 8   (38%) 24 (51%) 
Maximum Viral 
load 
1 013 265 448 447 1 711 249 3 637 244 
*Egg+: presence of faecal helminth eggs. Egg-: no faecal helminth eggs. IgEhi: high serum Ascaris 
lumbricoides-specific IgE. IgElo : low serum Ascaris IgE.  
Four levels of CD4 count threshold were set to grade immunodeficiency, ie <0.2, 0.2-0.34; 0.35-.5;>0.5 x109 
cells/L to represent Aids defining severe, moderate ,onset  and immunocompetent respectively. Also, four 
cutoff levels of virus burden were set at ≤33 000, 34 000-100 000;101 000;1 000 000 and  > 106 RNA 
copies/ml for the overall median burden in the group, increased, therapy initiation and AIDS defining levels 
respectively. (AETC, 2006) 
3.3.6   Correlations between Viral Load, CD4+ and CD8+counts. 
 
The relationship between virus burden and the number of immune cells targeted by HIV 
(CD4+ cells) and the number of CD8+ cells were assessed as a proxy indicator of 
disease progression in the four subgroups. The correlation in the subgroups 
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(representing the different infection phenotypes) were evaluated to determine if 
advancing disease (for instance a strong negative correlation between CD4+ and viral 
load) would be associated with certain groups of co-infected individuals. 
 
 
The relationships among viral load, CD4+ and CD8+ counts were assessed by Spearman 
Rank (r) correlation. 
 
3.3.6.1 Correlation between CD4+ and viral load 
The correlation between CD4+ counts and viral load was determined within the entire 
HIV-1+ group and within each of the 4 subgroups by the Spearman rank correlation. 
 
Table 3.8 a Correlation between CD4+absolute counts and viral load.  
HIV subgroups N r  p-value 
1(Egg+ IgEhi) 21 -0.61 0.01 
2 (Egg+ IgE lo) 35 -0.53 0.01 
3 (Egg- IgEhi) 21 -0.69 0.01 
4 (Egg-  IgElo) 47 -0.38 0.01 
All groups 124 -0.51 0.01 
*Egg+: presence of faecal helminth eggs; Egg-: no faecal helminth eggs; IgEhi: high serum Ascaris 
lumbricoides-specific IgE; IgElo: low serum Ascaris IgE. 
 
Overall there was a significant negative correlation (r= -0.51; p<0.05) between viral load 
and CD4+ counts when all the HIV+ participants were analysed as one group. This 
inverse correlation was stronger in both groups with high Ascaris IgE (the egg+/IgEhi and 
egg-/IgEhi groups) and moderate in the egg+/IgElo group  while in the egg-/IgElogroup the 
negative correlation was significant but weakest (Table 3.8a)  
 
3.3.6.2 Correlation between CD4+ and CD8+ absolute counts 
Correlation between CD4+ and CD8+ was determined in all the 124 HIV-1+ individuals 
and within each of the 4 groups by the Spearman rank correlation. 
 
Table 3.8 b Correlation between CD4+ and CD8+absolute counts 
HIV subgroups N r  p-value 
1(Egg+ IgEhi) 21 0.72 0.01 
2 (Egg+ IgE lo) 35 0.56 0.01 
3 (Egg- IgEhi) 21 0.38 0.09 
4 (Egg-  IgElo) 47 0.54 0.01 
All groups 124 0.54 0.01 
*Egg+: presence of faecal helminth eggs; Egg-: no faecal helminth eggs; IgEhi: high serum Ascaris 
lumbricoides-specific IgE; IgElo: low serum Ascaris IgE. 
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A significant positive correlation (r=0.54; p<0.05) was found in all 124 HIV positive 
participants between CD4+ and CD8+ counts. The egg+/IgEhi group had the strongest 
relationship between the two variables while this was moderate and similar in both 
groups with low IgE. The correlation was weakest in the egg-IgEhi group 3 (Table 3.8b).  
 
3.3.6.3 CD8+ vs viral load. 
The correlational relationship between CD8+ and viral load was determined within the 
entire group HIV-1+ and within each of the 4 groups by the Spearman rank correlation. 
 
Table 3.8 c Correlation between CD8+ and viral load.  
 
HIV subgroup N r  p-value 
1(Egg+ IgEhi) 21 -0.56 0.02 
2 (Egg+ IgE lo) 35 -0.06 0.75 
3 (Egg- IgEhi) 21 -0.10 0.67 
4 (Egg-  IgElo) 47  0.03 0.84 
All groups 124 -0.07 0.43 
*Egg+: presence of faecal helminth eggs; Egg-: no faecal helminth eggs; IgEhi: high serum Ascaris 
lumbricoides-specific IgE; IgElo: low serum Ascaris IgE. 
 
 
Although there was a very weak inverse correlation between CD8+ cells and viral load 
when all the HIV positive individuals were analysed as a group, only the egg+IgEhi group 
showed a stronger negative correlation (r= -0.56; p<0.05) between the two variables 
(Table 3.8c).  





The current chapter analysed lymphocyte proportions, eosinophils and viral loads in 
relation to HIV-1 with or without helminth co-infections. In addition to faecal egg 
excretion, elevated Ascaris lumbricoides specific IgE was also used to strengthen the 
distinction between helminth infection and non-infection and stratify immune phenotypes 
on the basis of egg excretion and specific IgE levels.  Possible associations between 
HIV-helminth co-infection and compromised responses to HIV were assessed in terms of 
differences in lymphocyte counts (and in particular CD4+ lymphocytes) and viral load 
between groups with or without dual infections. Correlates of HIV disease progression in 
the various subgroups were also evaluated in terms of correlations between CD4+, CD8+ 
counts and viral load. 
 
According to the study hypothesis, the immune profile of the HIV-singly-infected 
individuals without any evidence of worm infection (egg-IgElo) would be relatively 
competent compared to their dually-infected counterparts. Findings in the present 
section showed significantly lower eosinophils in the egg-IgElo when compared to the 
typical helminth infected, egg+IgEhi . No other  significant  differences between this egg-
IgElo  and the egg+IgEhi  subgroup was found, although the singly infected HIV positive 
subgroup had comparatively more individuals with lower virus burden  and CD4+ counts 
above 0.5 cells/ml.   In the absence of HIV infection, a tendency to higher T and non-T 
lymphocytes (significantly higher in total lymphocytes and a lower trend in eosinphils)   
was observed between the egg-IgElo and the typical helminth infected egg+IgEhi 
subgroup, although the rest of the differences were not statistically significant. When the 
dually infected subgroups (egg+IgEhi, egg+IgElo, egg-IgEhi) were campared, distinct 
immune profiles emerged that suggested that some helminth infection phenotypes could 
favour HIV replication while others do not.  
 
The fact that the results from the group of HIV-1 singly-infected individuals (egg-/IgElo) 
were not particularly different from those of the groups with evidence of worm infection, 
and were almost similar to those of the egg+IgEhi group could be due to the complex 
dynamics of interactions between the two infections.  
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When comparing the egg+/IgEhi and egg-/IgElo HIV uninfected groups, all measured 
variables, except the CD4:CD8 ratio, were lower (though not statistically significant 
except for eosinophils), in the former group. The relatively smaller numbers in the HIV 
negative subgroups could have influenced the power to obtain statistically significant 
differences.  The fact that no such differences were noted in the HIV positive groups may 
suggest the probability that HIV-induced immunosuppression could be responsible for 
masking any differences in the latter. Firstly the HIV+, egg-/IgElo group had the lowest 
median CD4+ counts (Table 3.4). Secondly, using CD4+ counts independent of virus 
burden, similar percentages of participants in the egg+/IgEhi and egg-/IgElo groups were 
severely immunocompromised (less than 0, 2x109 cells/L CD4+ counts) and were slightly 
higher in the egg-/IgElo group. Furthermore, the proportions of individuals with higher 
virus burden (as determined by viral load >105 copies/ml) were also similar in the two 
groups (also slightly higher percentage in the egg-/IgElo group).  The individual with the 
maximum viral load was found in this group (Table 3.4). Furthermore, three individuals in 
the egg-IgElo subgroup had virus burden exceeding 1 000 000 cpm.  These observations 
may support the suggestion that HIV-induced immune suppression could obscure 
differences resulting from the effects of helminth infection and non-infection that may be 
present in the two groups.  
 
Collorary to that suggestion may be an alternative, non-mutually exclusive explanation: 
The possibility that some participants within this group (without elevated IgE and no 
faecal helminth eggs) could be harbouring occult helminth infection as a result of being 
highly immunosuppressed was explored, in view of the unsanitary living conditions of 
this population. If indeed this group represents highly immuno-suppressed individuals, 
this could result in an inability to produce antibodies and excrete eggs.This is based on 
the reports that worm development and egg excretion are documented to be a function 
of a competent immune system: It has been shown in animal models that egg excretion, 
worm fecundity and larval size were smaller in immunocompromised mice compared to 
normal controls (Viney, 2002). Likewise HIV infected patients with lower CD4+ counts 
and coinfected with Schistosoma mansoni excreted fewer eggs compared to HIV-
uninfected schistosomiasis-patient controls (Karanja et al., 1997). The authors ascribed 
these differences to the requirement for a competent immune system for egg excretion.   
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On the other hand, if indeed this group represents highly immuno-suppressed 
individuals, it would be expected that all cellular components (including eosinophils, 
total, T, CD8+, NK and B lymphocytes would also be repressed, which was not  the case. 
In addition, the median viral load for this group was lower than in the two groups who 
had elevated IgE and eosinophilia, although the individual with the maximum viral load 
was in this group. However, the fact that  in the absence of HIV, there were differences 
in proportions of lymphocytes, wherein the egg+/IgEhi  group had  lower proportions of all 
lymphocyte subsets, compared to the group without evidence of helminth exposure  
suggests a confounder effect of HIV. The lower numbers of HIV negative groups limited 
the analysis. Based on these observations, the study hypothesis can neitherbe accepted 
or rejected, suggesting the need for increased numbers of controls for matching in future 
studies. 
 
However, when the dually-infected subgroups were analysed, several observations 
suggest that certain immunological phenoytypes of helmninth infection may favour HIV 
replication, thus by inference lend support to the study hypothesis that helminthiasis 
might enhance virus replication. Firstly, typical helminth infection (as reflected by the 
egg+/IgEhi status) was accompanied by eosinophilia and showed a trend towards the 
reduction of all lymphocyte subsets when compared to the other three subgroups. This 
tendency was observed in both HIV positive and negative groups. This finding concurs 
with the report that chronic helminth infections in Ethiopian adults resulted in disruptions 
in peripheral T cell populations (Kalinkovinch et al., 1998). The observed decrease in 
lymphocyte populations among the egg+/IgEhi individuals in this study, when interpreted 
in light of the fact that that lymphocytes play  a pivotal role in immune response to 
infection in general,  could indirectly  relate to a compromised immunological ability to 
respond to  HIV. This would be in agreement with the study hypothesis. 
 
A positive correlation between CD4+ and CD8+ counts was found in our study. Owing to 
the fact that the dynamics of total CD8+ cell numbers during HIV infection are such that 
they remain high throughout all the phases of infection (primary, chronic infection and 
advanced (AIDS),and the  fact that this is a cross sectional study and  total  CD8+ cell 
numbers, not HIV-specific CD8+T cell responses were evaluated, the positive correlation 
observed in the present analysis is fitting.  
   
 120 
Another observation in support of the study hypothesis is that high Ascaris lumbricoides 
IgE responders in the study population typically had associated eosinophilia particularly 
in the HIV negative group, and in the HIV+ this was observed only in the egg+IgEhi 
group: both high IgE and eosinophilia are features of Th2 responsiveness.  Among the 
HIV-1+ individuals, higher median viral load was found in both subgroups with high IgE. 
Upon grading the level of immunodeficiency by viral load, these groups also had the 
highest proportion of individuals with high virus burden. These findings suggest a 
relationship between Th2 responses and an increased potential for HIV replication as 
reflected by high virus burden.  In the HIV-1 uninfected group, hyper-IgE and 
eosinophilia showed a tendency towards relatively lower median CD4+ counts (0.67 and 
0.68 cells/ml compared to 0.75 and 0.76cells/ml respectively). By inference, it may be 
possible that if these people subsequently become HIV positive they would be less able 
to control the infection. Furthermore, eosinophils are documented to express CD4 
molecules and have been shown to be infectable by HIV in vitro (Conway et al., 1992; 
Weller et al., 1995). Hypothetically, increased frequency of these cells increases the 
number of host cells receptive to the virus and therefore possibly sustains its replication 
cycle. It is noteworthy that while both high IgE responders in the HIV negative group had 
eosinophilia while  in the HIV positive group, the egg-IgEhi subgroup  did not show an 
increase in these counts. One possible explanation could be the fact that this subgroup 
had the highest median viral load compared to all three subgroups. It could be related to 
virus-induced depletion of these cells that have been shown to be infectable by HIV. 
 
The relationship between high IgE, eosinophilia and higher viral load found in the 
present study therefore support the study hypotheses suggesting that (i) Th2 biased 
individuals fail to contain the HIV infection which is controlled by the Th1 CTL response 
(ii) helminth infections favour HIV replication in certain helminth immune phenotypes.    
 
It is noted that t, a significant inverse correlation between median CD4+ counts and viral 
load was found for the entire HIV positive group,. However, although this relationship 
was strongest in both groups with high IgE, it was strong in all groups with some 
evidence of helminth infections and weakest in the group without evidence of worm 
exposure (egg-/IgElo). High viral load and CD4+ decline are prognostic markers of HIV 
disease progression. Such a relationship as observed in the high IgE groups (and all 
helminth-infected participants) in this study (Table 3.8a) would suggest a negative effect 
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of Th2 responsiveness (and helminth infection) on HIV disease progression. However the 
sample size was very small to draw conclusions from this finding.   
 
A distinct group of individuals was seen in the present section in both HIV+ and HIV- 
groups. Although these participants were infected by helminths as shown by the 
presence of faecal eggs, Ascaris-specific IgE levels were low (egg+/IgElo). This group 
showed a tendency towards a better immune response to HIV: The observation of lower 
viral load (HIV+ group), higher CD4+ counts (HIV-group) and generally higher proportions 
of T- cell populations among the low Ascaris lumbricoides IgE responders in both HIV+ 
and HIV- participants suggests an advantage towards better control of HIV infection. 
Furthermore this group had the lowest proportion of individuals with immunodeficiency 
by both CD4+ counts and viral load grading.  
 
The fact that in both HIV+ and HIV-participants, low IgE groups who were stool egg 
positive had the lowest eosinophil counts (Tables 3.4 and 3.5) strongly suggests that 
these individuals lack the Th2 mediators (IgE globulinaemia and eosinophilia) that are 
associated with protection against helminths (Maizels et al., 2004). Positive stool egg 
without increased levels of Ascaris IgE in this group could theoretically suggest two 
possibilities. One could reflect a newly acquired infection before adaptive humoral 
responses are invoked, or could possibly imply their susceptibility to recurrent helminth 
infection in the absence of protective mechanisms conferred by IgE and eosinophils. The 
observations that this group had higher proportions of all lymphocyte subsets, suggest 
that their ability to respond to infections including HIV is comparatively competent e as 
indicated by higher median CD4+ counts and lower viral loads and argues favourably for 
the hypothesis that this group represents a distinct Th1 phenotype or lack of Th2 bias. 
Furthermore, the grading of proportions of individuals with immunodeficiency 
consistently showed that this group had the lowest percentages of individuals with 
advanced HIV disease in terms of viral load and CD4+ counts. 
 
Indeed, according to Maizels and Yazdanbakhsh (2003) one of the three phenotypic 
outcomes of chronic exposure to helminths is a “modified Th2” phenotype. According to 
these authors, the modified Th2 individuals are characterised  in part by  low IgE and 
high IgG4 antibody isotypes and low level of Th1 cells. They are highly susceptible to 
asymptomatic, heavy helminth infections and are thus a reservoir for transmission.The 
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egg+/IgElo status in the present study could be related to heavy infection in the absence 
of IgE secretion. 
 
 
Total B and NK cells form part of the immune system’s functional architecture, therefore 
it was necessary to quantify them in this study.  No significant differences in these 
subsets were noted between the different subgroups, although the turnover rates of B 
cells were shown to be positively related to CD4+ counts and viral load in a macaque-SIV 
infection model (De Boer et al., 2003). In the present study no relationship could be 
established either and the results were not shown.  
 
Finally, the study reveals data on phenotypes of HIV uninfected individuals residing in 
resource-limited settings in South Africa. The immunological markers that are relevant to 
HIV immune responses (CD4+ and CD8+) obtained from this study are lower than the 
CDC indices based on European reference ranges. However, the size of the sample 
representing presumably healthy individuals from this population was small therefore 
findings are interpreted with caution. The results are similar to locally generated 
reference ranges for Tygerberg hospital (P. Bouic, personal communication), which 
serve the community of Khayelitsha as well. 
 
3.4. Conclusions  
 
Four  distinct patterns of results were observed: 
 
1. No significant differences were observed when comparing the HIV positive egg+/IgEhi 
group with the HIV+ group having neither faecal eggs nor elevated Ascaris IgE except for 
significant lower eosinophil counts, relatively higher individual numbers with a lower viral 
load and higher CD4+ counts in the latter. However, in the absence of HIV, a tendency to 
higher median counts in the egg-/IgElo group with a significant difference in total 
lymphocytes and a lower trend in eosinophils were observed between these subgroups. 
The smaller sample size in the HIV negative groups possibly influenced the ability to 
reach statistical significance in differences among the other parameters. The results 
suggest a possibility of confounding by HIV. These outcomes suggest that the findings in 




2. When dually-infected subgroups were compared, the presence of helminth stool eggs 
and high IgE (egg+/IgEhi) showed  a tendency to reductions in all lymphocyte populations 
in both HIV infected and uninfected individuals.  . 
3.  The two groups with high IgE (the egg+/IgEhi and egg-/IgEhi groups) typically had 
elevated Th2 markers (high IgE and eosinophilia) and were associated with lower (but 
not statistically significant) CD4+ counts in the HIV negative group and higher viral loads 
in the HIV infected group. Both subgroups had the higher percentages of individuals with 
higher viral load. In addition, there was the strongest inverse correlation between viral 
load and CD4+ counts in these two subgroups. This has implications for HIV disease 
progression and helminth-induced Th2 predominance. 
4. Individuals with parasite eggs in stool but low Ascaris IgE (egg+/IgElo) tended to have 
higher absolute numbers of all lymphocyte subsets in both HIV- and HIV+ groups and in 
particular significantly higher CD4+ counts in the HIV- and lower viral load in the HIV+ 
groups. This subgroup of egg+/IgElo individuals demonstrated features of a typical 
modified Th2  helminth phenotype.  
 
Analysis of dually infected subgroups’ findings concur with the suggestions that helminth 
infections are associated with Th2 predominance, (indicated by eosinophila and high 
IgE); cause disruption of peripheral lymphocyte populations and may favour HIV 
replication. The results further suggest the existence of a phenotypically different group 
of individuals who could be better able to control HIV replication (as shown by lower viral 
load and higher CD4+ counts) but were susceptible to helminth infection as indicated by 
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Chapter 4 
Immunophenotyping of cell surface activation markers on T 
lymphocyte subsets of HIV positive and negative subgroups 




Both HIV and helminth infections are chronic and both induce widespread immune 
activation (Lawn et al., 2001; Borkow and Bentwich, 2004). It has been shown that 
immune activation contributes significantly to drive HIV disease progression.  Leng et al., 
(2001) demonstrated that immune activation correlated better with CD4+ cell decline than 
levels of HIV virus in plasma. Similarly, Hazernberg and colleagues (2003) showed that 
continuous immune hyperactivation correlates with AIDS progression. Even earlier 
workers illustrated this positive association between T cell activation and HIV infection 
advancement to AIDS (Mahalingam et al., 1993; Giorgi et al., 1999).  The cellular, 
molecular and biological mechanisms by which immune activation aggravates HIV 
pathogenesis have been thoroughly reviewed by Lawn et al. (2001) and Borkow and 
Bentwich (2004) and were described briefly in Chapter 1. 
 
Helminths have been widely implicated to cause extensive immune activation in 
developing countries (Bentwitch et al., 1995, 1996, 1997, 1999; Clerici et al., 2000; 
Borkow and Bentwich, 2004). A direct causal link between immune activation and 
helminth infection was demonstrated in the study by Kassu et al., 2003, in which 
treatment of parasitic infections reduced the level of immune activation among 
Ethiopians. 
 
Immune activation is accompanied by increased expression of a variety of cellular 
components. Typically, expression of the major histocompatibility complex (MHC) 
molecules on the surface of antigen presenting cells is central to effective antigen 
processing for presentation. As such, expression of the human leukocyte antigen-D 
related (HLA-DR) molecule is a classic marker of activation. Increased expression of this 
marker molecule has been associated with helminth-induced chronic activation of the 
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immune system. HLA-DR expression was significantly increased in all T cell subsets of 
newly-arrived Ethiopian immigrants to Israel who were infected with helminths 
(Kalinkovich et al., 1998). In HIV infection as well, HLA-DR is upregulated as T cell 
activation is a prominent feature of HIV (Hazernberg et al., 2003; Shang et al., 2005). 
 
Likewise, expression of chemokine receptors is strongly linked to activation. The G-
protein coupled receptor CCR5 for the chemokines RANTES, MIP-1α and MIP-1β that 
are involved in lymphocyte recruitment and activation, is reported to be elevated in 
chronic infections and particularly documented in chronic helminthiasis (Kalinkovinch et 
al., 1999; 2001 Clerici et al., 2000) as well as during HIV infection (Ostrowski et al., 
1998, Shalekoff et al., Iqbal et al., 2005, Shang et al., 2005). CCR5 is regulated by 
cytokines: IL-10 has been shown to upregulate its expression (Bleul et al., 1997; Sozzani 
et al., 1998) and is predominantly expressed on memory cells (Bleul et al., 1997).  
Helminths are documented to increase both the memory cell pool (CD45RO+) 
(Kalinkovinch et al., 1998) and IL-10 production (Borkow and Bentwich, 2004). It is 
therefore expected that under conditions of continuous helminth exposure, CCR5 would 
be elevated.  
 
Other cell surface markers associated with chronic infection include the IL-2 receptor α 
chain (CD25).  CD25+CD4+ cells were shown to suppress Th1 responses in mice infected 
with schistosomes and thus inferred to be responsible for Th2 polarisation in helminth 
infection (McKee and Pearce, 2004). The transferrin receptor (CD71) is also expressed 
by all proliferating, activated cells (Babusíková et al. 1999). It is an early activation 
marker, thus its increased expression indicates active proliferation and activation. 
 
In HIV infection, increased CD38 expression is associated with disease progression, with 
higher levels being indicative of poor prognosis (Kunkl, 1997; Shang et al., 2005). It is 
suggested that  approximately 20 % of CD8+ cells express CD38 in healthy individuals  
and in HIV infection,  levels above 50% CD8+ CD38+ signify extensively poor prognosis 
(Kunkl, 1997). Increased CD38 expression, in addition to signifying activation, would 
thus also indirectly assess the HIV disease progression.  
 
Since the two chronic infections (HIV and helminths) result in sustained immune 
activation, hypothetically, upregulation of activation markers on peripheral lymphocytes 
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would be more pronounced in co-infected individuals, and their immune responses to 
HIV would thus be attenuated. 
 
This chapter characterises the activation profile of HIV-1 infected and uninfected 
participants with or without intestinal parasite co-infection. To determine whether there 
are significant differences in the activation status among HIV positive individuals with  
evidence of exposure to or with active enteric helminth co-infection relative to those 
without helminths, the expression of activation markers on their T cell membranes were 
compared. In order to do this, cryopreserved PBMC’s were thawed, washed, stained 
with monoclonal antibody-fluorochrome conjugates and analysed by 4-colour flow 
cytometry. The percentages of cells expressing the activation markers CCR5, CD25, 
HLA-DR, CD38 and CD71 were determined on CD3+, CD4+ and CD8+ lymphocytes. HIV 
negative participants with or without helminth infections were included for comparisons 
by HIV status. 
 
4.2 Methods 
4.2.1. Selection of Participants 
 
Owing to budgetary constraints against the costs of the laboratory tests, a limited 
number of these individuals could be sampled to undertake the multiple assays for this 
pilot hypothesis testing study, hence only 40 HIV positive (ten in each of the four 
subgroups) and all the twenty-two HIV negative, eligible individuals were selected. The 
40 HIV+ participants were randomly selected  from 124 participants who had complete 
data sets in terms of stool egg results, Ascaris-specific IgE (for proper classification of 
helminth infection status) and  lymphocyte phenotypes  as described in section 2.3 
Figure 2.1 legend “Those eligible donated blood and stool samples. Helminth status was 
determined by both colproscopy and serology and lymphocyte immunophenotypes done. 
Those with incomplete data for helminth status classification were further excluded. A 
subset of the eligible participants was sequentially selected (every second individual) 
using study identification numbers for further immunological analysis. *Among the HIV- 
eligible participants, 23 did not submit the complete set of samples thus the remaining 22 
were included by default. The selected individuals were to have adequate cell numbers 
to allow multiple testing of their PBMCs.  
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4.2.2. Collection and Cryopreservation of PBMCs 
 
Blood specimens were collected into Cell Preparation Tubes (CPTTM) vacutainer tubes 
(BD) with Sodium Heparin (120 Units in 1 ml PBS) and submitted to the laboratory within 
3 hours (required to be less than 24 hours old).  
 
All the separation steps, except centrifugation, were performed under a laminar flow 
hood under aseptic conditions. For each patient sample, two of 2ml sterile Corning 
cryogenic vials (Adcock Ingram) were pre-labeled with patient code, study title, date and 
visit number. The CPT tubes were coded, labeled and centrifuged for 20 minutes at 
1600+-100g (2800rpm) at 22C. (NB: centrifugation at 4-8C inhibits collection of cells at 
interface). The tubes were inverted 5-10 times to mix plasma and cells.  Then the 
plasma and white cells were aseptically transferred to sterile, polypropylene 15ml conical 
centrifuge tubes (Lasec). The cells were sedimented by centrifugation at 400g for 10 
minutes at 22C.  The supernatant plasma containing platelets was transferred to a new 
sterile centrifuge tube and further centrifuged at 1100g for 10 minutes to pellet the 
platelets. Plasma (free of platelets) was then frozen at -80ºC.  Sterile PBS pH 7,2  
(Sigma) was added to the 14 ml mark of the conical centrifuge tube containing the 
pelleted cells and the tubes were capped and inverted five times to mix and wash 
thoroughly. The tubes were then centrifuged at 500+-50g at 22C for 10 minutes. The 
supernatant was decanted without disturbing the cells. Cell pellets were resuspended in 
14 ml sterile PBS, thoroughly mixed and the wash/centrifugation steps repeated once 
more. All excess PBS was removed and cold 0,5ml fetal calf serum (FCS) 
(Biowhittakker) was added to each tube to resuspend the cells which were then cooled 
on ice. A 20% v/v solution of Dimethylsulfoxide (DMSO) (Sigma) in RPMI 1640 culture 
medium with glutamine (Sigma) without penicillin and streptomycin was freshly prepared 
and cooled on ice. Two hundred and fifty microliters of the cell suspension on FCS were 
transferred to each of the two appropriately labeled 2ml cryogenic vials. Two hundred 
and fifty microliters of cold 20% DMSO in RPMI were added dropwise to each of the  
250 μl cells suspended in FCS (NB: The DMSO always was added to the cells and not 
the other way round) to give a final 10% DMSO concentration.  The cryogenic vials were 
wrapped in several layers of paper towel and frozen at -80C for at least 24 hours. The 
cryotubes were then transferred into Liquid Nitrogen (LN) storage tanks (they could be 
stored at -80C for one year or longer in liquid nitrogen). Datasheets describing each 
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sample’s identity, position in the storage boxes and liquid nitrogen tank were logged and 
kept safely. 
 
4.2.3 Retrieval and Thawing of Frozen PBMCs   
 
Forty baseline samples of PBMCs from HIV-1 positive participants and 22 from HIV 
negative controls (each in duplicates of 2ml cryovials each) were retrieved from 
cryopreservation. The respective positions of the samples were located from the storage 
data sheets. An adequate volume of liquid nitrogen was transferred to the holding 
Dewar. Samples were then quickly removed from the LN storage tank and immediately 
transferred to the temporal holder containing liquid nitrogen until ready to be thawed. 
 
The cryovials were immediately immersed into a 37ºC water bath and the cells were 
gently mixed while thawing. Once the last lump of solid ice dissolved, the cells were 
transferred into a 15ml Falcon polypropylene tube. Using a 10ml sterile, disposable 
pipette, cold, 10ml of RPMI with 10% FCS (both from Sigma) was added drop-wise to 
avoid rapid osmotic shock to the cells. The suspension was centrifuged for 10 min at 
400g at 22ºC) and all the supernatant containing DMSO removed aseptically. The 
pelleted cells were suspended in 10ml RPMI and washed once more by centrifugation as 
above.  The cells were resuspended in 1ml of culture medium RPMI-1640 with glutamax 
(Gibco), containing 10% human male AB serum, US origin, heat-inactivated (Gibco), 2-
mercaptoethanol (50µM), penicillin 100U/ml and streptomycin 1000ug/ml and counted.  
 
4.2.4 Enumeration of PBMCs 
 
Cell counts were performed by filling the Neubauer counting chamber with 10µl of cell 
suspension and the cells enumerated. A phase-contrast microscope was used to 
simultaneously discriminate between viable and non-viable cells. All viable and non 
viable cells were counted. For each sample no more than 10% dead cells were accepted 
for further experiments. The total volume of all cell suspensions was adjusted to 5.5 x106 
cells/ml, so that 5 ml was used for initiation of cultures (for studies in Chapter 5) and 0.5 
ml used for surface staining of activation markers (section 4.2.4). 
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4.2.5 Surface Staining and Flow Cytometric Measurements of Activation Markers 
 
To determine the ex-vivo activation status of participants, their PBMCs were labeled with 
directly conjugated monoclonal antibodies to surface markers of activation and 
measured by flow cytometry. 
 
4.2.5.1 Methodology and Modification  
 
The procedure described in the BD Biosciences/Pharmingen Product Catalog, Technical 
Resources (2003) was undertaken and modified for v-bottom plates as described in 
section 3.2.1.2 in Chapter 3 above. Further modifications were that the cells were 
resuspended in complete RPMI instead of staining buffer before staining. Different 
volumes of monoclonal antibodies (5, 10, 15 and 20 μl) were investigated and all yielded 
equivalent staining, thus 5 μl were used in all staining procedures. 
 
4.2.5.2 Procedure 
All monoclonal antibodies (α) were purchased from BD already directly conjugated to the 
fluorochromes as listed in Table 4.1. Forty baseline samples of PBMCs from HIV-1 
positive participants and 22 from HIV negative controls (in duplicate 2ml cryovials each) 
were retrieved. For each sample, 5 wells of the 96 well, v-bottom microtiter plate were 
designated for different antibody-fluorochrome conjugates as tabulated in Table 4.1. 
 
Table 4.1 Monoclonal antibody-fluorochrome combinations and microplate-well 
designation for samples. 
Combinations of monoclonal antibody-fluorochrome conjugates were added to each designated 
well of a microtiter plate for staining PBMC samples. Each sample was allocated 5 wells for 
labeling the surface markers CD3, CD4, CD8 and the activation markers CCR5, CD25, HLA-DR, 
CD38 and CD71.   
Well number 1 Well no. 2 Well no.  3 Well no. 4 Well no.5 
CD3 PerCP CD3 PerCP CD3 PerCP CD3PerCP CD3 PerCP 
CD4 APC CD4 APC CD4 APC CD8 FITC CD4 APC 
CD8 FITC CD8 FITC CD8 PE CD38 PE CD8 PE 
CCR5 PE CD25 PE HLA-DR FITC *CD28APC CD71 FITC 




Five microliters of each antibody conjugate was carefully pipetted to the bottom of each 
designated well. One hundred microliters of cell suspensions (from section 4.2.3 above), 
containing 1x105 cells/ml in complete RPMI with glutamax, human AB serum (Gibco) and 
antibiotics  were added to each corresponding well (five wells per sample) and mixed.  
The solutions were covered and mixed by gently shaking in a multiwell plate shaker 
(Sigma) at 1000 rpm for 30 seconds. The plates were incubated in the dark on ice for 45 
minutes.  The cells and antibody conjugates were pelleted by centrifugation at 2500 rpm 
for 3 min at 4ºC and the supernatant was aspirated by vacuum-suction. One hundred 
and eighty microliters of filtered wash buffer (1x PBS containing 0,1% sodium azide-
(NaN3), pH 7,2) was added to each well to resuspend the pellets and centrifuged as 
above. The wash-centrifugation step was repeated one more time. The stained cell 
pellets were resuspended in 180L of fixative (4% v/v formaldehyde in filtered PBS) and 
mixed thoroughly. The samples were then quantitatively transferred to 12x75mm BD 
FACSTM tubes containing 450 μl of 4 % v/v formaldehyde in filtered PBS.  These could 
be kept at 4º C in the dark for up to 24 hours or analysed immediately on the FACS 
CaliburTM flow cytometer. (NB: wells containing unstained cells from HIV-1 positive and 
negative individuals, cells labelled with isotype control antibodies as well as separate 
cells labeled with individual and combined antibody-flourochrome conjugates were 
included in each experiment for threshold and PMT settings, autoflourescence control, 
non-specific staining, negative population setting and spectral overlap colour  
compensation). 
 
4.2.5 Flow Cytometry: Acquisition and analysis 
 
The daily instrument standardization and maintenance was performed. Using the 
Cellquest software for four colour analysis, the unstained cells were first run through the 
instrument for the autoflourescence control and isotype controls for non-specific binding 
of monoclonal antibodies. Forward and side scatter detector PMT voltage and Amp gain 
settings were also adjusted using the unstained cells tube. The threshold value was set 
at 180 on forward scatter to exclude debris. Then tubes containing cells labeled with one 
and two antibodies were used to compensate for spectral overlap in the four channels 
between FL1 and FL2, FL1 and FL3, FL2 and FL3, and FL3 and FL4. Cells stained with 
isotype controls were used to exclude non-specific binding of antibodies. The following 
 138 
isotype controls were included: IgG1k and IgG2a FITC; IgG1k and IgG2a PE; IgG1k PerCP 
and IgG2a APC. Further, unstained cells from a presumably healthy (HIV and helminth 
negative) individual from the same community were also used to set the negative 
population marker. The cells from the study population appeared to have increased 
autofluorescence and/non specific staining than isotype controls and normal laboratory 
donor cells. In addition, the normal laboratory donor cells were obtained from individuals 
who were either of a different ethnicity, thus for the study, appropriate controls were 
selected from the study population individuals.  
 
The samples were then run on Cellquest software. A minimum of 10 000 events were 
acquired for each sample tube in list mode. Various gating strategies were attempted to 
eventually improve the recovery of all lymphocytes from the samples for optimal 
measurement of surface markers. The final gating strategy is described below: 
 
 
4.2.6 Gating strategy for lymphocyte subsets 
 
Lymphocytes were gated on side and forward light scatter properties as in region 1 (R1) 
of Figure 4.1. T lymphocytes were further differentiated by CD3 expression (R2) on the 
side scatter vs CD3 plot to improve discrimination of lymphocytes. The T lymphocyte 
subpopulations were separated on the CD4+ vs CD8+ dot plot, as R3 and R4 
respectively to create a stringent gate that would facilitate exclusion of double positive 
(CD4+ CD8+) cells. Finally all CD4+ (gated on R1, R2 and R3) and CD8+ (gated on R1, 
R2 and R4) expressing the respective activation markers were individually plotted. All 
analyses were done using this gating strategy. Quadrant markers were set using cells 
from an HIV and parasites negative individual from the same population as the use of 
laboratory healthy controls proved unsuitable. Use of density as well as dot plots yielded 
similar results. 
 
Membrane expression of T cell activation markers was determined using this four colour 
flow cytometry method. Percentages of each T cell subset expressing the relevant 
marker were established on gated lymphocytes.
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Figure 4.1. Gating strategy to identify percentages of CD3, CD4 and CD8 cells expressing 
activation markers (HLA-DR in this illustration A1-A6). 
PBMCs were labeled with monoclonal antibodies to CD3, CD4, CD8 and HLA-DR conjugated to 
PerCP, APC, PE and FITC fluorochromes respectively. The resulting fluorescence was measured 
by flow cytometry.  A1  A Lymphocyte  gate based on light scatter properties on the side scatter 
versus forward scatter dot plot was set in region 1 (R1) as lowest side scatter and highest forward 
scatter. A2 T lymphocytes are differentiated by CD3 expression (R2) on the side scatter versus 
CD3 dot plot, which facilitates the differentiation (in A3) of CD4+ and CD8+ cells in regions R3 and 
R4 respectively. The percentages of each T lymphocyte population expressing the particular 
surface markers on their membranes were then measured in A4, A5 and A6. CD38 expression on 
CD8+ was gated separately as illustrated in (B). A  Lymphocyte gate was based on light scatter 
and CD3 expression properties (R1) in B1.  CD8+ lymphocytes were gated on the CD3+ versus 
CD8+ plot in B2.  The percentages of CD8+T lymphocytes expressing CD38 on their membranes 
were then measured on the CD8 versus CD38 plot (B3). All positive cells appear on the upper 





 Median percentage cells expressing the activation markers were compared by Kruskal 
Wallis ANOVA within subgroups of HIV+ and HIV – individuals with and without helminth 
co-infection. Differences were considered significant at  p ≤ 0.05. 
4.3.1. Summary activation profiles in HIV+ and HIV – groups. 
 
Tables 4.2 and 4.3 summarise the median, minimum and maximum values of 
percentage expression of activation markers for each T cell subset in HIV+ and HIV- 
groups respectively. Generally, marked differences in median values for expression of 
surface markers were observed between the HIV positive and negative groups (Tables 





 Figure 4.2. Median percentage expression of surface activation markers on T lymphocyte 
subsets in HIV+ and HIV- subgroups with or  without helminth co-infection. PBMCs  were 
stained with fluorochrome-conjugated monoclonal antibodies to surface lymphotype and 
activation marker molecules and the proportions of T cell subsets expressing the particular 
markers quantitated by flow cytometry. Numbers on the Y axis represent percentages and each 
bar represents the median percentages of each lymphocyte type expressing the respective 
marker in each subgroup. It is noted that the HIV+egg+IgEhi subgroup expressed very high levels 

































































Table 4.2 Median percentage expression of surface activation markers on T lymphocyte 
subsets in HIV infected groups with or without helminth co-infection.  
Subgroups were classified according to presence or absence of faecal eggs and high or low 
Ascaris IgE. Cryopreseved PBMCs were stained with fluorochrome-conjugated monoclonal 
antibodies to surface lymphotype and activation marker molecules and the proportions of T cell 
subsets expressing the particular markers quantitated by flow cytometry. Values represent 
median percentages of each lymphocyte type expressing the respective marker in each subgroup. 
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Egg + IgE hi : faecal helminth eggs and high serum Ascaris lumbricoides-specific IgE (high IgE >0.35KU/L);  
Egg+ IgElo   :faecal helminth eggs and low serum Ascaris lumbricoides-specific IgE; (low  IgE <0.35KU/L) 
Egg- IgEhi  :no faecal helminth eggs and high serum Ascaris lumbricoides-specific IgE;  









































Figure 4.3 Histograms for distribution of viral load data in four subgroups of HIV positive subgroups 
with or without evidence of helminth infection. Ten individuals in each subgroup were randomly selected 



















Table 4.3 Median percentage expression of surface activation markers on T lymphocyte 
subsets in HIV uninfected subgroups with or without helminth co-infection. 
The subgroups were classified according to the presence or absence of faecal egg excretion and 
low or high serum Ascaris-specific IgE. Cryopreseved peripheral blood monocytes (PBMCs) were 
stained with fluorochrome- conjugated monoclonal antibodies to activation marker molecules and 
the proportions of T cell subsets expressing the particular markers quantitated by flow cytometry. 
Values indicate median percentages for each subgroup. Subgroups showing trends are 
underlined. 
Egg + IgE hi : faecal helminth eggs and high (>0.35KU/L) serum Ascaris lumbricoides-specific IgE;  
Eggs+ IgElo   :faecal helminth eggs and low (<0.35KU/L) serum Ascaris lumbricoides-specific IgE; 
Egg- IgEhi  no faecal helminth eggs and high serum Ascaris lumbricoides-specific IgE;  
Egg- IgElo  :no faecal helminth eggs and low serum Ascaris lumbricoides-specific IgE. 
 
 
4.3.2 Expression of surface activation markers in HIV positive and negative 
subgroups  
Flow cytometry analysis showed that expression of activation markers differed 
significantly between HIV positive and HIV negative groups (Figure 4.2) and also 
between subgroups within the HIV+ group according to helminth co-infection (Figures 
4.4 and 4.5). Representative plots of some of the markers illustrating these differences 
are depicted in Figures 4.5- 4.6. Plots of HIV negative groups for comparison are shown 












































































































































































































Figure 4.4 Expression of CD71 in CD4+ and CD8+ lymphocytes.  
Ex vivo PBMCs were phenotyped by four colour flow cytometry and proportions of CD4+ and 
CD8+ cells expressing CD71 determined. Autofluorescence was controlled for by unstained cells 
from an HIV negative and helminth uninfected individual. Matched isotype control antibodies were 
used to set the cut-off for separating negative and positive populations. Each dot represents an 
event. Positive cells appear in the right upper quadrants. The figure represents results from 
individuals representative of the egg+IgEhi with HIV co-infection (A) and the egg-IgElo HIV-1 singly-
infected (B) groups. CD71 expression on CD8+ cells is  markedly increased in an HIV+ individual 
with faecal helminth eggs and elevated serum Ascaris IgE (egg+IgEhi) (Panel A)  compared  to  a 
HIV+ individual without evidence of intestinal parasite infection (egg-IgElo) (Panel B). 
                                          
                                          
 
   
    
  
     
  
  
                                          
                                          
 
   
    









Figure 4.5 Representative plots: Expression of CCR5 by CD4+ and CD8+ cells in 
subgroups of HIV + individuals. 
PBMCs were stained with flurochrome-tagged monoclonal antibodies to CD3, CD4, CD8 and 
CCR5 and analysed using flow cytometry to determine the percentages of lymphocytes 
expressing CCR5.. Positive cells appear in the right upper quadrant. The percentages represent 
the medians for each cell subgroup and each plot is a representative subject from each group. 
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Figure 4.6 Representative plots: Expression of CD38 on CD8+ cells in HIV+ subgroups. 
Ex vivo PBMCs were phenotyped by four colour flow cytometry and proportions of CD8+ cells 
expressing CD38 determined. Autofluorescence was controlled for by unstained cells from an HIV 
negative and helminth uninfected individual. Matched isotype control antibodies were used to set 
the cut-off for separating negative and positive populations. Positive cells appear on the right 
upper quadrants. The percentages represent the median for each subgroup. Each dot plot is a 
representative plot of an individual in the respective group. The majority of individuals in the 






   
   






   
   







4.3.3 Activation profile and interactions between subgroups 
In order to  determine  interactions between subgroups with regards to HIV and helminth 
coinfections and  their immunological implication, the median percentage of cells 
expressing the activation markers were compared by ANOVA (Kruskal Wallis) within 
subgroups of HIV+  (Table 4.4 and Figure 4.7pages 149-150) and HIV- groups (Figure 4.6 




Figure 4.7 Kruskal Wallis Box and whisker plots for lymphocyte surface expression of activation 
markers in HIV+ subgroups.  
Ex vivo, cryopreserved peripheral blood mononuclear cells (PBMCs) were stained with fluorochrome-
conjugated monoclonal antibodies to CCR5,HLA-DR, CD38 and CD71 and the proportions of T cells 
expressing the particular markers quantitated by flow cytometry. Percentage median, 25-75 percentile, 
outlier and extreme values of these markers are shown for each subgroup and depicted along the y 
axis.Median percentage values of each subgroup was compared by Kruskal Wallis Anova for 
significant differences with bthe other subgroups. In all panels the groups and their sizes were: 
Egg+IgEhi group (n = 10): helminth egg excretion and elevated Ascaris lumbricoides IgE; Egg+IgElo (n=10): 
helminth egg excretion and low Ascaris lumbricoides IgE; Egg-IgEhi group (n=10):  No helminth egg 
excretion and high Ascaris lumbricoides IgE; Egg-Iglo (n=10): No helminth egg excretion and low Ascaris 













































































































































egg+lgEhi Egg+lgElo egg-lgEhi Egg-lgElo
P=0.01
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Table 4.4 Kruskal Wallis ANOVA, Median tests and multiple comparisons of Activation 
markers in HIV+groups.  
Lymphocyte expression of activation markers (CCR5, HLA-DR, CD25, CD38 and CD71) was 
measured by flow cytometry. Percentage medians of each activation marker were compared by 
Krushkal Wallis ANOVA for significant differences in each of four HIV+ subgroups. P values are 












CD4CCR5 39 0.01 0.01 
<0.01 
0.05 
1 & 3 
1 & 4 
2 & 4 






CD4CD25 40 0.03 0.04 1& 4 
CD4HLADR 40 0.01 0.01 
0.01 
1 & 3 
1 & 4 
CD8HLADR 40 0.01 0.04 
0.01 
1 & 3 
1 & 4 
CD3HLADR 40 <0.01 0.01 
0.02 
1 & 3 
1 & 4 
CD8CD38 40 0.01 0.01 
0.03 
1 & 3 
1 & 4 
CD4CD71 40 0.01 0.01 1& 3 




1 & 3 
1& 4 
Group 1 – Egg+IgEhi ; Group 2- Egg+IgElo  Group 3- Egg-IgEhi Group 4- Egg-IgElo  
IgEhi-high serum Ascaris specific IgE; IgElo – low serum Ascaris lumbricoides-specific IgE. 
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4.3.3.1 The egg+/IgEhi infection status is associated with significant increased 
expression of all activation markers in the HIV positive groups 
The HIV+, egg+IgEhi and egg-IgElo subgroups: 
When the HIV and helminth co-infected, egg+IgEhi subgroup was compared to the HIV-
singly infected egg-IgElo subgroup, both have similar median CD4+ counts, which were 
slightly higher (0.268 cells/ml) in the former compared to 0.22 cells /ml in the egg-IgElo 
subgroup.The median viral load was significantly higher in the dually infected egg+IgEhi 
group (Table 4.2 page 142).It is noted that the viral loads could not be matched before 
random selection of the subgroups.This group was also found to express statistically-
significantly higher levels of all activation markers (Table 4.2) than the singly-HIV, 
helminth non-infected (egg-IgElo) subgroup and all the other subgroups in the HIV 
positive group, both of which had higher and similar median CD4+ counts ( Table 4.2).   
 
 Expression of all measured activation markers was markedly increased in the egg+/IgEhi 
(typical helminth infection) group. All these differences were statistically highly significant 
(p≤ 0.01; and for CD4+CD25+ p=0.03) Figure 4.7 Panels A-I (page 149 ) and Table 4.2,).  
In this group, median CD3+, CD4+ and CD8+ expression of HLA-DR, were higher than in 
all the other three subgroups (Table 4.2 and Figure 4.7 page 1497 panels D-F, p≤ 0.01). 
In addition, median expression of CCR5 by CD8+ cells exceeded 90.0% while in CD4+ 
cells median CCR5 expression was almost doubled in this egg+/IgEhi group compared to 
the egg-/IgEhi and the egg-/IgElo groups (Table 4.2 ). Furthermore, the early activation 
marker-CD71 was 2-3 fold higher (p<0.001) than in the other three groups in both CD4+ 
and CD8+ compartments (Table 4.2 & Table 4.4 page 150; Figure 4.75 page 149 Panels 
H & I).  In most instances these differences in CD71 expression on CD8+ cells were 
distinct (Figure 4.4 page 145).  Finally almost all the CD8+ cells were CD38+ in this group 
(Fig 4. 6 page 147 and Table 4.2 page 142)  and this difference was also statistically 
highly significant (p=0.01). 
 
The highest levels of percentages of lymphocytes expressing all activation markers by 
the egg+IgE+ group is remarkable in view of the fact that in the preceeding chapter  
(Section 3.2.3.1),  this egg+IgEhi group was shown to have a tendency towards a 
generalized reduction of lymphocyte populations.  
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Comparisons between the egg+IgEhi and the egg-IgElo groups show that median 
expression of all activation markers was almost two-fold higher in the former group 
(Table 4.2 page 142). These results show a significant difference between the egg+IgEhi 
helminth/HIV co-infected group and the HIV-singly infected (egg-IgElo) group with 
regards to the level of immune activation. 
HIV negative groups 
Among the HIV- negative subgroups, the egg+IgEhi subgroup had lower median CD4+ 
counts compared to the four subgroups. No dramatic increases in activation markers 
were observed among these individuals and no statistically significant differences were 
observed in any of the variables analysed (Table 4.3 page 144). 
There was only apparent slight increase (nearly two-fold) in median CD4+ CCR5+ in the 
egg+IgEhi and egg+IgElo participants compared to the egg-IgEhi and the egg-IgElo 
subgroups. A trend towards higher CD8+ HLA-DR (p=0,09) was observed between the 
egg+IgElo and the egg-IgEhi . Likewise, expression of CCR5 on CD8+ cells displayed a 
trend towards higher levels between the egg+IgEhi and egg-IgEhi subgroups (Table 4.3). 
4.3.3.2 Stool egg positivity is associated with increased CD4 +CCR5+ and CD8+ 
CD38+  
The results show that the stool egg positive subgroups (egg+IgEhi and egg+IgElo) have 
more than two-fold median CCR5 expression by CD4+ cells, compared to the stool egg 
negative subgroups (egg-IgEhi and egg-IgElo) in the HIV+ group (Table 4.2 page 142).  
These differences were either highly statistically significant (p<0.01 or nearly significant 
(p=0.05) - Table 4.4 page 142. Furthermore, in both stool egg positive subgroups, 
median expression of CD38 by CD8+ lymphocytes exceeded 90% and this was 
statistically significant (Table 4.2 and Figure 4.7  page 149i52 Panel G).    
 
HIV negative groups 
Among the HIV uninfected individuals, both stool egg positive groups (egg+IgEhi and 
egg+IgElo) had two-fold higher levels of CD4+ CCR5+ compared to the stool egg negative 
subgroups (egg-IgEhi and egg-IgElo) but this difference was not significant (p=0,36). A 
trend for higher CD8+ CCR5 (p=0, 09) was also observed in both these subgroups with 





4.3.4 Correlations between activation markers and surrogate markers of HIV 
progression. 
Indicators of HIV disease progression (CD4+ counts and viral load) were correlated with 
all measured activation markers (Appendix 5, Table 4,5B). This was aimed at evaluating 
any association between the level of activation and HIV disease progression in the 
context of HIV/helminth coinfection.  Analysis of all the correlations using the Spearman 
rank order test  (Appendix 5) showed that no significant interactions were observed 
between CD8CCR5 and both disease markers, while CD4CCR5 showed a strong 
negative correlation in the two groups with high IgE(r =-0.75, p=0.01 andr=-0,72, 
p=0.03).No correlations between viral load and CD4 CCR5 were observed except for the 
egg+IgEhi subgroup with a strong positive correlation r=0.72, p=0.01.CD4 CD71 
correlated negatively with CD4 counts in the egg+IgElo  group (r=--0.81(p=0.02). 
 
 Further analysis was done on the classic marker of activation (HLA-DR) and on 
CD8CD38 because of its association with HIV disease prognosis. Because correlation 
values for CD4+HLA-DR and CD8+HLA-DR were similar to CD3+ HLA-DR, (Appendix 5) 
the CD3+HLADR correlations were used as a representative of all T lymphocyets 
interactions reported together with the correlations between viral load and CD4+ counts  
and the prognosis marker( CD8CD38) in Table 4.5. (It is noted that for practical reasons 
by experimental design, CD38 expression could only be assessed on CD8+ cells, and 




4.3.4.1 Correlation between CD3+ HLA-DR and CD4+ counts  
Analysis of all forty HIV positive individuals as one group, using the Spearman rank 
order test showed a significant negative correlation between HLA-DR expression on 
lymphocytes and total CD4+ counts. This inverse correlation was significant (r=-0.53, 
p=0.04) (and strong in the egg+IgEhi group (Table 4.5).   
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4.3.4.2 Correlation between CD8+CD38+ and CD4+ counts  
When all the HIV positive participants were analysed in one group, a significant inverse 
correlation was observed between CD8+CD38+ and CD4+ counts (Figure 4.8). Further 
analysis of subgroups showed that this correlation was strongly significant in the two 
groups with high Ascaris IgE (r=-0.69, p=0.03 and r = -0.72, p=0.02). Both groups with 
low IgE had weak correlations between CD8+CD38+ and CD4+ counts that was weakest 





















































































The HIV+egg-IgElo subgroup n=10
CD4
Scatterplots for Activation vs CD4+ 
counts
 
Figure 4.8 Scatterplots for activation versus CD4+ counts in HIV+ groups. The distribution of 
CD4+ conts in relation to CD8CD38 expression in HIV+ groups with or without helminth 
coinfection.  
 
4.3.4.3 Correlation between CD3+ HLA-DR and viral load 
Comparison of CD3+HLA DR and viral load showed a significant positive correlation in 
the entire group of HIV positive individuals. However this correlation was only significant 
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in the egg- IgEhi individuals when subgroups were analysed separately.  In the rest of the 
subgroups the correlation was not significant (Table 4.5).   
4.3.4.4 Correlation between CD8+CD38+ and viral load 
A strong and significant positive correlation was found between CD8+CD38+ and viral 
load in all forty HIV positive individuals analysed as one group. The positive correlation 
was strongest in the egg- IgEhi group followed by the egg+ IgElo group. No correlation 




Table 4.5 Correlations between activation markers and HIV disease progression indicators 
(CD4+ counts plus viral load).  
Spearman rank analysis of correlations between CD4+ and CD3+ HLA-DR, CD8+CD38+ and 
between viral loads was undertaken in HIV+ groups.  
Parameter Group N CD3+HLA-DR+ 
Spearman r 
 







CD4+ All 40 -0.43 0.01  -0.44  0.01 
 1(*Egg+ IgEhi) 10 -0.7 0.03  -0.69  0.03 
 2 (Egg+ IgElo) 10 -0.54 0.11  -0.43  0.21 
 3 (Egg- IgEhi) 10 -0.59 0.07  -0.72  0.02 
 4 (Egg- IgElo) 10 -0.56 0.09  -0.17  0.63 
         
Viral Load All 40 0.49 <0.01  0.68  <0.01 
 1(*Egg+ IgEhi) 10 0.49 0.14  0.07  0.85 
 2 (Egg+ IgElo) 10 0.07 0.86  0.69  0.03 
 3 (Egg- IgEhi) 10 0.65 0.04  0.72  0.02 
 4 (Egg- IgElo) 10 0.01 0.9  0.29  0.41 
     
* Eggs= faecal helminth eggs; high IgE = high serum Ascaris lumbricoides-specific IgE. All =all subgroups 









4.3.5 Comparison of HIV uninfected, helminth negative results with other studies 
 
In order to determine from the current study whether HIV negative individuals residing in 
local, resource limited settings (data from Table 4.3) present with an immune activated 
profile, a comparison with other published flow-cytometry-based studies is shown in 
Table 4.6 page 151. Comparison of the values obtained from presumably healthy 
participants in the present study with other population groups revealed similarly elevated 
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CD8CD38 in healthy Chinese and Ethiopians as well as the other healthy, HIV negative 
South African adults (Table 4.6). CD4 and CD8 HLA-DR values in the present study 
were comparable to the Ethiopian median values, which were all higher than those 
obtained from the Israeli controls. CCR5 was lower in the present study when compared 
to the results from the Chinese and the other South African studies. Although the 
numbers in the present study are smaller, the results presumptively suggest relatively 
high levels of expression of activation markers among HIV negative, helminth uninfected 
individuals residing in resource-poor setting in South Africa. 
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Table 4.6 Comparison of activation marker levels in different ethnic groups. 
Comparison of immune activation data (percentage expression) from HIV uninfected 
subjects of different ethnic groups as published in other studies. References are listed in 
the table legend. Values in brackets refer to reference 3. 
 
 




































Mean Mean Mean *Geo.mean Median Median 
CD4 CCR5 (26,8) 13,1 25,6 21,1 423,0 2,4 
CD8 CCR5 Nd Nd Nd 49,6 444,5 14,4 






15,1 Nd 7,8 
CD8HLA-DR 16,2 6,2 9,8 28,9 Nd 15,8 
CD8 CD38 56,4 34,5 42,5 51,8 450,7 
548,0 
49,8 
1. Shang et al., 2005; 2. Kalinkovinch et al., 1998; 3. Kalinkovinch et al., 2001; 4. Shalekoff et al., 
2001; 5. Shalekoff et al., 2004; Khayelitsha-Data from Table 4.3 in the present study. †Old 
migrant Ethiopians refers to Ethiopians who had immigrated to Israel and treated for helminth 







In this section, individuals in the four subgroups of the HIV+ group were randomly 
selected into each subgroup before viral load and CD4+ counts were available, hence 
the subgroups could not be matched for these variables. Subsequent analysis of these 
subgroups showed that the egg+IgEhi had the highest median viral load compared to all 
thre subgroups while the median viral load for the egg-IgElo was lowest. These two 
groups had similar median CD4+ counts (slightly higher, 0.27 counts/ml in the egg+IgEhi 
and lower, 0.22 counts/ml in the egg-IgEhi subgroup). This finding suggests that the two 
groups had similar levels of immunocompromise but were virologically very different. 
The results of this section have shown a significant association between immune 
activation and egg+IgEhi status in HIV co-infection. Furthermore, immune activation 
inversely correlated with markers of HIV disease progression particularly as determined 
by CD4+ counts in the co-infected individuals. 
 
A prominent finding was the highly significant association between immune activation (as 
determined by surface T cell expression of HLA-DR, CD38, CCR5 and CD71) and 
egg+IgEhi status where all these markers were significantly elevated in the egg+IgEhi and 
HIV co-infected group.  Notably this increased expression of activation markers in the 
egg+IgEhi group was more than double compared to the levels in the HIV singly-infected 
(without evidence of helminth infection) egg-IgElo group. No significant increase in 
immune activation was noted in the HIV-singly infected egg-IgElo group. The association 
between immune activation and higher viral load found only in the dually infected 
egg+IgEhi group concurs with the suggested notion that co-infection with HIV and 
helminths would increase immune activation and thereby possibly accelerate HIV 
replication.  This is supported by the finding that the HIV-singly infected egg-IgElo 
subgroup had lower viral load and no increase in immune activation marker expression. 
The fact that in both HIV+ single infection (egg-IgElo) and helminth single infection (HIV- 
egg+IgEhi) there was no remarkable increase in immune activation strongly suggests that 
dual infection by helminths and HIV increases immune activation which in part or wholly 
drives  virus replication. From our findings it is apparent that this effect is pronounced 
during a typical helminth (egg+IgEhi) infection.   
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In the HIV negative group, the helminth singly-infected egg+IgEhi subgroup had lowest 
CD4+ counts, just as the HIV singly infected (egg-IgElo subgroup) also had lowest CD4+ 
counts albeit lowest median viral load. In both instances immune activation was not 
increased, suggesting that other factors independent of immune activation or virus 
burden could contribute to lower CD4+ counts during infections. This also tallies with the 
suggestion that dual infection increases both  immune  activation and virus replication. 
 
Other important findings that support the study hypotheses were observed: firstly 
increased expression of CCR5 in CD4+ cells was associated with stool egg excretion 
irrespective of serum Ascaris IgE levels. This was reflected by significantly higher levels 
of CD4+CCR5+ in the two stool egg positive subgroups (the egg+IgEhi and egg+IgElo 
subgroups) compared to the stool egg negative subgroups (the egg-IgEhi and the egg- 
IgElo groups). Both CD4 and CCR5 are known to be critical mediators of HIV infection as 
viral receptors, thus increased levels of both receptors could increase susceptibility to 
HIV infection and enhance the virus replication cycle by increasing the rate of infection of 
new cells bearing these receptors.  Under this premise, the findings are in support of the 
study hypothesis that helminth infection increases HIV replication.  
 
CCR5 expression is regulated by cytokines; in particular IL-10 has been shown to 
upregulate its expression (Bleul et al., 1997; Sozzani et al., 1998) and is predominantly 
expressed on memory cells (Bleul et al., 1997).  Helminths are documented to increase 
both the memory (CD45RO+) cell pool (Kalinkovinch et al., 1998) and IL-10 production 
(Borkow and Bentwich, 2004). It is therefore expected that under conditions of 
continuous helminth exposure, CCR5 would be elevated. Indeed in this study, egg+IgEhi 
helminth infection was associated with elevated CCR5 levels in both HIV+ and HIV- 
groups although this was not statistically significant in the HIV- group though a strong 
trend was observed in the CD8+ subset (Tables 4.2 - 4.4). High levels of CCR5 were 
especially evident in CD8+cells and more prominently in HIV+ individuals. 
 
The association between stool egg excretion and elevated CD4+CCR5+ found in this 
study is consistent with the findings reported by Secor et al. (2003) where patients with 
active schistosomiasis were found to express higher surface densities of both CCR5 and 
CXCR4 than cured schistosomiasis patients. Similarly, co-infection with TB and HIV was 
shown to be associated with elevated CCR5 in both CD4+ and CD8+ lymphocytes 
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(Shalekoff et al., 2001). In the present study, the HIV and helminth coinfected group 
(egg+IgEhi) had the highest levels of CD4+ and CD8+ CCR5 expression compared to all 
the subgroups. Expression of chemokine receptors (including CCR5) and their 
respective ligands facilitates migration of immune cells to sites of antigen presentation 
(Janeway et al., 2001). CCR5 upregulation during recurrent antigenic challenge (as 
would occur during chronic helminth and HIV infections) is expected and the findings of 
the present section concur with this concept. 
 
Secondly, in the HIV+ group, the median expression of CD38 on CD8+ cells was 97% in 
the egg+gEhi group, and this was statistically highly significant (p= 0.01) when compared 
to the egg-IgEhi subgroup, and also significant (p<0.03) compared to the egg-IgElo 
subgroup (Table 4.4 page 150). The egg+gElo group also had 92.0% median 
CD8+CD38+, thus CD38, a poor prognosis marker for HIV disease (Liu et al., 1997; 
Shang et al., 2005) was elevated in both subgroups with stool eggs. This increase in 
CD38 expression among stool egg positive subgroups could suggest more advanced 
HIV disease in these individuals. In the context of the study hypothesis, these results 
suggest that helminth infection that is associated with stool egg excretion in the 
presence of HIV increases the level of immune activation and since CD38 elevation is 
associated with poor prognosis, these results imply that HIV progression may be 
particularly enhanced by a typical fecund (egg+) intestinal helminth infection. However it 
should be noted that all HIV infected subgroups had more than 80.0% median 
CD8+CD38+ in this study (Table 4.2 page 142). 
 
Thirdly, analysis of correlations also showed significant associations between the level of 
immune activation and indicators of HIV disease progression in HIV/helminth co-infected 
individuals. These were more clearly evident when disease progression was assessed 
by absolute CD4+ counts. Expression of the characteristic marker of activation (HLA-DR) 
on lymphocytes negatively correlated with CD4+ counts (Spearman r = -48) and this was 
more significant in the egg+IgEhi group (Spearman r =-0.70, p=0.03). This finding strongly 
suggests that egg+IgEhi helminth infection induces immune activation which has a 
negative influence on the host’s ability to respond to infections including HIV because 
CD4+ cells are an integral part of a competent HIV immune response.  
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In addition, CD38 expression, the prognostic marker of HIV progression correlated 
negatively with CD4+ counts (Spearman r = -0.44) and this negative relationship was 
more significant in both groups with high Ascaris-specific IgE (Spearman r = -0.69 and -
0.72 respectively-Table 4.5 page 155). High IgE is associated with a Th2 biased 
response to helminths. This negative association between CD8+CD38+ and CD4+ counts 
in the Th2 biased subgroups further suggests a negative influence of helminths on HIV 
disease progression.  Indeed, Liu et al. (1997) showed that upregulation of the CD38 
antigen is associated with CD4+ T cell depletion and is a stronger indicator of 
progression to AIDS. Our results agree with their finding, and they are in support of the 
hypotheses being tested in the present study. 
 
 
In parallel analyses of correlations, viral load was also used as an indicator of advanced 
HIV disease. A positive correlation was observed between viral load and CD3+ HLA-DR, 
and also between viral load and CD8+CD38 expression among all the HIV infected 
individuals. However, these relationships were not clearly interpretable amongst the 
subgroups in the context of co-infection. Interpretation of these observations suggests 
that generally the higher level of immune activation correlated with higher virus burden in 
the entire HIV infected group.  
 
Overall results of correlations between immune activation and CD4+ counts and viral 
loads in the present study concur with those reported by Leng et al. (2001), where they 
compared the correlation between immune activation and CD4+ counts and viral load. 
The authors found that CD4+ counts correlated better with activation than did viral load 
(Leng et al., 2001). They found a significant positive correlation between viral load and 
immune activation but it was not as strong as the correlation between immune activation 
and CD4+ T cells. Furthermore, Sousa et al. (2002) demonstrated a direct causal 
relationship between immune activation and CD4+ depletion, and that viral load is 
indirectly related to immune activation.  These results also corroborate the hypothesis 
suggesting that immune activation drives CD4+ T cell depletion (Sousa et al., 2002; 
Grossman et al., 2006) and is indirectly related to virus burden (Sousa et al., 2002). 
 
 
Taken together, these findings provide suggestive evidence that immune activation 
induced by helminths may increase virus replication as indicated by increased virus load 
in the dually-infected subgroup. This is in agreement with the key proposition of the 
 163 
study hypothesis: helminth infection induces immune activation which in turn enhances 
HIV disease advancement. The finding that the HIV negative, egg+IgEhi subgroup had 
lowest median CD4+ counts may suggest an association between helminthiasis and 
lower CD4+ counts, which were also found in the HIV+ egg+IgEhi group, (although the 
HIV+ egg-IgElogroup  also had low median CD4+ count).  
 
The classic immune response to worm antigens is characterized by strong Th2 biasing 
that is accompanied by downregulatory circuits resulting from increased Treg activity,  
alternatively-activated macrophages and dendritic cells that induce Th2 cell 
differentiation (Rodriguez-Sosa et al., 2002; Maizels and Yazdanbakhsh, 2003; Maizels 
et al., 2004; Diaz and Allen, 2007) and selective depletion of effector cells (Borkow and 
Bentwich, 2004). Literature review suggests that these mechanisms of immune 
dysregulation are evolutionary parasite strategies of downmodulating the inflammatory 
host responses directed against them and also minimizing host tissue damage (Maizels 
and Yazdanbakhsh, 2003). This parasite response then effectively attenuates HIV 
immune responses through Th1-Th2 counterbalancing (Diaz and Allen, 2007); selective 
depletion of the effector memory pool, and generalized anergy induced by Tregs (Maizels 
and Yazdanbakhsh, 2003; Borkow and Bentwich, 2004).  Owing to the chronic nature of 
helminthiasis, activation of such responses is also persistent, thereby exerting a long 
lasting negative influence on anti-HIV immunity during co-infection. Such biased, chronic 
activation also provides a favourable mileu for virus replication through activation of pro-
transcription factors and upregulation of HIV receptors. (Lawn et al., 2001) within an 
anergic immune environment (Borkow and Bentwich, 2004).  
 
  
An analysis of the activation profile in the absence of HIV infection was also undertaken 
to determine if helminth infection alone results in increased expression of activation 
markers. No dramatic increase in all activation markers was seen in theHIV negativt 
groups. However, in the HIV uninfected, egg+/IgEhi group a tendency towards increased 
expression of CD8+CCR5, was observed. In addition, the egg+/IgEhi and the egg+IgElo 
groups had almost twofold levels of CD4+CCR5 compared to the other subgroups. 
Conspicuously, CD8+CCR5+ and CD4+HLA-DR+ were highest relative to all the other HIV 
negative subgroups in the egg+/IgEhi group although these differences were not 
statistically significant. The small numbers in the subgroups of HIV uninfected individuals 
probably reduced the statistical power for this analysis. 
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Furthermore, it is reported that approximately 20.0% of CD8+ are CD38+ in healthy 
individuals (Kunkl, 1997). However, Kalinkovinch et al. (2001) reported a mean value of 
34.0% among healthy Israelis, and 43.0-56.0% among healthy immigrant Ethiopians in 
Israel. Shang et al (2005) reported a mean level of 52.0% of CD8+CD38+ among 13 
healthy Chinese participants. Our results (median 49.8% CD8+CD38+ in the HIV 
negative controls) are similar to both the Ethiopian and Chinese results. In two other 
South African studies, (Johannesburg, Gauteng Province) median CD38 expression on 
CD8+ cells obtained from healthy adult African donors were 50,7%  and 48.0% 
(Shalekoff et al., 2001; 2004).  
 
The percentage of median CD8+CD38+ expression in the populations cited above is 
higher than the 20.0% stipulated by Kunkl (1997), which is probably based on European/ 
Caucasian reference values. The relatively elevated CD8+CD38+ among HIV negative 
normal individuals reported previously in these, and the present study is consistent with 
the suggestion that generalised immune activation is present in populations residing in 
developing countries as a result of chronic exposure to infectious agents (Bentwich et 
al., 1995; 1996; 1997; 1999; Clerici et al., 2000; 2001). Considering the unsanitary 
conditions and poverty in Khayelitsha (as described in Chapter 2), it would be plausible 
that these individuals are constantly exposed to enteric helminths and other pathogens 
and thus chronically immune activated. 
 
Finally, it is acknowledged that the other immunological hypothesis regarding the 
interaction between HIV and helminths suggests the possibility that HIV infection and 
progression could positively influence the pathogenesis of helminthiasis. Brown et 
al.(2006)  have reviewed the bi-directional effects of both infections and highlighted 
several confounding in the studies that have addressed this concept. In the present 
study, there is suggestive evidence that the exposure to helminths probably preceded 
HIV infection in this cohort.  More than 70% of the participants remembered previous 
epidsodes of helminth infection both when they were children and when they were 
adults.  Approximately 60% recalled childhood worm infestation (Adams et al., 2006).  
Under these circumstances and their living conditions, it is more likely that recurrent 
exposure to worms was a common event before HIV seroconversion, thus the immune 
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response to helminths existed prior to HIV exposure. Our approach therefore looked at 
the influence of helminths on HIV immune response.   
 
4. 5 Conclusions 
 
This work confirms that egg+IgEhi helminth status during HIV co-infection results in a 
highly activated immune profile as reflected by markedly increased expression of all 
activation markers. This was associated with a higher median viral load in the typical 
heminth and HIV co-infected subgroup. Notably the poor prognosis marker, CD38 was 
highly expressed by  CD8+ cells in this subgroup and there was a strong, significant 
negative correlation between HLA-DR expression on lymphocytes and the absolute 
CD4+ counts.  The finding that almost all the CD8+ cells were CD38 positive in this group 
and the negative correlation between increased immune activation and low CD4+ counts 
further suggest that HIV progression could be accelerated in the individuals with the 
egg+IgEhi profile of helminth infection. 
 
Secondly, the egg+IgEhi and the egg+IgElo subgroups (egg excretion positive status) and 
HIV co-infection presented a more activated profile compared to the stool egg negative 
subgroups, as shown by elevated CCR5 on CD4+ cells as well as more than 90.0% 
median expression of CD38 on CD38+ cells in both egg positive groups.  These 
observations suggest that egg excretion increases immune activation and may increase 
susceptibility to, and accelerate HIV infection.  
 
Thirdly, a strong negative correlation between CD38 expression and CD4+ counts was 
found in both groups with high Ascaris IgE (the egg+IgEhi and the egg-IgEhi groups). 
 
The consistent inverse correlation between immune activation and low CD4+ cell 
numbers that was not found between viral load and immune activation could suggest 
that immune activation impacts more significantly on CD4+ cell depletion than it does on 
viral load per se in HIV-helminth co-infections. It is noteworthy that a positive correlation 
between viral load and CD38 expression was found in the group of all the HIV positive 
individuals, confirming that CD38 expression is associated with advanced HIV disease.  
The results overall show a negative association between immune activation and 
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surrogate markers of HIV disease progression, and this was more evident in individuals 
with egg+IgEhi worm infection and in Th2- biased participants (high Ascaris IgE 
responders) which agrees with the hypothesis that helminth infection may contribute to 
HIV pathogenesis through exacerbation of immune activation and Th2 predominance. 
 
Furthermore, the sample of HIV negative individuals residing in Khayelitsha as 
represented by the HIV-uninfected and helminth negative group in this study also tended 
to present an activated immune profile. It is acknowledged however, that the HIV 
uninfected participant numbers was too small (N=7) to make conclusive inferences for 
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Proliferative and cytokine responses in HIV-1 positive and 
negative subgroups with or without helminth co-infection 
5.1 Introduction 
 
The simplified normal sequence of events during a stimulating antigen encounter by the 
immune system is: Stimulus → Immune activation →Differentiation into effector/memory 
cells→Stimulus eliminated→Immune response suppression/and activation-induced 
apoptosis. The last step of immune suppression mitigates against immune-induced 
pathological damage to tissues involved in the immune process (Janeway et al., 2001; 
Maizels et al., 2004). It is mediated by regulatory/suppressor T cells (T regs) (Maizels et 
al., 2004; Diaz and Allen, 2007). These cells secrete or express on their surface 
downregulatory molecules, the prominent among them being CTLA-4, and the cytokines 
IL-10 and TGFβ (Borkow and Bentwich, 2004; Maizels et al., 2004; Diaz and Allen, 
2007). Failure to eliminate the stimulating antigen results in abberration of the process, 
characterised by chronic activation, cellular dysfunction and suppression, plus increased 
activation-induced apoptosis (Lawn et al., 2001).  
 
In helminth infections the host fails to eradicate the antigen in the absence of 
chemotherapy. In HIV, even therapeutic intervention does not eliminate the antigen. This 
constant stimulation of the immune system is cited as the main cause of the quantitative 
immune dysregulation and cellular functional defects encountered in the two infections 
(Hazernberg et al., 2003; Borkow and Bentwich, 2004).  
5.1.1 Cytokine and proliferative responses in helminth infection 
 
The archetypal type 2 cytokine immune response to helminths is characterised by 
increased IL-4, IL-5, IL-9, IL-10, and IL-13. In addition to this universal response, 
helminth infections are accompanied by intricate processes of altered immune 
responses.  
 
Firstly, helminth infection is associated with specific suppression of the immune 
responses directed against their antigens, for example, schistosomiasis, (Grogan et al., 
1996) and onchocercariasis (King et al., 1993) infected individuals had impaired 
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responses to schistosomal and filarial antigens respectively.This immune suppression 
then extends beyond antiparasite responses and becomes generalised to unrelated 
antigens (Actor et al., 1993; Borkow and Bentwich, 2004; Maizels et al., 2004).  
 
Secondly the helminth-induced Th2 polarised immune response spills over to bystander 
cells, influences the response to other non parasite antigens, and skews them to a Th2 
phenotype: In mice studies, Nippostrongylus brasieliensis infection was shown to induce 
differentiation of naïve, non-parasite specific T cells into Th2 cells (Liu et al., 2002). In 
humans, significantly impaired proliferative, IL-2 and intereferon γ responses have been 
documented in tetanus toxoid-vacinated, Onchocercariasis-infected children (Cooper et 
al., 1998); Ascaris lumbricoides-infected adults vaccinated with cholera toxin (Cooper et 
al., 2000; 2001) and BCG vaccinees infected with various helminths had attenuated T 
cell and skin test responses (Elias et al., 2001). Neonates and infants sensitised in utero 
with schistosoma and filarial antigens showed 26-fold reduction of T cell intereferon γ 
responses to PPD compared to their unexposed counterparts (Malhotra et al., 1999).  
 
Lastly generalised anergy as a strategy for dampening the immune response directed 
against infecting parasites, is a feature of helminthiasis (Borkow and Bentwich, 2004). 
The increased expression of regulatory cytokines IL-10 and TGFβ, increased levels of 
the downmodulatory protein-CTLA-4 plus decreased levels of the costimulatory molecule 
CD28 contribute to the immune suppression and anergy during helminthiasis (Maizels 
and Yazdanbakhsh, 2003; Borkow and Bentwich, 2004). Both IL-10 and TGFβ have 
been shown to negatively correlate with T and B cell proliferation (Cooper et al., 1998; 
Borkow and Bentwich, 2004). Proliferation of these cells in response to antigens would 
therefore be impaired. 
 
As a result, this background Th2 bias and immune suppression spill-over is suggested to 
influence the course of infection with other intracellular pathogens such as TB and HIV, 
whose control is largely dependent on Th1 biased responses (Bentwich et al., 1999). The 
attenuated responses to mycobacterial antigens and the general failure of BCG 
vaccination in sub-Saharan Africa and other developing countries have been attributed 
in part to helminth-induced immune dysregulation associated with helminth infection 




5.1.2 HIV infection: cytokine and proliferative responses 
 
During HIV infection, similar changes in immune function are reported, i.e generalised 
anergy, increased IL-10 and TGFβ and impaired proliferative responses (Borkow and 
Bentwich, 2004). HIV infection is also characterised by disruption of the cytokine 
networks. The initial response to the virus is increased levels of the antiviral Th1 cytokine 
IFNγ and the lymphoproliferative IL-2 (Boaz et al., 2002; Bahbouhi et al., 2004). 
Literature suggests that as disease progresses these cytokines decline and an increase 
in proinflammatory cytokines TNFα, IL-1, IL-6 and IL-8, and the Th2 cytokines IL-4 and 
IL-10 occurs (Kedzierska and Crowse, 2001). According to the popular and controversial 
Th1/Th2 theory, Th1 (or type 1) cytokines are associated with protective cellular 
responses and good prognosis in HIV infection (Clerici and Shearer, 1994; Klein et al., 
1997). Furthermore, later studies confirmed the existence of CD4+ T cells that 
simultaneously produce both type 1 cytokines (IFNγ and IL-2) that are associated with 
better control of HIV (Sousa et al., 2001; Sieg et al.,2001; Boaz et al., 2002). 
 
Defective lymphoproliferative responses by HIV-specific lymphocytes are well 
documented (Palmer et al., 2002; Borkow and Bentwich, 2004) and have been shown to 
correlate negatively with disease progression (Day et al., 2007). 
   
5.1.3 Hypothetical interactions between HIV and helminth infections 
 
From the above, it is thus reasonable to expect that helminths may negatively influence 
the immune responses to HIV by further increasing impaired proliferation and skewing 
the response to a Th2 phenotype. It is therefore hypothesised that infection by helminths 
compromises/influences immune responses to HIV as reflected by the type of cytokines 







The present chapter then evaluates cellular functional responses by means of (i) 
proliferation of PBMCs in response to stimulation with mitogen, recall antigens as well as 
HIV-1 p24 and Ascaris lumbriciodes antigens and (ii) determining the profile of cytokine  
production in unstimulated cells and in response to the specific antigens. The objectives 
were to determine if HIV and helminth coinfected individuals (i) secrete predominantly 
Th2 cytokines, (ii) have impaired proliferative responses to mitogens and antigens 
compared to their helminth uninfected counterparts. The profile of inflammatory 
cytokines is also assessed. The first section evaluated proliferative responses as 
measured by the expression of the proliferation nuclear antigen Ki67 by flow cytometry. 
Simultaneous detection of the modulatory protein CTLA-4 was undertaken. The second 
section assessed the profile of cytokines by multiplex technology in HIV infected 
individuals with or without evidence of enteric parasite exposure. Owing to the costs of 




Optimisation of culture conditions was first undertaken. The type of suitable mitogen 
(including Phytohaemagglutinin (PHA) or Phorbol myristate acetate/Calcium Ionomycin 
(PMA: IO) type of recall antigen (Purified Protein Derivative (PPD) or Streptokinase), the 
specific antigens (HIV-1 p24 and Ascaris lumbricoides crude antigen) and their optimum 
working concetrations were evaluated.  Different incubation periods (6, 24, 48, 72 and 
120 hours) were also assessed. IL-4 and IFNγ cytokine Elisa (R and D Inc.) were used 
for determination of optimal culture coditions. The full preparation of antigens, media and 
optimisation of the culture conditions are described fully in Appendix 6 page-254. 
Finally PHA was used as a suitable mitogen and Streptokinase was selected over PPD 
because of its consistent results.The rationale for using streptokinase was based on its 
proven potency as a recall antigen (Youkeles et al., 1991) and in this work it was used 
as a positive control for proliferative capacity in response to recall antigen, while PHA 




5.2.1 In vitro culture and stimulation of PBMCs 
 
5.2.1.1 Samples 
PBMCs which had been frozen in liquid nitrogen were retrieved from cryopreservation as 
decribed in section 4.2.1. These cells were cultured in the presence of molecules 
associated with antigen presentation (anti-CD28 and anti-CD49d) without stimulation 
(designated unstimulated) and stimulated with mitogen and antigens following 
recommended standard laboratory methods. Forty samples of PBMCs from HIV-1 





Cells were suspended at 1x106 cells/ml in complete RPMI 1640 (cRPMI) with glutamax 
and supplements (anti-CD28 and anti-CD49d (BD), 1μg/ml each; 10% human male AB 
serum (Gibco); 2-mercaptoethanol (βME) 50μM; Penicillin 100U/ml and Streptomycin 
100ug/ml (Gibco)). The cultures were set up with or without stimulants in 48-well 
polypropylene tissue culture plates in 1 ml total volumes. For all 40 HIV-1 positive 
participants, five wells per individual were assigned, one well containing medium and 
cells only (unstimulated) and four containing cell suspensions in cRPMI and the various 
stimulants. For the 22 HIV-1 negative participants, one unstimulated and three 
stimulated culture wells were assigned as shown in Table 5.1.  The plate contents were 
mixed at 1000 rpm for 1 minute in a plate shaker and then incubated at 37ºC in a 
humidified 5% CO2 incubator for 5 days.  On day 5, without disturbing the cell pellets, 
800 μl supernatants were collected into 4 sterile, appropriately labeled Eppendorf vials 
(each vial containing 200 μl of supernatant).The vials were centrifuged and placed into 
storage boxes and immediately transferred to a -70ºC freezer for later analysis of 
cytokine production (Section 5.2.3) and the cell pellets aliquoted for proliferation marker 







Table 5.1 Culture plate setup for stimulation assays. 
The different stimulants were added to 1x106 cells/ml of cRPMI in 48-well tissue culture plates for 
each sample assigned to the designated well. Samples for HIV-1 positive participants were 
distributed into 5 wells while those of HIV-1 negative participants were added into 4 wells. 
 
 
Stimulating Antigens   
HIV-1 Positive  HIV-1 Negative 
Unstimulated (cRPMI +cells)  Unstimulated(cRPMI +cells) 
PHA 5ug/ml (Sigma) PHA 5ug/ml 
HIV-1 p24 5ug/ml (R&D Inc.)  
Streptokinase 2ug/ml  
(Aventis) 
Streptokinase 2 ug/ml 
A. lumbricoides 10 ug/ml A. lumbricoides 10 ug/ml 
A.lumbricoides= Ascaris lumbricoides crude antigen homogenate. Details of sources and 
preparation are in Appendix 6 page 254. PHA Phytohaemagluttinin; cRPMI complete RPMI 
medium 
 
5.2.2 Determination of Proliferative Responses to Stimulants in cultured PBMCs: 





A few methods were explored to identify a proliferation marker that would be suitable for 
the limited number of cells available for cultures.  The two markers of proliferation, Ki67 
antigen and Proliferating Cell Nuclear Antigen (PCNA) were found to be suitable. Poor 
and inconsistent staining was experienced with the latter and the former was then 
chosen for subsequent experiments. The procedure for Ki67 was further optimised to 
determine the best method for the flow cytometric recovery of stained (proliferating) 
cells.  
 
5.2.2.1 Anti-Ki67 and anti- CTLA-4 staining 
 
The final modified staining included staining for the downregulator of T cell stimulation, 
CTLA-4. Surface staining for CD3 expression was excluded as this staining proved 
unsuccessful due to poor light scatter properties of alcohol-preserved cells. PBMCs from 
40 HIV-1 positive participants had each been cultured unstimulated or in the presence of 
PHA, HIV-1 p24, Streptokinase and Ascaris lumbricoides antigens. Control samples from 
22 HIV-1 negative individuals were cultured unstimulated, or challenged with PHA, 
streptokinase and A. lumbricoides antigens. After removal of supernatants, the cell 
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cultures (from section 5.2.1.2) were enumerated and 500 μl aliquots adjusted to contain 
5 x106 cells. For each sample, 5 wells of a 48-well microplate were designated for the 
respective stimulant (in duplicates) as listed in Table 5.1. Twenty microliters each of 
monoclonal antibody-fluorochrome conjugate (CTLA-4 APC) were carefully pipetted into 
the bottom of all designated wells. One hundred microliter aliquots of each sample were 
pipetted into each of the corresponding wells containing the antibodies. The solutions 
were mixed by shaking the plates in the shaker at 1000rpm for 30 seconds. Plates were 
then incubated on ice for 45 minutes in the dark. For washing, the plates were then 
centrifuged at 1500rpm with the brake on at 4ºC for 3 minutes and supernatant carefully 
aspirated. The wash/centrifugation step was repeated one more time. The pelleted cells/ 
100 μl were transferred to 50ml polypropylene tubes. Five milliliters of cold 80% ethanol 
was added dropwise, while vortexing the cell suspensions. The cells were then fixed and 
permeabilised by incubation for at least 2 hours at  -20ºC (in most cases were incubated 
overnight- they could be used up to 60 days after fixing). Forty milliliters of wash buffer 
(1X PBS with 1% fetal calf serum and 0,09%  NaN3,  pH 7.2)  was added to the fixed 
cells and the tubes centrifuged at 1000 rpm (with the brake on) for 10 minutes. The 
supernatant was carefully aspirated and discarded.  A further wash-centrifugation step 
was repeated two more times and all supernatant completely removed.  The cells were 
resuspended in 100 μl of wash buffer and transferred to designated wells containing 20 
μl of anti Ki67-FITC conjugate (BD Pharmingen) in 48-well microtiter plate. The sample-
antibody solutions were mixed in a plate shaker at 1000 rpm for 30 seconds and 
incubated on ice for 45 minutes in the dark. One hundred and eighty microliters of wash 
buffer was dispensed into each well and the plates centrifuged as above. The washing 
steps were repeated once more. The pellets were resuspended in 180 μl of wash buffer 
and transferred to FACS tubes containing 350μl of wash buffer.  Flow cytometric 
analysis of the samples then followed.  Control samples wells were included: IgG1 κ 
FITC and IgG2a APC isotype controls, unstained cells, stimulated and unstimulated cells 
stained with anti-Ki67 FITC only, anti-CTLA-4 APC only, and with both sets of 
antibodies.  
 
5.2.2.2 Flow cytometric detection: Data Acquisition and analysis 
 
The daily instrument standardization and maintenance was performed. Using the 
Cellquest software for four colour analysis, the unstained cells were first run through the 
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instrument for the negative autoflourescence control and threshold setting. Forward and 
side scatter detector PMT voltage and Amp gain settings were also adjusted using the 
unstained cells tube. The threshold value was set at 180 on forward scatter to exclude 
debris. Cells stained with isotype controls were used to exclude non-specific binding of 
antibodies. The following isotype controls were included: IgG1k FITC and IgG2a APC. 
Further, unstained cells from a HIV negative and helminth uninfected individual were 
finally used to set the negative population marker as isotype control tubes were found 
unsuitable for this. The samples were then run on Cellquest software. A minimum of 10 





In the side scatter versus forward scatter dot plot, the lymphocyte region (R1) was 
established. For each participant, the unstimulated tube was used to set the gating 
region and the curser was left unchanged for all subsequent tubes of stimulated cells for 
the particular individual. Thus the R1 lymphogate region of the unstimulated cells tube 
was also used for gating the stimulated cells for each individual. Dotplots for Ki67 vs 
CTLA-4 were drawn and histogram plots were drawn with markers separating the 
negative and positive cell populations, each for Ki67 and CTLA-4 fluorescence intensity 






Figure 5.1 Gating strategy for Ki67 and CTLA-4 expression by lymphocytes.   
PBMCs were cultured in RPMI medium without stimulation and with HIV-1 p24, PHA, Ascaris lumbricoides, 
or Streptokinase challenge for 5 days. These cells were fixed, permeabilised, stained with anti-Ki67 FITC 
and anti-CTLA-4 APC conjugates. Expression of these proteins was analysed on gated lymphocytes by flow 
cytometric determination of fluorescence intensity. A. Side scatter vs forward scatter properties were used to 
differentiate lymphocytes in region 1(R1) B. The unstimulated cells tube B (upper right) was used to set the 
curser, and then the stimulated cells (streptokinase in this example) were gated on the same region. All 
subsequent stimulated cells were gated on the same region set on unstimulated cells tube for each 
individual. 
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5.2.3 Detection of cytokine production by PBMCs 
5.2.3.1 Methodology-Multiplex Human Cytokine Assay 
For these tests 40 samples from HIV infected participants were analysed. Cell culture 
supernatants that had been harvested after five days’ culture (section 5.2.1.2) were 
retrieved from -70°C freezers and allowed to cool to room temperature before assays 
were set up. The Human cytokine LINCOplex KIT (13-plex) assay was used as per the 
manufacture’s instructions to detect a range of thirteen cytokines. Briefly, plates were 
BSA- blocked and washed. Cytokine standards, controls and unknown samples were 
added (50μL total volumes) to 96 well plates in duplicates and incubated with antibody-
immobilised micro beads. After washing, biotynilated detection antibodies were 
incubated with the bound cytokines.  Fluorescent (Phycoerythrin- labeled) streptavidin 
was added. A final wash was followed by resuspension in sheath fluid for analysis in the 
Bioplex array reader (Biorad) using the Bioplex Manager 4.1 software.  Fifty beads per 
region were collected. A seven-point standard curve (range 0; 3,2; 16; 80; 400; 2000 and 
10 000pg/ml) was constructed using a 5 parameter  logistic (5PL) regression and the 
concentration of each cytokine calculated against this curve.   
5.2.4 Statistical methods 
 
The median was used and Kruskal Wallis ANOVA was used to compare the differences 
between the subgroups. 
5.3 Results  
The proliferative capacity and cytokine production of cells from HIV infected and 
uninfected persons with or without evidence of helminth exposure were measured. 
PBMCs were incubated  for five days with or without stimulation and proportions of cells 
expressing the proliferation nuclear antigen Ki67 and downregulatory  molecule CTLA-4 
determined by flow cytometry. Culture supernatants were analysed for cytokine 
production by multiplex (Bioplex, BioRad Inc) technology. 
 
5.3.1 Results of Preliminary experiments 
Optimum concentrations of stimulants were 5ug/ml each for PHA and HIV-1 p24, 2ug/ml 
for streptokinase and 10ug/ml for the Ascaris crude antigen preparation. The suitable 
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incubation period was found to be five days particularly for the antigens, although PHA 
responses had already peaked on day 3 for IL-4 production while interferon γ peaked at 
day five for specific antigens. It became clear that optimum culture conditions differed for 
PHA and specific antigen as well as for the two cytokines IL-4 and IFNγ, and a 
compromise was a five day culture, because the more important outcome was for 
antigen-specific responses. 
   
5.3.2 Proliferation Assay Results: Unstimulated (baseline) and stimulated 
proliferation responses to mitogen and recall antigens: Ki67 and CTLA-4 
expression in HIV+ and HIV- groups:   
Background (unstimulated) values were subtracted from the values obtained in each 
antigen-specific response. There were indeed differences in the expression of Ki67 in 
the absence of stimulation and also in response to stimulants between the two HIV 
groups, with a significantly lower Ki67 median values in HIV negatives than HIV positives 
in unstimulated cells (p=0.01). Also, within the subgroups, there were differences in the 
levels of background Ki67 and these are compared separately from the net antigen-
specific responses. The median percentage expressionof Ki67 and CTLA-4 within the 
subgroups are summarized in Figure 5.2 for HIV positive and negative groups. Antigen 
specific responses were generally higher in the HIV negative group compared to the HIV 
positive groups (Figure 5.2 panels B and D) Streptokinase p=0.05 and Ascaris p=0.29). 
These differences in antigen-specific proliferative capacity can possibly be ascribed to 
the effect of HIV infection. It should be noted that the numbers of some of the HIV 
negative subgroups were smaller than those of the HIV+ groups. The finding of higher 
antigen responses despite smaller numbers in this group is noted. However for statistical 





























































Figure 5.2 Median percentage expression of proliferation nuclear antigen (Ki67) and Cytotoxic T 
lymphocyte antigen-4 (CTLA-4) in lymphocytes in HIV+ (A and B) and HIV- subgroups (C and D) with 
or without helminth co-infection.  A and C represent summary Ki67and CTL-A4 net responses to all 
stimulants while B and D show  net  Ki67 responses to specific antigens in HIV+ and HIV- groups 
respectively.  PBMCs were incubated unstimulated or stimulated with PHA, Ascaris lumbricoides and 
Streptokinase antigens. After five days of culture, cells were stained with monoclonal antibodies to Ki67 and 
CTLA-4 and proportions of stimulated or unstimulated cells expressing these markers were determined by 
flow cytometry. Median values in the y axis are expressed as percentages. In all panels the groups and their 
n sizes were:  Egg+IgEhi group (HIV+ n = 10,HIV- n=5) helminth egg excretion and elevated Ascaris 
lumbricoides IgE; Egg+IgElo (HIV+n=10, HIV-n=7) helminth egg excretion and low Ascaris lumbricoides IgE; 
Egg-IgEhi group  (HIV+n=10, HIV-n=3); Egg-Iglo (HIV+n=10, HIV-n=7) No helminth egg excretion and low 
















5.3.3 Proliferation profile within subgroups of HIV positive and negative 
subgroups 
 
The comparison of proliferative capacity between the subgroups of HIV positive 
individuals was done by Kruskal Wallis Anova and subgroup medians are summarised in 








Figure 5. 3 Kruskal Wallis Box and whisker plots for proliferation antigen - Ki67 and CTLA-4 antigen 
expression on unstimulated  lymphocytes of HIV+ subgroups. 
Lymphocyte expression of Ki67 and CTLA-4 was determined by flow cytometry. The median percentages 
were compared by Kruskal Wallis ANOVA to determine significant differences within the subgroups of HIV+ 
individuals. Ascaris-crude whole worm antigen of Ascaris lumbricoides. Its preparation is detailed in 

























































































































































































































5.3.4. Interactions of proliferation profiles in subgroups of HIV positive and 
negative subgroups. 
 
5.3.4.1 The HIV+, egg+IgEhi group is associated with increased expression of Ki67 
proliferation antigen in unstimulated cells. 
 
In HIV infected, egg+IgEhi participants, expression of Ki67 in unstimulated was 
significantly higher (p=0.01) cells than in the egg-IgElo and the other two subgroups.  In 
relation to the other HIV+ subgroups, the median Ki67 expression by unstimulated cells 
was up to four to eight times higher in this subgroup compared to the egg-IgElo (p <0.01), 
the egg+IgElo (p=0.01), and the egg-IgEhi (p=0.01) subgroups Furthermore, in most 
instances, the expression of Ki67 was higher in unstimulated than in antigen-stimulated 
cells in the egg+IgEhi subgroup (Figure 5.4). Subsequently, the median percentage 
values for the antigen responses equaled zero for all specific antigens (Figure 5.2 panel 
B). 
 
The background values were then subtracted from the values obtained in the antigen 
stimulated cells.  
The HIV-, egg+IgEhi  and egg-IgElo subgroups 
There were no significant differences in expression of Ki67 in unstimulated cells when 
the HIV negative, helminth infected individuals were compared to the helminth 
uninfected subgroup. However, the median percentage Ki67 was slightly but 
insignificantly higher in the egg+IgEhi subgroup (median 4,3%, compared to 1,1%, 1,0% 
and 2,6% respectively for the other three subgroups).  
In all the HIV negative subgroups almost all background (unstimulated) values were 
lower than stimulated ones. 
5.3.4.2 The egg+IgEhi group shows a tendency towards impaired proliferative 
responses to recall and specific antigens but potent mitogen responses. 
 
In the HIV/helminth co-infected, egg+IgEhi subgroup, there were consistenly low antigen–
specific (HIV-1 p24 and Ascaris) and recall antigen (Streptokinase) Ki67 responses 
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relative to the egg-IgElo and all the other subgroups (Figure 5.2 panel B) while mitogen 
responses remained high (Figure 5.2 panel A).  These differences were however not 
significant (p=0.41, 0.19 and 0.31 for p24, streptokinase and Ascaris, respectively). Of 
note is the fact that compared to the HIV-singly infected individuals, the egg+IgEhi 
subgroup had undetectable levels with zero median Ki67 responses to all specific 
antigens while these were  1.4%, 0.6% and 1.1% for p24,  streptokinase and Ascaris 
antigens respectively in the HIV+ egg-gElo subgroup.  
 
Notably, the strong Ki67 responses to PHA mitogen were highly significant (p=<0.01) in 
all groups with some evidence of helminth exposure (the egg+IgEhi, the egg+IgElo and the 
egg-IgEhi groups) compared to the egg-IgElo group (Figure 5.2 panel A)  
 
In this (egg+IgEhi) subgroup, most participants had enhanced PHA mitogen proliferative 
responses while HIV-p24 and Ascaris antigen responses were decreased (Figure 5.5) in 
this egg+IgEhi group ).  It is noted however that some individuals within this group made 
strong antigen-specific responses (Figure 5.6)  
The HIV-, egg+IgEhi group 
Among the HIV uninfected groups, antigen specific responses were similar for the 
egg+IgEhi and all the other three subgroups, particularly for the Ascaris stimulated Ki67 
expression responses. 
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Figure 5.4 Illustrates increased expression of Ki67 on unstimulated cells. Cells cultured without stimulation 
(Panel A) show increased expression of KI67 compared to HIV-p24 (panel C) and Ascaris-antigen (panel D)-
challenged cells in an HIV-1 infected, egg excreting individual with elevated Ascaris IgE. PBMCs were stained with 
monoclonal antibodies to Ki67 and CTLA-4 conjugated to FITC and APC respectivelyand analysed for proportions of 
cells expressing these molecules by flow cytometry. Percentages in this figure represent all cells expressing Ki67 (top 
and bottom right quadrants). 











Figure 5.4  Increased mitogen and low specific-antigen responses in an HIV+ Egg+IgEhi individual. 
Enhanced PHA responses (panel B) compared to Ascaris (panel C) and HIV-1 p24 (panel D) specific 
antigen responses in an HIV+ individual with egg+IgEhi status. PBMCs were stained with monoclonal 
antibodies to Ki67 and CTLA-4 conjugated to FITC and APC respectively and analysed for proportions of 
cells expressing these molecules by flow cytometry. Percentages in this figure represent all cells expressing 
















Figure 5.5 Potent antigen specific responses (HIV-p24, panel C and Ascaris antigen, Panel D) from an 
HIV positive–Egg+IgEhi helminth infected individual.  
PBMCs were stained with monoclonal antibodies to Ki67 and CTLA-4 conjugated to FITC and APC 
respectively and analysed for proportions of cells expressing these molecules by flow cytometry. 








































5.3.4.3 CTLA-4 Responses 
5.3.4.3 The HIV+ egg+IgEhi group is associated with increased CTLA-4 expression 
in unstimulated cells 
The downregulatory protein CTLA-4 in unstimulated cells in the egg+IgEhi group did not 
differ with that of the egg-IgElo group but was significantly higher  in relation to the 
egg+IgElo subgroup (p=0.04;  
 
Notably CTLA-4 expression in response to PHA challenge was also statistically 
significantly higher (p<0.001) in both groups with stool eggs (the egg+IgEhi and egg+IgElo 
groups- Figure 5.2 panel A).  Low or undetectable levels of this molecule were observed 
for antigen specific stimulated cells in all the HIV+ subgroups. 
 
The HIV- egg+IgEhi 
CTLA-4 responses were significantly increased for Ascaris and streptokinase stimulated 
cells in the egg+IgEhi subgroup (p=0.03 and 0.05 respectively) Figure 5.2 panel C. No 
significant increases in CTLA-4 were observed in the other subgroups. 
 
Two other observations made in the HIV- groups: 
1) Contrary to the responses observed in the HIV infected participants, the background 
Ki67 expression was significantly higher (p=0.03) in the helminth-negative egg-IgElo 
subgroup (, Figure 5.5 in Appendix 5.3) which probably suggests that these individuals 
have some background immune response to some antigenic challenge. 
 
2) Among the HIV negative participants, both groups with high IgE had significantly 
higher proliferation responses to the recall antigen Streptokinase (Figure 5.2 Panel C).  
This could reflect that high IgE  possibly decreases  the threshold for immune 
responsiveness to recall antigens. 
 
It should be noted that in both HIV positive and negative groups, some responses to 
Ascaris antigen challenge were made by the groups without faecal eggs and low specific 
IgE (egg-IgElo) (medians 1.1% and 2.64% in HIV- and HIV+, respectively) These may 
suggest that there is some level of exposure to Ascaris antigens in the environment, or 
reflects past exposure/cleared past infection. 
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5. 3.7 Results of Cytokine Production Patterns  
According to the theoretical interactions between HIV and helminths, type 2 cytokines 
induced by helminths would decrease the Th1 cytokines that are essential for HIV 
control. On the other hand, HIV disease progression is cited to be associated with 
increased Th2 cytokines or reduction in Th1 response (Clerici and Shearer, 1994). In 
order to determine if HIV and helminth co-infected individuals present a predominance of 
type 2 cytokine profile and/or diminished type 1 cytokines, baseline cytokine production 
was compared in HIV+ subgroups with and without evidence of helminth exposure. 
Proinflammatory cytokine profiles were also assessed as they are cited to increase as 
HIV progresses (Valdez and Lederman, 1997). Furthermore, cytokine responses to 
stimulation with HIV-1 p24 and Ascaris worm antigens were analysed. 
 
5. 3.7.1 Cytokine production by unstimulated cells  
 
The median values of baseline (unstimulated) cytokine production are shown in Table 
5.2. A wide range of individual levels was detected,therefore prominent patterns are 
reported in the respective groups.  Low background IL-5 and IL-13 levels were generally 
obtained in all the groups while IL-7 levels were undetectable. The level of expression of 
IL-1RA in particular, and to an extent IL-6 and IL-8 was very high, and many values for 
these cytokines were extrapolated outside the standard curve upper limit of 10 000 pg/ml 
(Table 5.2).  
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Table 5.2 Unstimulated Cytokine Production in HIV+ subgroups 
.Median percentage expression of extracellular cytokines in unstimulated cell cultures in HIV infected groups with or 
without helminth co-infection. PBMCs at a concentration of 1x106 /ml of cRPMI were cultured without stimulation at 37°C 
for five days and supernatants were collected, centrifuged and stored at -70°. Later the supernatants were analyzed by 








































































































































































































*Eggs- faecal helminth eggs. Hi /lo IgE- high or low serum Ascaris lumbricoides-specific IgE. IL interleukin; IL-1RA  
interleukin-1 receptor antagonist; IFNγ interferon gamma;IP-10 interferon-inducible protein 10; TNFα Tumor necrosis 
factor alpha; GM-CSF granulocyte-monocyte stimulation factor; RPMI=complete RPMI medium. Values extrapolated 
outside the standard curve’s range are given as greater than 10 000. 
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5.3.8 Patterns of cytokine production by unstimulated cells in HIV+ subgroups 
5.3.8.1 Cytokine profiles in the egg+IgEhi and the egg-IgElo subgroups 
The egg+IgEhi subgroup had significantly lower levels of the anti-inflammatory IL-1RA 
(p=0.04), and a lower trend for the Th1 cytokines IL-2 (p=0.07) and IFNγ (p=0.09) and all 
the Th1 cytokines except for the GM-CSF were lower but not significant when compared 
to the egg-IgElo subgroup, while both groups had similar proportions of proinflammatory 
cytokines but IL-8 was significantly lower (p<0.01) and TNFα higher, but not significant in 
the egg+IgEhi individuals.The Th2 cytokines were similar in both groups,  The regulatory 
IL-10 was lower but not significant in the egg+IgEhi group Table 5.2. 
5.3.8.2 Type 1 cytokines are decreased in the egg+IgEhi group  
 
All individuals in the egg+IgEhi group had undetectable baseline levels of the 
lymphoproliferative cytokine, IL-2 and a trend between this group and the egg-IgElo group 
(p=0.07) was observed.  
Similarly, in the egg+IgEhi group the antiviral cytokine, interferon gamma (IFNγ) was 
undetected in all except only one participant with 1,14pg/ml IFNγ. Median IFNγ 
production by unstimulated cells differed significantly between this group and the 
egg+IgElo (p=0.02) and the egg-IgEhi (p=0.04) groups and there was a trend for a 
decrease in this group when compared to the egg-IgElo group (p=0.09)  
5.3.8.3 The Th2 cytokine IL-4 is higher while Th1 cytokines (IL-2 and IP-10) and the 
regulatory cytokine IL-10 are lower  in high IgE responder (egg+IgEhi and egg-IgEhi) 
sugroups. 
 
The median expression of the classic Th2 cytokine, IL- 4, was highest in the two groups 
with elevated Ascaris IgE (egg+IgEhi and the egg-IgEhi groups) Table 5.2. This difference 
was statistically highly significant between the egg-IgEhi and the egg+IgElo groups 
(p=0.01) and between the egg-IgEhi and the egg-IgElo groups (p=0.02).In addition, while 
all participants in the egg+IgEhi group had undetectable IL-2 levels, this cytokine was 
produced by unstimulated cells in only 1 of the 10 egg-IgEhi participants, such that 
median IL-2 levels were marginal in both groups with high IgE (Table 5.2), and there was 
a weak trend between the egg+IgEhi and the egg-IgElo groups (p=0.07)Table 5.2). 
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Table 5.2 shows that the levels of the interferon inducible protein (IP)-10 were also lower 
in these high IgE groups (lowest in the egg+IgEhi group)  compared to the low IgE 
responders (the egg+IgElo and egg-IgElo groups). 
 
Furthermore, median values for the regulatory cytokine IL-10 were lowest in the 2 groups 
with high Ascaris IgE (medians 30.7 and 40 pg/ml) compared to the low IgE groups 
(medians 116.3 and 146.6 pg/ml).   
5.3.8.4 The egg+IgElo individuals have higher IFNγ (type-1), and lower IL-4 (type 2) 
cytokines.    
The egg+IgElo group had the highest median IFNγ, and this was statistically highly 
significant compared to the egg+IgEhi (p=0.01) and the egg-IgEhi groups (p<0.01) Table 
5.2. Notably, the medians for IL-2 and IP-10 (Th1) were also highest in this group (Table 
5.2).  
 
The median value for IL-4  was lowest in this egg+IgElo group and this was highly 
significantly lower compared to the egg-IgEhi and the egg+IgEhi groups (p=0.01.   
 
The regulatory cytokine IL-10 was higher (but not significantly, p=0.16) in this subset of 
individuals compared to both high IgE responder groups. 
5.3.8.5  Proinflammatory and anti-inflammatory cytokine production by 
unstimulated cells. 
 
The proinflammatory cytokines IL-6 and IL-8 and the anti-inflammatory interleukin-1 
receptor antagonist (IL-1RA) were highly expressed in most of the samples. This was 
more often the case in IL-1RA where all the values in the egg-IgElo and in five of the ten 
individuals in the egg-IgEhi group far exceeded the upper curve limit and could not even 
be extrapolated. For both IL-6 and IL-8 most values were extrapolated outside the 
standard curve upper limit therefore data for these three cytokines may not be accurate.  
However as the results stand, there were two significant observations in the secretion 
patterns of these cytokines.  
 
Firstly, the two groups with positive stool eggs (egg+IgEhi and the egg+IgElo) had 
remarkably lower levels of IL-8. These differences were statistically highly significant 
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between the egg+IgEhi and the egg-IgElo (p=0.01) and between the egg+IgElo and the egg-
IgElo (p<0.01) groups  
Secondly the anti-inflammatory cytokine IL-1RA was also lower in both stool egg positive 
groups, with a significant difference between the egg+ IgEhi and the egg-IgElo groups 
(p=0.04 Table 5.6).   
 
Finally, as the secretion levels of the other proinflammatory cytokine tumor necosis 
factor (TNF) α were within the curve plot range, it was observed that the two groups with 
positive helminth stool eggs (egg+IgEhi and the egg+IgElo) had higher medians for TNFα 
compared to the stool egg negative groups (egg-IgEhi and the egg-IgElo) (Table 5.2) 
although this difference did not reach statistical significance. 
In summary the stool egg positive groups had higher levels of TNFα and lower levels of 




5. 3. 9 Cytokine production in antigen-stimulated cells 
For the final antigen–specific results, the background (unstimulated) cytokine production 
values were subtracted from the specific result for each sample. 
5.3.9.1 Cytokine production in HIV-1 p24-challenged cells 
 
It was observed that cytokine responses to HIV-1 specific antigen challenge were 
distinctly lower than background (unstimulated) levels. This was particularly the case 
with the proinflammatory cytokines (IL-6, IL-8 and all the type 2 cytokines (IL-4, IL-5 and 
IL-13 (Table 5.3).   
5.3.9.2 Comaprison between the dual infected HIV+ egg+IgEhi and HIV singly-
infected egg-IgElosubgroups  
Comparison between the egg+IgEhi and egg-IgElo subgroups shows that the Th1cytokine 
IP-10 was significantly lower (p=0.04) in the egg+IgEhi individuals while IL-2 and GM-CSF 
were undetected in both groups. All the pro-inflammatory cytokines were higher, but not 
significant in the former group in HIV p24 stimulated cultures (Table 5.3). The IL-10 
levels were similar in both groups. Th2 cytokines were not detectable after stimulation of 
cultures with HIV p24 in the current assay except in a very few individuals in all 
subgroups. No other significant differences were observed between the dually infected 
and HIV-singly infected subgroups for the HIV antigen stimulations. 
5.3.9.2 The Th1 cytokines (IL-2 and IFNγ) are lower  in HIV-1 p24 stimulated cells of 
the egg+IgEhi group individuals  
 
None of the individuals in the egg+IgEhi group produced detectable levels of IFNγ in 
response to HIV-1 p24 stimulation. The group median differed significantly from the 
egg+IgElo group (p=0.01), from the egg-IgEhi group (p=0.04) and from the egg-IgElo group 
(p=0.05). 
 
IL-2 expression in response to HIV-1 p24 stimulation was generally low in all groups 
however; none of the PBMCs obtained from the egg+IgEhi group participants seemed to 
produce it upon challenge with HIV-1 p24 ( Table 5.3). This was similar to the findings in 
unstimulated cytokine results wherein these individuals had undetectable levels of IL-2. 
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5.3.9.4 The egg+IgElo group had higher IFNγ responses to HIV-1 p24 
 
The highest median IFNγ of 11.1pg/ml  (Table 5.3) was found in the egg+IgElo group and 
this was significantly higher than the value for the egg+IgEhi group (p=0.02). 
 
The regulatory cytokine IL-10 median was three- to four- folds higher in the egg+IgElo 
group compared to the three other subgroups (Table 5.3). 
 
No other distinct patterns were observed in terms of cytokine profiles and HIV/helminth 
infections in response to HIV-1 p24 stimulation. 
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Table 5. 3. Cytokine production in response to HIV-1 p24 challenge. 
Expression of cytokines in HIV-1p24 (p24) antigen-stimulated cell culture supernatants in HIV infected groups with or 
without helminth co-infection. PBMCs at a concentration of 1x106 /ml of cRPMI were stimulated with p24 and cultured at 
37°C for five days and supernatants were collected, centrifuged and stored at -70°. Later the supernatants were analysed 
by the multiplex technology Bioplex ( BioRad) for cytokine expression. Results are presented as median, minimum and 




















































































































































































































*Eggs- faecal helminth eggs. Hi / lo IgE- high  and low serum Ascaris lumbricoides-specific IgE. IL interleukin; IL-1RA 
interleukin-1 receptor antagonist; IFNγ interferon gamma; IP-10 interferon-inducible protein 10; TNFα Tumour necrosis 
factor alpha; GM-CSF granulocyte-monocyte stimulation factor; RPMI=complete RPMI medium. 
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5.3.10 Cytokine production by Ascaris worm-challenged cells  
 
Although antigen specific responses to challenge with worm antigen generally invoked 
stronger responses compared to HIV antigen stimulation assays (Tables 5.3 and 5.4), 
levels of the anti-inflammatory cytokine IL-1RA and most IP-10 levels were undetectable 
in these assays.  As in HIV-1 p-24 stimulated assays, no distinctive patterns of cytokine 
profiles were discernible in terms of interactions between helminth and HIV infections in 
the worm antigen stimulation experiments. 
5.3.10.1 The egg+IgEhi and egg-IgElo subgroups 
Comparison between the egg+IgEhi and Egg+IgElo subgroups showed that all the pro-
inflammatory cytokines were higher but not significant in the former. No significant 
differences were observed between the two groups for the Th1, Th2 and regulatory 
cytokines in Ascaris-stimulated cultures.  
 
5.3.10.2 The egg+IgElo  subgroups has high proinflammatory IL-6 and IL-8 
The one outstanding finding was the significantly higher levels of the proinflammatory 
cytokines IL-6 and IL-8 found in the egg+IgElo  group (p=0.03 and p=0.04 respectively, 





Table 5.4 Group medians for cytokine responses to Ascaris  crude antigen stimulation. 
Median percentage expression of extracellular cytokines in Ascaris antigen-stimulated cell cultures in HIV 
infected groups with or without helminth co-infection were determined. PBMCs at a concentration of 1x106 
per milliliter of cRPMI were stimulated and cultured at 37°C for six days and supernatants were collected, 
centrifuged and stored at -70°. Later the supernatants were analysed by the multiplex technology Bioplex ( 



































































































































































































*Eggs- faecal helminth eggs. Hi IgE- high serum Ascaris lumbricoides-specific IgE. IL interleukin; IL-1RA interleukin-1 
receptor antagonist; IFNγ interferon gamma;IP-10 interferon-inducible protein 10; TNFα Tumor necrosis factor alpha; GM-
CSF granulocyte-monocyte stimulation factor; cRPMI=complete RPMI medium. Preparation of the Ascaris crude antigen 
detailed in Appendix 6. page 254.. 
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5. 4 Summary findings 
There were some assay limitations in the present chapter, however some distinctions 
were revealed within the groups who differ in terms of proliferative responses, in 
constitutive and in stimulated cytokine production. The first is the egg+IgEhi group: When 
compared with the HIV singly infected egg-IgElo, some differences were noted in this 
dually infected subgroup.This group was shown to have high background expression of 
Ki67 and CTLA4. Antigen specific proliferation tended to be lower despite potent 
mitogen responses in this group. Cytokine profiling showed that at baseline as well as in 
response to HIV-1 p24 challenge this group persistently had low and/or undetectable Th1 
cytokines (IL-2, IFNγ and IP-10).  
The second distinction was that high IgE responder groups (the egg+IgEhi and the egg-
IgEhi) typically had higher background IL-4 (Th2) and lower Th1 cytokines (IL-2 and IP-10) 
with lower IL-10 levels. 
 
Finally the egg+IgElo group had higher levels of Th1 cytokines in unstimulated and HIV-1 
p24 stimulated cell responsesas well as lower background  IL-4 (Th2). IL-10 levels were 
high at baseline, in HIV-1 p24- and Ascaris worm-challenged cells in this group. 






According to the study hypothesis, worm infection leads to predominance of type 2 
cytokines, or conversely, diminished type 1 responses. Further, expression of 
proinflammatory cytokines is suggested to increase during worm infection and as HIV 
infection progresses (Kedzierska and Crowse, 2001; Lawn et al., 2001). Increases in 
type 2 and inflammatory cytokines is associated with HIV disease progression 
(Kedzierska and Crowse, 2001; Borkow and Bentwich, 2004) while the proinflammatory 
cytokine TNFα is reported to enhance HIV replication (Lawn et al. 2001).  With regards 
to HIV and worm co-infection, this would impair effective HIV immune control and 
accelerate progression to AIDS. Furthermore, the proliferative capacity of cells from 
individuals with HIV (Day et al., 2007) or both HIV and helminth infections (Borkow and 
Bentwich, 2004) is attenuated with a deleterious effect on immune competence.  Thus, 
to further investigate whether individuals with both infections are immunologically 
compromised in terms of HIV immunity, the proliferative capacity and cytokine profiles 
were analysed in unstimulated and antigen-stimulated PBMC cultures. 
 
Ki67 is well recognised as a proliferation-related nuclear protein (Gerdes, 1990). Its 
expression is therefore used as a marker for proliferating cells and was used in this work 
to characterize the capacity of PBMCs to proliferate in response to antigenic stimulation.  
 
CTLA-4 protein expression is induced by activation and binds the B-7 molecules with 
higher affinity than CD28 (the costimulatory molecule). This binding inhibits T cell 
signaling thereby downregulating the activation process (Janeway et al., 2001). As such 
the expression of CTL-A4 counteracts immune activation and can be a phenotypic 
marker of activation. 
 
The results of the present section, notwithstanding the design limitations, tend to 
suggest that dual infection   with HIV and egg+IgEhi status lends support to the study 
hypothesis. 
 
Firstly, expression of Ki67 (the cell proliferation nuclear protein) was significantly 
increased in PBMCs of participants in the egg+IgEhi subgroup in the absence of 
stimulating antigen,  This was observed even when this subgroup was compared to the 
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HIV+ egg-IgElo single infected individuals.Expression of CTLA-4 molecule was also 
significantly increased in unstimulated PBMCs of individuals in the egg+IgEhi group. Ki67 
is expressed by proliferating cells at G1, S and M phases of the cell cycle (Iatropoulous 
and Williams, 1996). Brunner et al. (1999) showed that CTLA-4 inhibits cell cycle 
progression through reduction of cyclin-dependant kinases. In 2001, Leng et al. 
illustrated that simultaneous increase of both Ki67 and CTLA-4 indicates activated cells 
arrested at the G1 phase and therefore not necessarily proliferating cells. Therefore the 
finding of marked increase of these molecules in unstimulated cells of participants with 
both HIV and egg+IgEhi helminth infection strongly suggests immune hyperactivation. 
This corroborates the findings in Chapter 4 of this thesis wherein all activation markers 
were highly increased in this group.  
 
Secondly, the HIV-1 positive, egg+IgEhi worm co-infected individuals had significantly 
higher responses to mitogen challenge when compared to the egg-IgElo group (without 
helminth infection), implying that their cells were viable and capable of proliferation. 
However this egg+IgEhi subgroup showed decreased proliferative (Ki67) responses to 
HIV-1 p24, streptokinase and Ascaris worm antigens (Figure 5.2 PanelB) and typical 
dotplots in Figure 5.4 although these were not statistically significant. Expression of 
CTLA-4 in response to these specific antigens was similar in all the subgroups, without 
any significant differences thus showing that the Ki67 reductions corresponded to 
decreased proliferation per se.  
 
The lower proliferative responses to specific antigens and strong mitogen responses in 
the dually infected HIV+ egg+IgEhi individuals  agree with  previous reports that HIV and 
helminths selectively target and downregulate specific responses directed at them: HIV 
tat was shown to block CD26 (a costimulatory molecule) thereby attenuating effective 
transduction of the stimulation signals (Subramanyam et al., 1993). Likewise, both HIV 
and helminths are documented to downregulate expression of another costimulatory 
molecule, CD28 (Borkow and Bentwich, 2004), thus inducing generalised and specific 
anergy to themselves and other infecting pathogens.   
 
Notably, in this study, there were significantly strong PHA responses in all the subgroups 
with evidence of helminth exposure (either stool positive and/or high Ascaris IgE) in the 
HIV infected group, also suggesting that these cells retain their capacity to proliferate in 
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response to non-specific stimulation. The results then further support the suggestion that 
antigen specific responses are compromised in the presence of HIV- helminth co-
infections. 
 
The second part of this chapter examined the cytokine responses with and without 
antigen specific challenge in HIV-1 infected subgroups only. Unstimulated PBMC 
cytokine assays presumably represent the ex vivo profile of background cytokine 
production with a reasonable measure of inaccuracy. In the case of HIV and worm co-
infections this may represent cytokine production in response to the two infecting 
pathogens. Upon analysis of unstimulated cytokine production patterns certain findings 
of the present section were inclined towards the study hypothesis.  
When the HIV+ egg+IgEhi   subgroup was compared with the HIV singly-infected egg-IgElo 
individuals, there were significantly lower levels of the anti-inflammatory cytokine( IL-
1RA) p=0.04 and trends for lower type 1 cytokines IL-2(p=0.07) and IFNγ  (p=0.09). In 
HIV p24 stimulated cultures, the Th1 cytokine IP-10 was also significantly lower in the 
egg+IgE hi individuals. Within all the HIV positive subgroups there was an association 
between egg+IgEhi worm infection status and low baseline production of type 1 cytokines. 
IL-2 and IFNγ were undetectable and significantly lower while IP -10 median was lowest 
in individuals with HIV and egg+IgEhi worm infections. The significantly lower Th1 
cytokines, more importantly IFNγ and IL-2 in this group has serious implications for HIV 
disease whose control is largely mediated by these cytokines. IL-2 is a major 
lymphoproliferative cytokine that also drives differentiation of lymphocytes into armed 
effector cells while IFNγ, the antiviral cytokine plays a pivotal role in elimination of virally-
infected cells (Janeway et al., 2001). Production of these two cytokines was lower not 
only in unstimulated PBMCs but also in cells stimulated with the HIV-1 p24 antigen. 
Lower levels of IL-2 by the egg+IgEhi group is also in line with the tendency towards low 
antigen-specific proliferative capacity in these individuals as shown in section 5.3.4.2. 
Furthermore, the significant reduction of IL-2 and IFNγ with a tendency towards 
decreased antigen-specific proliferative responses in the egg+IgEhi group corresponds 
with the notion that defective IL-2 production is associated with advancing HIV 
immunodeficiency (Clerici and Shearerr, 1994). In addition, the simultaneous reduction 
of IL-2 and IFNγ in this group tallys with the findings by Sousa et al (2005) confirming 
that HIV-1 progression is associated with reduction of the population of CD4+ 
lymphocytes with potent proliferative capacity and ability to produce IL-2 and IFNγ. 
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Indeed these authors demonstrated the recovery of this population after 4 weeks of 
highly active antiretroviral therapy (HAART). In the same context, the results of the 
present section corroborate the findings in Chapter 3 of this thesis where a tendency 
towards reduction of CD4+ lymphocyte numbers in the egg+IgEhi group was observed, 
although absolute total numbers, not the functional aspect of CD4+ cells were 
analysedin this work. In addition, in the first section of this chapter it was shown that 
CTLA-4 expression was significantly increased in this egg+IgEhi group. CTLA-4 inhibits 
production of IL-2 among other downmodulatory functions (Janeway et al., 2001). These 
provide an immunological basis that is in line with    the hypothetical interaction between 
HIV and helminth coinfection (particularly in the egg+IgEhi individuals).  
These, and the fact that comparison between the egg+IgEhi and egg-IgE lo individuals 
revealed lower trends for background IL-2 and IFNγ and significantly lower anti-
inflammatory IL-1RA is  further suggestive of an inclination for support of the study 
hypothesis that dual helminth and HIV infection impairs type 1 cytokine responses that 
are critical in anti-HIV cell mediated immunity. 
 
Secondly, high IgE responder subgroups (egg+IgEhi and egg-IgEhi) had significantly 
higherbackground IL-4 levels as expected. In addition these two groups also had lowest 
median values for the type 1 cytokines IL-2 and IP-10. High IgE and IL-4 production are 
typical Th2 helminth responses. Their association with reduction of type 1 cytokines, as 
found in the present work concurs with the hypothesized compromise in type 1 response 
to HIV as a result of helminth-induced Th2 biasing.  
 
Thirdly, a noteworthy observation that the stool egg positive groups (egg+IgEhi and 
egg+IgElo) had higher baseline levels of TNFα may be biologically relevant although it 
was not statistically significant. Egg excretion may be associated with ongoing 
inflammatory processes (Secor et al., 2003) hence TNFα increased accordingly in the 
stool egg excretors in this study. This cytokine is reported to stimulate HIV replication 
(Lawn et al., 2001). The elevated TNFα by egg excretors supports the suggestion that 
helminth infection results in increased levels of proinflammatory cytokines, particularly 
TNFα, and thus hypothetically could accelerate HIV-1 replication.  
 
The background levels of the other inflammatory cytokines IL-6 and IL-8 and the anti-
inflammatory IL-1RA were very high such that they were extrapolated outside the upper 
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range of the standard curve. The interpretation therefore could be inaccurate and will not 
be discussed in terms of co-infection interactions. It should be noted as well that the 
expression of IL-6 is dependent on the stage of the infection. It was shown in vitro that 
expression of IL-6 in helminth infection is stage-dependent: acute infections produced 
low levels while chronically infected cells produced higher levels of IL-6 (Rodriguez-Sosa 
et al., 2002). The obscure results found in the present work could be explained in part by 
the fact that the duration of both HIV and helminth infections in all the subgroups 
examined in this study are not known. Some individuals could be at the chronic stages of 
infections while others recently acquired the infections just prior to study 
commencement. The finding that significantly lower levels of IL-8 were accompanied by 
lower IL-1RA (Table 5.3) in the stool egg positive groups is also at variance with the 
documented inverse relationship between these cytokines. IL-1RA was reported to 
decrease IL-1-induced production of IL-6 and IL-8 (Garat and Arend, 2003), and thus is 
classified as an anti-inflammatory mediator in this context. This discordance further 
affirms that the interpretation of the profile of IL-6, IL-8 and IL-1RA may not be straight 
forward in the context of co-infection and need further investigation. 
 
The final section of the results analysed cytokine production after stimulation of PBMCs 
with HIV-1p24 and Ascaris worm antigens. In this section a remarkable observation was 
the generalised marked reduction in the level of cytokine production in response to the 
specific antigens compared to those secreted by unstimulated cells. This was particularly 
evident in the proinflammatory cytokines in HIV-1 p24 stimulation assays, (Table 5.3).  
 
A prominent finding in the HIV-p24 antigen stimulation assays was the significantly lower 
IFNγ (type1 response) in the egg+IgEhi group when cells were stimulated with HIV-p24 
antigen. As discussed above, IFNγ plays an important role in HIV immune control. 
 
In  Ascaris worm stimulated assays, significantly lower levels of IL-6 and IL-8 were 
observed in the egg-IgElo group ( Table 5.4), which is in keeping with the fact that these 
are acute proinflammatory cytokines, which may not be expected to rise in response to 
worm challenge in PBMCs from helminth uninfected individuals. On the other hand, 
these two inflammatory cytokines were significantly increased in the egg+IgElo subgroup. 
As indicated in Chapter 3, the egg+IgElo resemble the modified Th2 phenotype. The 
increased IL-6 and IL-8 found in these egg-IgElo individuals corresponds well with the 
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assertions that (i) the modified Th2 individuals are susceptible to recurrent, heavy 
helminth infections (Maizels and Yashdanbakhsh, 2003) and (ii) helminth-chronically 
infected cells produced higher levels of IL-6 (Rodriguez-Sosa et al., 2002). 
 
It was observed that the patterns of many of the antigen-specific (HIV-1 p24 and Ascaris 
worm antigens) cytokine responses were not clearly defined. A combination of factors 
possibly contributed to this: While in vitro antigen stimulation in the presence of added co 
stimulatory molecules may mimic the antigen processing, presentation and associated 
signal transduction in the human body, many dynamic normal physiologic factors may be 
“distorted” during the in vitro modeling of the process, and in particular use of PBMCs 
that had been frozen. For example Godoy-Ramirez et al (2004) recommended use of 
diluted whole blood for optimized antigen specific responses in culture for intracellular 
cytokine assays. Ideally freshly drawn whole blood, which is superior to previously frozen 
PBMCs, should have been used in conjunction with intracellular cytokine staining to 
detect antigen specific responses in the present study. However, the ideal was 
compromised because of technical logistics and because the same set of PBMCs had to 
be split and used for surface staining of activation markers and the remainder used for 
culture. Following culture the cells had to be split for Ki67 staining and other assays. It 
was a challenge to find individuals with adequate numbers of cells to do all the assays 
particularly because of the generally low counts in HIV infected participants.  
 
Another limitation of this section of the study was difficulty to find balance for optimum 
incubation period for all the cytokines analysed, against the requirement for longer 
incubation to expand antigen-specific cellular responses (Godoy-Ramirez et al., 2004). 
Although optimisation experiments were undertaken, owing to cost implications, only two 
cytokines were investigated (IFNγ and IL-4) from which an optimum of five days was 
found for antigen-specific responses. Furthermore, bulk culture of PBMCs for cytokine 
assays to define antigen-specific responses may not be a true reflection of the in vivo 
setting, particularly under conditions of HIV and helminth infections: T lymphocytes are 
mainly the major source of many cytokines and in addition monocytes and macrophages 
produce some (Janeway et al., 2001). Disruptions in lymphocyte populations as found 
during HIV and helminth infections, and the redundant nature of cytokine production may 
therefore confuse the interpretation of such responses in bulk PBMC cultures. In 
addition, re-stimulation of PBMCs with cognate antigen reactivates the cells which then 
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enter into cell cycling. This process is regulated by cytokines. The cytokines in turn will 
regulate Suppressors of Cytokine Signalling (SOCS) at a later stage of activation in 
order to regulate and maintain homeostasis (Yu et al., 2003). It is expected that the 
kinetics of this process differs for each cytokine. Stringent control of these cycles for 
each cytokine in culture would therefore be necessary to obtain accurate optimum 
secretion and downregulation timepoints, which was not feasible in this work. This may 
be one of the reasons why some cytokine levels were distinctly lower in specific antigen 
stimulated than unstimulated cells (the negative feedback cycle could have been 
activated by antigen stimulation in the 5 day culture). 
 
 
Finally, culture of PBMC in vitro for five days may have increased the apoptosis for two 
reasons. In vitro assays of PBMCs are known to be more likely to increase antigen-
induced apoptosis while also, cells of HIV-infected individuals are documented to be 
highly susceptible to programmed cell death (Minami et al., 2006; Porichis et al., 2007). 
As a result determination of cytokine levels under these conditions may affect some or 
all of the results.  Some or all of the factors discussed above may have contributed to the 
limited findings in antigen-specific cytokine responses in the present work. 
 
Another major finding of this study is the subset of individuals who were excreting eggs 
but have low Ascaris IgE, defined as egg+IgElo. This group had higher background levels 
of type 1 cytokines IFNγ, IL-2 and IP-10 plus the lowest IL-4 levels. Even in HIV-1 p24 
stimulated assays this group had a higher IFNγ response. Of note, the levels of the 
regulatory cytokine IL-10 were highest at baseline, in HIV-1 p24 and worm antigen 
stimulated cells in these individuals. IL-10 downregulates antibody class switching to IgE 
(Maizels and Yazdanbakhsh, 2003). Production of this antibody is promoted by IL-4 
(Janeway et al., 2001: 370). Therefore the profile of egg+IgElo group fits perfectly with the 
modified Th2 model proposed by Maizels and Yazdanbakhsh (2003). These authors 
described three types of Th phenotype outcomes that follow after exposure to helminth-
(Schistosoma and Brugia malayi) infections. The first, referred to as modified Th2 
phenotype is characterized by clinically asymptomatic helminth infections and the 
individuals are highly susceptible to persistent heavy infection and constitute the main 
reservoir for transmission. They have marked regulatory cell (Treg) activity accompanied 
by high IL-10 levels, low IgE and high IgG4. In the present work, the egg+IgElo group 
 209 
typify this modified Th2 response by consistently displaying high IL-10 levels and low IgE 
responses in the presence of infection (faecal eggs).  In chapter 3 this group was shown 
to have a relatively competent immune response to HIV; they had higher CD4+ counts, 
lower viral load and higher proportions of lymphocyte subsets. 
 
A second phenotype described as the uncontrolled Th1, in which the individuals are 
susceptible to infections and have uncontrolled inflammatory disease, , high IgE and low 
IgG4 subclass. In the present study, this may be represented by the group with egg+IgEhi 
worm infection, having high Ascaris IgE and excreting faecal eggs.  This group (together 
with the egg+IgElo group) had higher median values for TNFα (proinflammatory) which 
corresponds well with the described phenotype. It is noted that there is an anolmally in 
terms of HIV response in these individuals.  Although they are designated to be 
uncontrolled Th1, by Maizels and Yazdanbakhsh (2003), in our work they were unable to 
produce the same Th1 cytokines against HIV or worms in culture. In the two dimensional 
immunological map presented by Diaz and Allen (2007), the Th1–Th2 axis is 
superimposed with the inflammatory-regulatory axis, with various types of infections 
distributed along the four planes, for example the helminths are on the Th2- regulatory  
end while allergy and autoimmunity are on the opposing Th2-inflammatory end of the 
map. In this model, these authors suggest that this separation along the inflammatory-
regulatory axis is determined by both the differences in the strength of the Th17 
response as well as the presence of the Treg cells.  The Th17 cells are key to the 
inflammatory component of the model and are known to play a key role in innate immune 
responses against extracellular bacteria (Kolls and Linden, 2004). Their role in human 
HIV  and helminth infections has not been fully defined. Cecchinato et al., (2008) 
showed that in the SIV–macaque model, this subset of CD4+ T cells is diminished in the 
mucosal and systemic sites compared to Th1 cells. Helminths are documented to 
suppress the immune system by various mechanisms including alteration of the the 
innate immune cells such as the macrophages and dendritic cells (Rodriguez-Sosa et al.  
2002; Maizels et al., 2004). The answers to this inconsistency may possibly lie in the 
ability of helminths to interefere with immune cell function, specifically the mechanism by 
which Th17 cells interact with the Treg  and the Th1 cells to produce the phenotype 
observed in this study .It is likely that the final outcome observed in this group, that is 
their inability to control worms allows the worms to activate immune responses that are 
detrimental to the host in controlling HIV through manipulation of the Th1,Th17 and Treg 
 210 
balance. In addition, the fact that the classification by Maizel and Yazdanbakhsh in 2003 
did not take the role of the inflammatory Th17 cells into consideration may have resulted 
in a misnomer of the “uncontrolled Th1” description in our speculative interpretation with 
the recent model by Diaz and Allen ( 2007).  Another possibility would be the fact that 
the present work analysed responses to the Ascaris lumbricoides and Trichuris trichuria 
while Maizel and Yazdanbakhsh (2003) based their classification on responses to 
Schistosoma and Brugia malayi. The differences in the immune responses to the 
different types of helminths have been suggested (Modjarrad and colleagues, 2005) In 
the context of the present findings, uncontrolled Th1 activity was not evident. 
 
The third phenotype is characterized by balanced Th1/Th2/Treg cell activities with 
proportional distribution of the IgE and IgG4 antibody isotypes and regulatory cell activity. 
The balanced Th1/Th2 response is sufficient to kill the invading parasites and hence the 
group is classically resistant to infection. In our work this phenotype would be 
represented by the individuals with high IgE but no faecal eggs (the egg-IgEhi group). 
 
These finding are significant because they reveal an important aspect of classifying 
helminth infection. It is apparent that the different phenotypes of helminthiasis impact 
differently on the immune responses to infections including HIV as shown by findings in 
this study. The value of serological classification in addition to stool egg positivity 




Despite the limitations of the study, some findings emerged which are inclined towards 
support of the study hypothesis. Stool egg positivity with high Ascaris specific IgE in HIV 
infected participants consistently showed impaired immune responses:    simultaneously 
elevated Ki67 and CTLA-4 consistent with increased immune activation, a tendency 
towards antigen specific, proliferative hyporesponsiveness, impaired type 1 cytokine 
responses in unstimulated and antigen stimulated cells and increased   background 
TNFα levels.  
 
High IgE responders also showed a tendency towards this impairment of type 1 
responses while egg excretion was associated with a tendency towards elevated TNFα. 
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Finally, the egg+IgElo group displayed an immune profile that is consistent with the 
modified Th2 phenotype.  
 
Taken together, these findings are suggestive of possible support for the hypothesis 
under investigation, with a prominent interaction between egg+IgEhi worm infection and 
HIV co-infection., However the experimental limitations restrict any direct interpretation 
and inference being made from these findings. Future studies could improve on the 
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Challenges and limitations of the study. 
6.0 Introduction 
 
The current research hypothesis is addressing an area that is still largely controversial 
because similar studies have reported conflicting outcomes, although some reviews 
have provided strong supportive evidence for immunological interactions between HIV 
and helminth infection and or treatment, as discussed in the preceeding chapters. For 
this reason there is a need for properly designed studies that will give conclusive 
evidence.   
 
Both HIV and helminth infections are chronic. HIV infection has different stages, each 
characterised by different pathogenesis and immunologic features. Likewise, helminth 
infections have different life cycle phases, and even feature concomitant immune 
responses to the various cycles. Thus, an ideal design for studies of co-infections with 
these two organisms would be a prospective cohort study with randomised sampling. 
Such a study should also enrol a large enough sample population to allow for statistical 
power, with participants followed over a substantial time period, in order to derive 
convincing and conclusive results.  
 
Ideally these studies should be done on both children and pre-teenagers where both 
worm burdens and viral load tend to be higher, as well as adults. The cohort should then 
comprise of age and sex matched groups of uninfected, singly and dually infected 
individuals. For helminths, the groups would need to be stratified for the species as well 
as worm burdens. The follow up would be determined by the species and each stratified 
group would be measured for time-to logarithmic CD4 decline or increase in viral load 
above baseline.  
 
The effects of disease stage and duration would be monitored from the younger 
generation (presumably the period between non –sexual activity into the period after 
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approximately one year after sexual activity initiation (for risk of HIV acquisition ( ages 
between 9 and  twelve to fifteen). This would enable monitoring of acquisition of helminth 
infection and HIV seroconversion by regular screening for both infections using both 
antigen detection (including PCR) and serological markers. The additional requirement 
for rigorous methods of follow up, regular screening and large sample size would be the 
additional sampling features necessary for this cohort. Exposures would be measured by 
demographic profiling,, personal hygiene habits, occupational exposure, socio-economic 
status (for risk of both infections) as well as sexual risk behaviours. Outcomes would be 
acquisition of both infections, and also HIV disease progression markers in those 
infected.  These would need to be matched for baseline CD4+ counts and viral loads as 
major outcomes of disease stage among the HIV singly-or dually infected, and CD4+ 
counts among the uninfected. The timing of acquisition of the two infections should 
enable the analysis of bi-directional interactions of the two infections. 
 
The study requirements above dictate the need for substantial funding, more so as it 
includes costly laboratory assays as well as the costs of maintaining a large number of 
individuals for follow-up over a long period of time.  Being cognizant of the above facts, 
the current study had a number of challenges which bore inherent limitations. Although 
these have been highlighted in the relevant chapters in detail, they are summarized in 
this section.  
 
 




The first challenge for the present study was to obtain the appropriate funding to meet 
the study requirements. The budgetary constraints then impacted on the overall study 
design and methodology limitations as outlined in the following paragraphs. Some of the 
limitations resulted from logistical issues. These limitations have been alluded to in the 
relevant chapters; therefore the present section briefly outlines each of them. 
6.1.2 Recruitment of HIV negative individuals 
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One of the criteria for participation in the study was the requirement for HIV testing. At 
the time of the study’s initiation, there were no Antiretroviral Therapy (ART) programmes 
in public health facilities and it was difficult to motivate people to undergo testing in the 
absence of available treatment and with the stigmatization that accompanies HIV 
infection.. As a result the sample sizes for the HIV negative controls became smaller 
within the subgroups.  
 
6.1.3 Logistics of Laboratory Sample Processing 
 
The ideal was immediate processing of samples as soon as possible after collection. 
Large numbers of blood samples were drawn on the same day during each visit.  
Several of the laboratory tests require immediate processing soon after blood is drawn. 
Although some were processed by the collaborating laboratories (full blood counts, viral 
load, total and specific IgE) all the immunology assays including all flow cytometry work 
as well as PBMC separation had to be done by the investigator of this study. Therefore 
the PBMC had to be isolated on the same day of collection and frozen for later analysis 
as other high priority analyses had to be undertaken on the same day of collection. 
Ideally ex vivo PBMC should be analysed soon after separation. In addition, intracellular 
cytokine staining of whole blood would have been the best choice; however, this assay 
also requires immediate processing. This would not have been feasible.  
 
6.1.4 The possible presence of undiagnosed chronic infections 
 
The concurrent presence of STIs or latent TB infections could artificially alter the 
immunological parameters such as the levels of inflammatory cytokines, Th1-Th2 cytokine 
biasing, increased CD25+ regulatory T cell expression and immune activation profiles. 
This would then affect the overall interpretation of the results in the subgroups.  Attempts 
were therefore made to identify the presence of other infectious diseases such as 
sexually transmitted infections, tuberculosis and any chronic infections from case record 
files and through interviewing patients. However, the absolute exclusion of other occult 
infections may not be guaranteed. If present, and if these had a significant influence on 
the immune system, these may have affected the results. However it is envisaged that 
the attempts made to exclude these may have minimised this possible confounder. 
 221 
 
6.2 Study Limitations 
6.2.1 Study design 
 
A cross sectional design to study the two chronic infections is a major limitation of this 
work. Although the dates of the first HIV diagnosis were collected from the case record 
files, this did not necessarily indicate the actual date of seroconversion. Likewise, data 
on the history or recall of past worm infection was collected, but this also cannot be 
expected to provide accurate information on worm infections, including chronicity. In all 
likelihood individuals at different stages of the two infections were analysed together.  
However, as a pilot study for hypothesis testing, the study sufficed to identify important 
parameters for designing future research of co-infection as well as providing valuable 
information that has not been previously reported in South Africa. 
6.2.2  Sample size and sampling 
 
Although the sample size was calculated appropriately for power prior to the initiation of 
the main study, the actual numbers eligible for additional immunological work in this 
study became smaller. In addition the costs of the laboratory tests did not allow for 
testing of all available samples.  
 
Sampling bias could also have been introduced during the recruitment of HIV positive 
individuals who were enrolled to the HIV Support group. Sampling bias in this case 
refers mostly to the HIV positive group. Owing to the fact that the HIV positive individuals 
were recruited from attendees of an HIV Positive Support Group, which then limited 
proper randomisation of these participants. These individuals had already been tested 
for HIV, some from a previous antenatal screening, although others had tested 
voluntarily in the local Voluntary Counselling and Testing Facility. Some of the 
individuals therefore may have (some time before the study commencement), had a 
clinical condition that made the clinic referral to a VCT facility, although such individuals, 
and those who had been pregnant in the previous six months, would not have been 
enrolled into the study (by exclusion criteria). 
 222 
6.2.3 Lack of adequate numbers of HIV negative controls 
 
To exclude the confounding effects of HIV infection, there should have been similar 
numbers of adequately matched negative controls for all the assays. Owing to the 
smaller number of HIV negative individuals enrolled, and also due to the costs of the 
cytokine assays, this was not possible. 
6.2.4 Lack of age-and sex control 
 
Consequent to the limited numbers of participants eligible for all analyses, the ideal 
comparison method of controlling for age and sex confounding was an additional 
limitation. Of importance is the fact that both age and sex affect many immunological and 
haematological parameters.  
 
The majority of participants were females in both HIV positive and negative groups. The 
HIV negative participants were slightly older (median ages were 30.6 and 40 for the HIV 
positive and negative groups respectively). These factors are acknowledged as possible 
contributors to the limitations of the study. 
 
6.2.5 Types of specimens 
 
For cytokine analysis, as mentioned above, more relevant information is obtained from 
intracellular cytokine staining for specific antigen responses. Use of PBMCs that had 
been frozen and thawed yields results that are inferior to those obtained from fresh 
whole blood cultures. However due to logistical problems the PBMCs were the only 
feasible sample type for additional immunological tests. 
 
Culture of PBMCs from HIV positive individuals for five days further compromised the 
quality of the results. These cells are documented to be susceptible to increased 
apoptosis. However, the assay included 13 cytokines, and optimisation assays found five 
days to be an optimal compromise. The limited number of cells from HIV positive 
individuals did not allow for a staged collection of supernatants in numerous wells and 
multiple plates. The most reliable results may be those of the unstimulated cells. 
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In addition, the use of the dual-platform method for obtaining absolute lymphocyte 
counts may have had two inherent sources of random laboratory errors. However it is 
expected that these were minimal as quality control measures were taken during each of 
the two analyses. 
6.2.6 Cohort heterogeneity 
The main variability could be the fact that the individuals in the presesent cross sectional 
analysis cpouild be at different stages of both HIV and helminth infections, while these 
are chronic manifestations, particularly HIV being a progressive infection.  
The inter- and intra- individual variation in many variables in the present study could also 
constitute a limitation to the study.  
 
Inter individual Variability 
The clinical course and outcome of HIV infection is known to vary widely from individual 
to individual. Such variability includes the differences in susceptibility,   viral set point, in 
the rate of progression to full blown AIDS and the different opportunistic infections 
manifestations. Amongst the host of factors that are responsible for these variations is 
the existence of genetic variants (Carrington et al., 2001). Even in helminth infection, 
differences in worm burden have been associated with genetic predisposition (Quintell, 
2003). Several other factors contribute to such variation in the pathogenesis of 
infections, and these include inter alia, environmental factors (hygiene), nutritional 
status, social behaviour including alcohol consumption, and smoking.  Also, although 
many biological parameters have a normal Gaussian distribution, there is great variation 
among these both in health and in disease, hence in our study, this variation could also 
contribute to some bias. 
 
Intra-individual Variation 
Variations in some of the outcome variables in the present study, such as CD4 counts 
(Raboud, et al., 1995) and viral loads (Napravnik et al.,2002) have been documented 
within the same individuals.  
It was encouraging to find some significant results in the present work despite the 
limitations and challenges. These may suggest that the interactions found in this work 
are considerable enough. 
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It however is noted that the conclusions derived may have been influenced by the cross 
sectional design of the study and sampling strategy for the HIV positive group that was 
attending the support group. If for example the enrolled participants were at an 
advanced stage of HIV / with acute or chronic helminth infection, the effect of the 
interaction would be overestimated. On the other hand, if most participants were at an 
early phase of HIV with acute or chronic helminthiasis, the effect of the relationship 
between the two infections would be underestimated. 
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Discussion and Conclusions  
7.0 Overview 
 
The coincident geographic distribution of HIV and helminths in developing countries has 
led to many immunological hypotheses that suggest a detrimental influence of helminths 
on HIV pathogenesis. In vitro and ex vivo models have been used in studies that attempt 
to assess this relationship. These have focused mainly on the chronic immune activation 
that results from prolonged exposure to helminth antigens, the generation of a strong 
Th2-biased response and induction of generalised anergy in infested hosts (Lawn et al., 
2001; Borkow and Bentwich, 2004). Several studies regarding this interaction have been 
published.  They address different aspects of immunological mechanisms of helminth-
induced alterations in HIV disease patterns. These include increased susceptibility to the 
virus (Shapira-Nahor et al.,1998; Gopinath et al., 2000), augmented transmission 
through increased expression of receptor molecules (Clerici et al., 2000; Kalinkovinch et 
al., 2001; Secor et al., 2001), activation, Th2 -biasing  and enhanced replication (Maggi 
et al., 1994; Gopinath et al., 2000; Lawn et al., 2001), impaired virus clearance (Actor et 
al., 1993) and accelerated progression to AIDS.  
 
The effects of deworming on HIV progression have also been analysed (Wolday et al., 
2002; Elliot et al., 2003; Lawn et al., 2000; Brown et al., 2004; Kallestrup et al., 2005; 
Modjarrad et al., 2005). Some have reported a beneficial effect of deworming (Wolday et 
al., 2002; Kallestrup et al., 2005) while others have not found this effect.  The reasons 
for the conflicting results are many and varied. Study and experimental designs differed. 
Some of these studies analysed different species of helminths and it is reported that 
immunological interaction with HIV is species-specific (Modjarrad et al., 2005). The 
timing of deworming and analysis of the effects thereof is also suggested to be critical 
(Brown et al., 2006). One of the most important factors was the fact that these studies 
relied on the presence of eggs in stools to diagnose intestinal nematode infections, 
although some complemented the diagnosis of schistosomiasis, strongyloides and 
filariasis with circulating anodic antigen, Elisa, charcoal culture and Knotts concentration, 
respectively. Use of single stool specimens and microscopy has limited diagnostic value. 
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Subsequently the risk of misclassifying intestinal helminthiasis is high and this error 
could have serious implications for studies that purport to determine the effects of co-
infection. 
 
In this thesis, two stool samples collected on two consecutive days were used to detect 
the presence of parasite eggs by the formol ether concentration and Kato-Katz methods. 
The effect of the two species, Ascaris lumbricoides (Ascaris) and Trichuris trichiura (Tt), 
on immune responses to HIV was assessed in the present analysis. Indeed, previous 
work in the study community revealed that these intestinal parasites were the most 
prevalent.  (Anonymous (KTT), 2001, Adams et al., 2006).  An important aspect that 
underpinned this work was the use of serology: Ascaris lumbricoides-specific IgE 
(subsequently referred to as IgE) in addition to stool egg microscopy, to improve the 
diagnostic sensitivity of the latter in classifying helminth infection status. Use of this 
serological marker was chosen because at the time, no Trichuris trichiura crude antigen 
was available. However, because of documented extensive antigenic cross reactivity 
due to antigen sharing between the Trichuris trichiura and Ascaris lumbricoides species 
(Lilly-white et al., 1991; Bhattacharyya et al., 2001), the Ascaris-specific IgE would thus 
suffice as a serodiagnostic marker for exposure to these two intestinal helminths. To that 
effect, four subgroups of participants were stratified on the basis of stool egg-positivity 
/negativity and Ascaris lumbricoides-specific IgE levels. These subgroups were the (i) 
stool egg positive and high IgE (egg+IgEhi); (ii) the stool egg positive and low IgE 
(egg+IgElo); (iii) the stool egg negative and high IgE (egg-IgEhi) as well as (iv) the egg 
negative, IgE low (egg-IgElo) subgroups. The latter status presumably suggests lack of 
recent infection and/or past exposure to these helminth parasites.  
 
The classification by stool eggs and IgE status proved to be critically relevant because it 
delineated distinctive groups who proved to be phenotypically different in terms of 
immunological interactions between helminth and HIV co-infections. The first group 
presented a typical T-helper 2 (Th2) immune response to helminths that was consistently 
detrimental to HIV immune responses, the egg+IgEhi group.  A second distinctive 
phenotype, the stool egg positive and low IgE (egg+IgElo) subgroup of individuals whose 
response to helminthiasis is consistent with a modified Th2 phenotype, appears to retain 
relative immunological competence to control HIV infection. Other patterns of 
immunological interactions also emerged on the basis of different aspects of helminth 
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infection. For example some immunological associations (as will be discussed in the 
following paragraphs) were found in groups with the presence of stool eggs irrespective 
of IgE levels (egg+IgEhi and egg+IgElo). These include association between stool egg 
positivity and higher expression of CD4+ CCR5 and CD8+CD38+ and higher TNFα levels. 
Other interactions occurred in groups with elevated IgE irrespective of presence or 
absence of stool eggs (egg+IgEhi and egg-IgEhi), such as higher viral loads, lower type 1 
cytokines and significant inverse correlation between CD8+CD38+ and CD4+ counts. 
These findings are consistent with the model presented by Maizels and Yazdanbakhsh 
(2003) where they described three phenotypic outcomes of helminth infections, one of 
which was the modified Th2 group. These individuals are highly susceptible to 
helminthiasis but respond with a low IgE, high IgG4 and high regulatory activity 
phenotype. The second group responds with a typical high IgE/low IgG4, uncontrolled 
Th1 activity while the third group is charaterised by a balanced Th1/Th2/Treg which allow 
the individuals to clear the infecting parasites. 
 
7.1 The profile of the study participants 
 
Analysis of the general characteristics of the study population in Chapter 2 showed that 
the prevalence of intestinal helminth infections is high (40-60%) in adults residing in a 
resource-limited area (Khayelitsha, Western Cape). Estimation of prevalence was 
improved by use of both egg excretion and serum Ascaris-specific IgE.  Furthermore, 
these individuals presented  a high total IgE responder profile (both HIV+ and HIV-) as 
shown by an eight-fold median total IgE above the method reference range in HIV 
uninfected individuals. Even in the presence of HIV, a five-fold higher level of total IgE 
was found. This finding concurs with earlier suggestions that Africans generally present 
with an elevated IgE phenotype and this was concluded from a study conducted in a 
similar (Xhosa) ethnic group (Gerrard, 1985; Haus et al., 1988).  IgE class switching is 
mediated by CD4+ Th2 cells, therefore by inference this could suggest a general increase 
in Th2 cell populations in these individuals. 
 
Different forms of immune dysregulation by helminths and their effect on HIV responses 




7.2 Characterisation of T cell subsets, eosinophils and viral loads 
 
In chapter 3, the proposed dysregulation of T cell populations by helminths (Kalinkovinch 
et al., 1998) and subsequent impaired ability to respond to HIV was assessed through 
lymphocyte phenotype analysis including total, T, B, NK,  CD4+ and CD8+ lymphocyte 
counts,  eosinophil counts and viral load determination.  
 
It was noted that the expectation based on the study hypothesis was that the HIV singly 
infected egg-IgElo group would have a more competent immune profile relative to the 
HIV+ egg+IgEhi dually infected subgroup.This was however not observed in this section.  
The two groups had similar numbers of CD8+, NK and B lymphocytes while total 
lymphocytes and CD4+ cells were lowest in the egg-IgElo subgroup. Among the HIV 
negative individuals, some differences were noted between the two groups. Although not 
statistically significant, all lymphocyte populations were higher in the egg-IgEhi HIV- 
group compared to the egg+IgEhi subgroup. The smaller sample size in the HIV- group 
was postulated to influence the powe to detect statistical differences in this group.Under 
these conditions, a possibility of confounding by HIV was suggested. 
. 
When the dually-infected subgroups were analysed,several results were consistent with 
the study hypothesis. Firstly, the egg+IgEhi group had significant eosinophilia, 
approximately three-fold high viral loads and generally lower absolute counts for all 
lymphocyte populations.  Generalised reduction of lymphocytes may be associated with 
altered ability to respond to infections including HIV in particular. T lymphocytes play a 
critical role in containing the virus. Eosinophils are proposed to increase the number of 
activated cells that are infectable with HIV since they express the receptor CD4 molecule 
and in vitro studies showed that when these cells are activated, they can be infected by 
HIV (Lucey et al., 1989; Freedman et al., 1991).  Their high levels in tissues including 
vaginal and rectal mucosa could be playing a role in increasing HIV hetero-and 
homosexual transmission, respectively during helminth infections. 
 
 
Secondly, the other group with elevated IgE (egg-IgEhi group) also had eosinophilia and 
three-fold higher median viral load values compared to the low IgE groups (the egg+IgElo 
and egg-IgElo groups). Both eosinophilia and high IgE are classic Th2 responses that are 
universally induced by helminth infections. The association of these mediators with 
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higher viral loads supports the concept that Th2 polarisation by helminths suppresses the 
protective Th1 responses and hence promotes HIV progression (Clerici and Shearer, 
2001; Borkow and Bentwich, 2004). A significant negative correlation between viral 
loads and absolute CD4+ counts was found in all HIV+ subgroups, but this correlation 
was strongest in the two high IgE groups. In addition, these groups had the highest 
proportion of individuals with the highest viral loads. These findings further endorse the 
notion that Th2-biased responses are associated with advancing HIV disease (Clerici 
and Shearer, 2001) with a direct implication for helminths as classic, strong Th2 inducers 
and their influence on HIV immune responses. 
 
Lastly,in direct contrast to these responses of high IgE groups, the modified Th2 
responders (egg+IgElo) group had significantly higher median absolute CD4+ counts and 
helper/suppressor ratios, generally higher median absolute numbers of all lymphocytes 
accompanied by the lowest median viral load. This finding suggests a Th1 phenotype 
with a better ability to control the HIV viral infection in these individuals, lending further 
support to the concept that predominance of a Th2 response is associated with impaired 
responses to HIV.  
 
7.3 Immune activation and HIV- helminth co-infections 
 
Immune activation has been widely implicated as playing a pivotal role in HIV 
pathogenesis through various pathways (Lawn et al., 2001; Borkow and Bentwich, 2004; 
Kamal and El Sayed Khalifa, 2006).  In further addressing the study hypothesis, Chapter 
4 sought to define the activation status of the defined subgroups and relate the results to 
HIV progression. This was achieved through flow cytometric determination of expression 
of activation markers CCR5, HLA-DR, CD38 and CD71 and correlating these to markers 
of HIV progression (viral load and CD4+ counts).  
 
Comparison between the dually infected HIV+egg+IgEhi  and the egg-IgElo subgroups 
showed increased expression of activation markers in the dually infected subgroup, 
which was more than double compared to the levels in the HIV singly-infected (without 
evidence of helminth infection) egg-IgElo group. No significant increase in immune 
activation was noted in the HIV-singly infected egg-IgElo group. CD4+ counts were 
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similarly low in the two groups (slightly higher, 0.27cells/ml in the egg+IgEhi , compared to 
0.22 cells/ml in the egg-IgElo subgroup). 
 
The findings in this section strongly lend support to the hypothesis: dual infection with 
HIV and helminths induces immune hyperactivation and impair immune responses to 
HIV. Firstly, the HIV+, egg+IgEhi group had a highly activated profile as reflected by 
highly significant increases in median expression of all the measured activation markers 
(CCR5, HLA-DR, CD25, CD38 and CD71). Nearly all the CD8+ cells were CD38-positive 
in this group. A significant negative correlation between CD4+ absolute counts and 
lymphocyte expression of the classic activation marker (HLA-DR) was found and it was 
strongest in the egg+IgEhi group. In addition, expression of CD38 on CD8+ cells also 
correlated negatively with CD4+ counts and this interaction was higher in this group. The 
highly activated immune profile found in this egg+IgEhi group concurs with the hypothesis 
that helminths induce sustained immune activation. The strong inverse correlation 
between activation and CD4+ counts, plus excessive expression of CD38, a poor 
prognosis marker, strongly suggest progression of HIV infection in this highly immune 
activated group.Furthermore, the virus burden was higher in this highly activated 
subgroup, while CD4 counts were.  Taken together, these provide strong suggestive 
evidence that helminth-induced immune activation may be associated with accelerated 
HIV replication as shown by highest viral load and possibly HIV progression as 
determined by CD4+ decline and CD38 expression.  
 
Furthermore, the notion that HIV replicates better in activated immune cells (Lawn et al., 
2001) is strongly supported by these and the finding that this group had the second 
highest median viral loads (Chapter 3). The concept that helminth infections enhance 
virus replication in infested hosts through increased immune activation would therefore 
be compatible with our results. This is supported by the finding that the HIV-singly 
infected egg-IgElo subgroup had lower viral load and no increase in immune activation 
marker expression. The fact that in both HIV+ single infection (egg-IgElo) and helminth 
single infection (HIV- egg+IgEhi) there was no remarkable increase in immune activation 
strongly suggests that dual infection by helminths and HIV increases immune activation 
which in part or wholly drives  virus replication. From our findings it is apparent that this 
effect is pronounced during a typical helminth (egg+IgEhi) infection.   
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There were highly significant increased levels of CCR5 expression on CD4+ cells in both 
groups with positive stool eggs (egg+IgEhi and egg+IgElo).  In both these groups there 
was also significantly high (more than 90%) expression of CD38 on CD8 + cells. Two 
implications for helminth induced immune dysregulation are interpretable from these 
findings. Firstly the association between helminth egg-positivity and increased CCR5 
expression strongly supports the proposition that helminths are associated with 
increased susceptibility to, and increased transmission of HIV infection (Borkow and 
Bentwich, 2004). Increased expression of these two HIV receptor molecules (CD4 and 
CCR5) increases the number of cells available for new infection as well as expansion of 
infection to new cells in individuals who are already infected. This finding concurs with 
those of Secor et al. (2001), who found that egg excreting patients with active 
Schistosoma mansoni infection expressed higher levels of the co-receptors CCR5 and 
CXC4 compared to their treated counterparts.  Secondly, high CD38 expression 
indicates poor prognosis in HIV infection. The relationship between increased 
expression of this marker and helminth egg excretion lends support to the suggestion 
that helminth infections accelerate HIV progression.  
 
In addition, the inverse correlation between CD4+ counts and CD8+CD38+ was strongest 
in both groups with high IgE (egg+IgEhi and egg-IgEhi). This further suggests an 
association between Th2 polarisation (high IgE) and advancing HIV disease, as related 
by declining CD4+ counts and increasing CD38 expression. 
 
A positive correlation existed between viral load and immune activation markers. 
However this relationship was not as strong as that found between immune activation 
and CD4+ counts within the subgroups. These results tally with those reported by Leng et 
al. (2001) who described  immune activation as correlating better with CD4+ counts than 
viral load.  These results suggest that immune activation has a direct impact on CD4+ cell 
depletion whereas other mechanisms may affect the impact on virus burden. Indeed 
other studies have demonstrated that immune activation drives CD4+ depletion  
(Grossman et al., 2002; Sousa et al., 2002) and is indirectly related to virus burden 




7.4 Lymphocyte proliferation and cytokine production 
 
In Chapter 5, the proliferative capacity and cytokine production in response to antigens 
and mitogen stimulation were evaluated. The Ki67 proliferation antigen and production of 
thirteen cytokines of different classes (inflammatory, Th1 and Th2) were used to 
investigate in vitro cellular immune competence. Peripheral blood mononuclear cells 
(PBMCs) were cultured for five days unstimulated or stimulated with Phytohaemaglutinin 
(PHA) mitogen, Streptokinase (recall antigen), recombinant  HIV-1 p24 and Ascaris 
lumbricoides crude worm antigens. This approach had a few limitations. First, in vivo 
measurements of cytokine production in response to antigen stimulation are optimally 
mimicked by antigen-specific intracellular staining of freshly-isolated, diluted whole blood 
(Godoy-Ramirez et al., 2004). In the present study this ideal could not be achieved for 
logistical reasons hence the use of bulk PBMCs was resorted to. Secondly, it was 
challenging to obtain an optimum culture period for a range of thirteen cytokines 
(although optimisation of conditions was done for IFNγ and IL-4) against the requirement 
for longer incubation for expansion of antigen-specific responses. 
 
It should thus be noted that the antigen-specific responses for both proliferation and 
cytokine production studies did not yield very clearly defined patterns of responses. It is 
highly likely the five-day in vitro culture of cells from HIV and helminth infected 
individuals may have been affected negatively by increased apoptosis. It is reported that 
the process starts in as few as 12-18 hours in activated cells (Zunino et al., 1996).  This 
could be further complicated by the fact that both HIV and helminth infections are 
documented to be associated with increased programmed cell death (Borkow and 
Bentwich, 2004). In addition, Hodge et al. (2000) reported that PBMC cultures are more 
susceptible to apoptosis compared to whole blood.  Activation-induced apoptosis in 
antigen-stimulated PBMC long term cultures of HIV positive individuals could therefore 
have influenced the results.  Most of the significant findings consequently were made on 
the baseline (unstimulated) assays. Nonetheless we believe that valuable information 
was obtained from the results of the antigen-stimulated cultures. 
 
In this study, expression of Ki67 as a measure of proliferative potential was 
complemented by simultaneous measurement of cytotoxic T lymphocyte associated 
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antigen 4 (CTLA-4) to differentiate between activation- and proliferation-induced 
elevation of Ki67 production. Simultaneous increases of the two molecules are 
considered to indicate activated cells arrested at the G1 stage of proliferation (Brunner et 
al., 1999). The egg+IgEhi group had significantly higher levels of background Ki67 
expression; however CTLA-4 was also significantly raised, thus reflecting immune 
activation induced Ki67 production. This was in keeping with the highly activated profile 
of this group reported in Chapter 4 of this thesis.  When the egg+IgEhi group was 
compared with the HIV singly infected egg-IgElo, some differences were noted in this 
dually infected subgroup.This group was shown to have high background expression of 
Ki67 and CTLA4.  Cytokine profiling showed that at baseline as well as in response to 
HIV-1 p24 challenge this group persistently had low and/or undetectable Th1 cytokines 
(IL-2, IFNγ and IP-10).  
 
In stimulated assays, all the helminth infected subgroups (the egg+IgEhi, the egg+IgElo 
and the egg-IgEhi groups) had potent Ki67 responses in response to challenge with PHA 
mitogen. However the egg+IgEhi group displayed a tendency towards lower proliferation 
in response to the HIV-1 p24, streptokinase and Ascaris specific antigens. This apparent 
reduced capacity to proliferate in response to specific antigens (despite retained 
proliferation to mitogen) concurs with the proposed induction of specific anergy by 
helminth infections (Maizels and Yazdanbakhsh, 2003, Borkow and Bentwich, 2004), 
thus impairing effective immune responses to HIV as per the present study hypothesis.  
  
Cytokine production assays also demonstrated results that support the hypothetical 
negative influence of helminthiasis on immune responses to HIV. The antiviral Th1 
cytokine IFNγ was significantly lower in the baseline (unstimulated) cells from individuals 
in the egg+IgEhi group. Likewise another Th1 cytokine, IL-2 showed a lower trend in this 
group. IL-2 induces lymphoproliferation and differentiation into effector cells (Janeway et 
al., 2001), therefore its reduction is in keeping with the reduction in antigen-specific 
proliferation discussed in the preceding paragraph.  Furthermore, these two cytokines 
together with IP-10were undetectable or present at very low levels when cells were 
stimulated with the HIV-1 p24 antigen in this group. Both IFNγ and IL-2 are known to 
play a critical role in antivirus immunity, including HIV control (Janeway et al., 2001). 
These results therefore uphold the proposed negative influence of helminths on effective 
control of HIV infection. 
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Further support for our hypothesis was the finding that both high IgE responder groups 
(egg+IgEhi and the egg-IgEhi) had significant levels of the Th2 cytokine IL-4 and low 
secretion of the Th1 cytokine IL-2. These results confirm an inverse association between 
Th2 responses (high IgE, increased IL-4) and Th1 responses in relation to helminth 
infection.  They support the argument that helminths induce Th2 polarisation at the 
expense of the protective anti-viral Th1 responses and this Th1 to Th2 shift has been 
associated with HIV progression (Clerici and Shearer, 1993, 2001).  
 
Constitutive production of the two proinflammatory cytokines IL-6 and IL-8 was high and 
fell outside the standard curve range of the Luminex assay and the interpretation of 
these results could therefore be flawed.  Levels of tumor necrosis factor alpha (TNFα), 
another inflammatory cytokine, were higher in both egg positive groups (egg+IgEhi and 
the egg+gElo ) although this did not reach statistical significance. Induction of NF-κβ by 
TNF is implicated with a pro-replicative role for HIV (Lawn et al., 2001).  
 
Finally, the modified Th2 (the egg-IgEhi) group had highly significantly increased levels of 
the Th1 cytokine IFNγ and highest median IL-2 levels, while IL-4 was significantly lower. 
In keeping with the modified Th2 phenotype, the regulatory cytokine IL-10 was higher in 
this group. Most importantly, the individuals in this group produced significantly higher 
levels of IFNγ in response to HIV-1 p24 challenge. This further endorses our proposition 
that these individuals maintain or retain immune competence to control HIV infection 
despite being coinfected with helminths. 
 
 
7.5 In summary: 
 
While in most instances, no significant differencesw were noted betweenthe egg-IgElo 
and the egg+IgEhi subgroups, results from this work suggest that individuals with high 
Ascaris-specific IgE in serum and with Ascaris lumbricodes and or Trichuris trichura 
eggs in stools represent a typical Th2 (as opposed to a modified Th2) immune response 
phenotype. These individuals consistently demonstrated  evidence for a potentially 
deleterious influence of helminths on immune responses against HIV. In all the chapters 
significant findings that concur with the study hypothesis were found within this group. 
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Briefly, participants in this group showed a tendency towards altered peripheral blood 
cell composition (lymphocytopaenia, significant eosinophilia), a highly activated immune 
profile, altered immune response to HIV (a trend towards low antigen-specific 
lymphoproliferation, and reduction of protective Th1 cytokine levels) and higher viral 
load). 
 
While the typical Th2 responder (egg+IgEhi) status displayed the most pronounced and 
detrimental immunological interaction between helminths and HIV, other responder 
phenotypes to helminth infestation also displayed this deleterious interaction. The 
presence of stool eggs irrespective of Ascaris specific IgE levels was associated with 
significantly  increased expression of CCR5 on CD4+ cells (implication for increased HIV 
transmission);  higher background TNFα levels (upregulation of proviral transcription of 
HIV, (Lawn et al , 2001)) and significant  expression of CD38 on CD8+ cells (suggestive 
of HIV progression). On the other hand, the Th2 features (eosinophilia and high Ascaris-
specific IgE, irrespective of presence or absence of stool eggs) were also seen to affect 
different aspects of immune system dysregulation with regards to HIV pathogenesis. 
These included the finding of higher frequencies of eosinophilia, higher viral loads, 
higher percentages of individuals with severe immunodeficiency; a stronger inverse 
correlation between absolute CD4+ counts and CD8+CD38+  plus reduced Th1 and 
increased type 2 cytokines. 
 
Lastly, a prominent finding was that the modified Th2 responders (egg+IgElo) appear to 
control HIV better than their typical Th2 counterparts. This was shown by higher 
proportions of lymphocyte populations, lower viral load plus lower numbers of individuals 
with advanced immunodeficiency in terms of CD4+ counts, lower Th2 and higher type 1 
cytokines and it confirmed the existence of major phenotypic differences with profound 
immunological implications between the two groups. These suggest that some 
individuals may be susceptible to helminth infections but have a modified Th2 phenotype 
and control HIV infection better. The apparent improved control of HIV fits with the 
increased IL-10 (regulatory cytokine) levels in this group and concurs with the alternate 
theory that regulatory pathways associated with helminth infections may downregulate 
the pro-replicative inflammatory processes that promote HIV transcription and replication 
(Lawn et al., 2001; Brown et al., 2006).  
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7.6 Concluding remarks 
The present study was designed to test the hypothesis that helminths impair immune 
responses to HIV.  The study had limitations, such as possible selection bias in HIV 
positive support group attendees, a cross sectional design, and the small sample size. 
Moreover, the fact that HIV is a progressive infection and that there is a lack of 
information regarding chronicity/duration of HIV infection will further impact on the 
findings of a cross sectional design of the study. However the significant findings noted 
despite these limitations are encouraging, thus strongly suggesting existence of 
immunological interaction between helminthiasis and HIV. 
 
The results presented in this thesis provide evidence that the presence of intestinal 
parasite eggs in stools of infested individuals represents only a part of the helminth 
infection phenotype, which can be further delineated by levels of helminth-specific IgE 
(and IgG4) (Maizels and Yazbandashksh, 2003).  Grouping according to stool egg 
positivity alone would misclassify infection and non-infection, obscure the recognition of 
additional phenotypes with major implications for the interpretation of studies addressing 
immunological effects of co-infections with helminths. 
 
The author concludes that helminth infections may be associated with deleterious effects 
on the immune responses to HIV in certain groups of susceptible individuals based on 
the key findings that: 
 
(i)The egg+IgEhi status clearly confers an immunologically compromised immune 
response to HIV. This status reflects susceptibility to helminth infection and displays 
negative influences on the response to HIV infection and progression as measured by 
viral load and decreased CD4+ cell count. 
(ii) A Th2 biased profile linked to helminth infection is also associated with some 
compromised immune response to HIV. 
(iii) The presence of nematode stool eggs irrespective of IgE levels also affects some 
aspects of HIV pathogenesis or immune responses.  
(iv) The individuals with stool parasite eggs but low IgE (or modified Th2 responders) 
may maintain some immunological resilience towards HIV infection. 
 
 237 
The present work has made a contribution to the body of new knowledge in South Africa. 
The significance of including the serological marker (IgE) to enhance the diagnosis of 
intestinal nematodes but also to further define immune phenotypes in the context of 
helminth infection is considered an important finding. This has implications for the design 
of future studies aimed at analysing helminth coinfection and more importantly, 
interpretation of such studies.   
 
Recommendations 
It is therefore recommended that properly designed and controlled studies be extended 
and should include serological tests (parasite specific IgE and IgG4) to differentiate the 
immune phenotypes of helminth infection.  
 
Based on the finding that helminthiasis is in some individuals associated with more 
advanced HIV infection it is highly recommended that concerted efforts be made to 
control helminth infections, particularly in those with high risk for HIV infection and in 
those with known HIV infection. This will make a contribution towards a holistic approach 
to prevention of and management of HIV infection. Sustained mass deworming of 
preschoolers, scholars and adults combined with improved sanitation programmes and 
education campaigns should be implemented to decrease both worm burden in 
individuals and the number of infected individuals, which would also reduce the overall 
transmission of helminths, although the present data does not address the 
immunological effect of deworming on responses against HIV. Further studies that 
analyze the effect of deworming on co-infected individuals are needed as these have 
yielded conflicting results. However, it may be beneficial to implement effective helminth 
control in children and subsequently at regular intervals in settings with a high 
prevalence of worm infection. This would prevent co-infection with HIV which has now 
been shown to adversely affect anti-HIV responses. An integrated health care approach 
that addresses prevention (and where indicated treatment) for both, and other prevalent 
health care issues, may have major public health benefits. 
 
The effect of helminth infection on other infections, including tuberculosis, should also be 
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Appendix 1. Box and Whisker plots of lymphocyte subsets for HIV-1 negative 
subgroups 
J p=0.09





















































Figure 3. 3 Panels J-L. Kruskal Wallis Box and whisker plots for lymphocyte phenotypes in HIV- 
groups. Whole EDTA blood was stained with fluorochrome-conjugated monoclonal antibodies to CD45, 
CD3, CD4, CD8, CD19, CD16 and CD56. Percentages of cells expressing these surface molecules were 
determined by FacsCalibur flow cytometry using the MultiTest software. Full blood counts were done for 
eosinophil counts and dual platform calculation of absolute lymphocyte counts.  Egg+IgEhi group (n =9) stool 
helminth egg excretion and elevated Ascaris lumbricoides –specific IgE;   Egg+IgElo group  (n=9) helminth 
egg excretion and low Ascaris lumbricoides IgE;   Egg-IgEhhi group (n=11) No helminth egg excretion and 
high Ascaris lumbricoides IgE; Egg-IgElo group  (n=10) No helminth egg excretion and low Ascaris 

















































Figure 3. 3 Kruskal  Wallis Box and whisker plots for lymphocyte phenotypes in HIV- groups. 
Percentages of cells that were CD4 positive and CD8 positive were determined by flow cytometry on labeled 
whole blood. Absolute counts were calculated from these percentages and the full blood counts. Kruskal 
Wallis ANOVA was used to determine differences between subgroups. H/S Ratio =T helper/T suppressor 
ratio. 









































Figure 3. 3  Kruskal  Wallis Box and whisker plots for lymphocyte phenotypes in HIV- groups.  
Percentages of NK and B lymphocytes were determined  by flow cytometry on labeled whole blood. 
Absolute counts were calculated from these percentages and the full blood counts. Kruskal Wallis ANOVA 



































Fig. 4.3 B Expression of CCR5 by CD4+ and CD8+ cells in subgroups of HIV - subjects. 
PBMC’s were stained with flurochrome-tagged monoclonal antibodies to CD3, CD4, CD8 and 
CCR5 then analysed by flow cytometry for the proportions of lymphocytes expressing the 
respective surface markers.  The percentages represent median group percentage of each cell 













Fig. 4.5 B Expression of CCR5 by CD4+ and CD8+ cells in subgroups of HIV - subjects.    
Percentage expression of CCR5 on lymphocyte subsets was determined by flow cytometry. 
Positive cells appear on the right upper quadrants. The percentages represent the median for 
each group. Each plot is for a representative subject from each group. 
Figure  4.2B 
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Figure 4.6B Representative plots: Expression of CD38 on CD8+ cells in HIV- subgroups.  
Percentages of CD8 positive cells expressing CD38 were determined by flow cytometry Positive 
cells appear on the right upper quadrants. The percentages represent the median for each group. 




















Appendix 4.  Box and Whisker plots for activation markers in HIV- subgroups. 
p=0.35


























































Figure 4.8 Panels J-L Kruskal Wallis Box and whisker plots for lymphocyte surface 
expression of activation markers on HIV- subgroups. Ex vivo- cryopreserved, peripheral blood 
monocytes (PBMC’s) were stained with fluorochrome-conjugated monoclonal antibodies to 
activation marker molecules and the proportions of T cells expressing the particular markers 
quantified by flow cytometryusing CellquestTMsoftware.  Median percentage expression of these 
markers were determined for each subgroup. In all panels (J-R), the groups and the sample sizes 
were: Egg+IgEhi group (n = 5) helminth egg excretion and elevated Ascaris lumbricoides IgE; 
Egg+IgElo  group (n=7) helminth egg excretion and low  Ascaris lumbricoides IgE;  Egg-IgEhi group  
(n=3) No helminth egg excretion and high Ascaris lumbricoides IgE; Egg-IgElo group (n=7) No 









































































Figure 4.8 Kruskal Wallis Box and whisker plots for lymphocyte surface expression of 
activation markers on HIV- subgroups. 
Expression of surface activation markers ( HLA-DR in these panels) was determined on PBMCs 
of HIV uninfected subgroups by flow cytometry. Significant differences between medians of 









































































Figure 4. 8 Panels P-R.  Kruskal Wallis Box and whisker plots for lymphocyte surface 
expression of activation markers on HIV- subgroups 
Expression of surface activation markers ( CD38 and CD71) was determined on CD4 and CD8 
lymphocytes of HIV uninfected subgroups by flow cytometry. Significant differences between 






Appendix  5.  
Table 4.5 b. Correlations between activation markers, CD4+ counts and Viral load.  
 
Factor Group CD4+HLADR+ 
Spearman r 
  (p) 
CD8+HLA-DR+ 
Spearman r 
  (p) 
CD3+HLA-DR+ 
Spearman r 
















CD4+ All (n=40) -0.4 (0.01) -0.39 (0.01) -0.43 (0.01) -0.44 (0.01) -0.31(0.06) -0.03(0.85) -0.47(<0.01) -0.37(0.02) 
 (Egg+ IgEhi) 
(n=10) 
-0.56(0.04) -0.53(0.04) -0.7 ( 0.03) -0.69(0.03) -0.75 (0.01) 0.01(0.96) -0.30(0.42) 0.30(0.41) 
 (Egg+ IgElo) 
(n=10) 
-0.25(0.49) -0.50(0.13) -0.54 (0.11) -0.43(0.21) -0.72(0.03) 0.47(0.21) -0.55(0.1) -0.59(0.07) 
 (Egg- IgEhi) 
(n=10) 
-0.64(0.05) -0.50(0.1) -0.59(0.07) -0.72( 0.02) -0.04(0.91) -0.34 (0.09) -0.81(0.02) -0.83(0.01) 
 (Egg- IgElo) 
(n=10) 
-0.38(0.27) -0.35( 0.21) -0.56(0.09) -0.17 (0.63) -0.48(0.51) 0.09(0.8) 0.02(0.97) 0.2(0.61) 
Viral 
Load 
All(n=40) 0.54 (p=0.01) 0.40 (0.48) 0.49 (<0.01) 0.68(<0.01) 0.41(0.01) 0.19(0.25) 0.31(0.07) 0.21(0.19) 
 (*Egg+ IgEhi) 
(n=10) 
0.73 (0.01) 0.31(0.38) 0.49( 0.14) 0.07(0.85) 0.5(0.14) -0.38(0.27) 0.58(0.08) -0.70(0.03) 
  (Egg+ IgElo) 
(n=10)  
0.13 (0.7) 0.04(0.9) 0.07(0.86) 0.69(0.03) 0.22 (0.58) -0.33(0.38) -0.07(0.85) 0.08(0.82) 
 (Egg- IgEhi) 
(n=10) 
0.54(0.1) 0.35(0.33) 0.65 ( 0.04) 0.72(0.02) 0.47(0.17) -0.33(0.34) 0.86(0.01) 0.57(0.11) 
 (Egg- IgElo) 0.30(0.41) 0.23(0.43) -0.01(0.9) 0.29 (0.41) -0.32(0.37) 0.14(0.7) -0.22(0.58) -0.07(0.86) 
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Appendix 6   Box and Whisker Plots for proliferation in HIV- subgroups. 
 

























































































Figure 5 .5  Kruskal Wallis Box and Whisker plots for proliferation antigen - Ki67 and CTLA-4 antigen 
expression  on lymphocytes of  HIV- subgroups.  Previously-cryopreserved PBMCs were thawed, 
stained with fluorochrome-conjugated monoclonal antibodies to Ki67, and CTLA-4 and percentages of cells 
expressing these molecules determined by FacsCalibur flow cytometry using the Cellquet software. In all 
panels the groups and their n sizes were:  Egg+IgEhi group  (n = 5) helminth egg excretion and elevated 
Ascaris lumbricoides IgE; Egg+IgElo (n=7) helminth egg excretion and low Ascaris lumbricoides IgE; Egg-
IgEhi group  (n=3)  No helminth egg excretion and high Ascaris lumbricoides IgE; Egg-Iglo (n=7) No helminth 
egg excretion and low Ascaris lumbricoides IgE. 




















































































































Figure 5 .5 Kruskal Wallis Box and Whisker plots for proliferation antigen - Ki67 and CTLA-
4 antigen expression  on lymphocytes of  HIV- subgroups.   
The proliferation antigen Ki67 and regulatory antigen CTLA-4 were assayed by flow cytometry on 
PBMCs and their median percent expression compared between subgroups of HIV uninfected 





Appendix 7  Preparation of stimulating antigens and media 
 
5.1.1. Mitogens  
 
 Phytohaemagglutinin (PHA). Lectin from Phaseolus vulgaris). (Sigma)  Cell 
culture tested. A 5mg/ml vial was reconstituted aseptically with 5 ml sterile, low 
endotoxin 1x PBS without calcium or magnesium (BioWhittakerTM) made in pour 
water (SabaxTM) to make 1mg/ml stocks. Twenty microliter aliquots were made in 
sterile vials and kept at -20ºC. Phorbol myristate acetate (PMA) (Sigma). The 1 
mg vial was dissolved in 0, 1 ml DMSO and made up to 1ml with sterile, tissue 
culture grade water to make 1mg/ml. Ten microliter aliquots were frozen at -20ºC 
and thawed once for use. Final working concentrations of 50ng/ml and 20 ng/ml 
were made for optimization experiments.  
 Calcium Ionomycin (IO)   (Sigma). Dissolved in 1ml ethanol to make 1mg/ml and 
10 μl aliquots stored at -20ºC. A working concentration of 1000 ng/ml was used. 
Two combinations of concentrations were used to find the optimal stimulatory 
one (i) 50 ng /ml PMA and 1ug/ml calcium ionomycin (ii) 20 ng/ml PMA and 
1ug/ml calcium ionomycin. 
 
5. 1. 2 Recall antigens 
 
 Streptase (Streptokinase) Aventis. Each vial contained 750 000 I.U. of 
streptokinase. Since 1 I.U. =0.011ug thus 10ug = 1000 I.U. A 1000 I.U. /ml 
(10ug/ml) working concentration was made. The stocks were made to be 100x 
concentrated (100 000 I.U. /ml). The 5ml vial was reconstituted in 7,5ml tissue 
culture grade PBS to make a 750 000 I.U. /7,5 ml which was 100 000 I.U./ml. 
Aliquots of 50 μl each were made and stored at -80ºC and thawed once during 
use. Two concentrations (2 ug /ml or 250 I.U. /ml and 10ug/ml or 1000 I.U/ml) 
were used to optimize the culture conditions. For each, 2,5 μl and 10 μl were 
used for each well containing 1 ml volume of culture. 
 Purified Protein Derivative (PPD) obtained from Weybridge Veterinary Institute 
(UK). Reconstituted to 2mg/ml stock in PBS (endotoxin <0.12EU/ml) and aliquots 
of 400 ug/ml were kept at -20ºC and thawed once for use. A working 
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concentration of 5 ug /ml was used to stimulate the cultures, for which 12, 5 μl of 
the 400 ug/ml stock was added to each 1 ml culture. For the 1 ug /ml, 2,5 μl was 
used. 
 
 5.1.3 Medium and Supplements 
 
RPMI 1640 culture medium with glutamax (Gibco,). The complete RPMI 1640 medium 
with glutamax (cRPMI) contained 10%human male AB serum, the antibiotics and 
supplements at the concentrations described below.  
 No Azide Low Endotoxin monoclonal anti-CD28 (BD Pharmingen). The 0,5mg 
vial was dissolved in 0,5ml tissue culture grade PBS to make 1mg/ml. To 
supplement cultures, with 1ug/ml, 1 μl was added to each 1ml culture volume.  
 No Azide Low Endotoxin monoclonal αCD49d (BD Pharmingen). Also the 0,5mg 
vial was dissolved in 0,5ml tissue culture grade PBS to make 1mg/ml and 1 μl 
added to each 1ml culture volume. 
  2- Mercaptoethanol. (βME) Riedel de Haen. A 1000x stock solution was 
prepared by adding 2μl of βME into sterile 2,86ml sterile, tissue culture grade 
(low endotoxin) water. Fifty microliter aliquots were stored at -20ºC for up to a 
month. These were thawed once. A final working concentration of 50μM (3,5μl/L) 
was used.  
 Penicillin 100U/ml Gibco. A 100x stock was made, aliquoted and stored at -20ºC 
and each aliquot was thawed once. 
 Streptomycin100ug/ml. Gibco. A 1000x stock was prepared and aliquots frozen 
at -20ºC and thawed once during use. 
 Human (male) AB serum. Heat inactivated. US origin. Gibco. The serum was 
centrifuged at 4ºC at 1500 rpm and the lipoproteins removed. Smaller volume 
aliquots (5ml) were filtered through 0,22μ acetate filters and were kept at -20ºC 




 HIV-1 p24 Antigen High Purity grade. Research Diagnostics Inc. A recombinant p24 
(H x B2 strain produced in pichia pastoris) that reacts with AIDS sera and 
monoclonal antibodies specific for conformational and linear epitopes. The 1mg vial 
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was reconstituted in 0,36ml of sterile tissue culture grade 0.02M sodium phosphate 
to make a 2, 8 mg/ml solution. Aliquots of 400ug/ml were made and stored at -80ºC 
and thawed once during use. Two concentrations (1 and 5 ug/ml) were titrated to 
obtain the optimum quantity for cell stimulation: 2,5, μl and 12, 5 μl were added to 
each 1 ml of culture, respectively.  
 
 PBS-soluble adult Ascaris lumbricoides helminth antigens 
 Sources:  
 
Two sources of whole Ascaris lumbricoides worms were used. The first lot was kindly 
donated by Natalie Nieuwenhuizen from Professor Frank Brombacher’s Immunology 
Laboratories at the University of Cape Town, South Africa. These had been collected from 
South Africa. The worms  had been washed, sexed and already extracted when they were 
donated. 
 
The second lot was a kind donation from Professor Jan Bradley of the University of 
Nottingham, UK. These worms  had been collected in Cameroon, West Africa. They had 
been washed and sexed in the UK and female worms were donated for this study.  These 
were transported on dry ice and immediately stored at -80ºC immediately upon arrival in 
South Africa. 
 
Preparation of Ascaris lumbricoides helminth extracts. 
 
The worms were cut into small pieces in a sterile Petri dish and transferred to 50ml Falcon 
tube. Approximately 10 ml of sterile, tissue culture grade PBS was added. The slurry was 
homogenized at 24 000r/minute in a Type 2 homogeniser (KA, Labortechnik, Stakefen, 
Janke & Kunkel, Gmb).The homogenate was aliquoted into 2ml sterile Eppendorf tubes and   
centrifuged at 14 000 rpms for 1 hour at 4ºC (until the supernatant was clear).The 
supernatants were then pooled and filtered through 8um, then through a 0.45um and finally 
through 0.22um acetate filters. Sterile aliquots were then made and stored at -80ºC.These 




5.1.5 Determination of protein contents of the Ascaris lumbricoides helminth extract: 
BCA colorimetric assay 
 
The protein content in the helminth extract was determined using the BCA kit (Pierce) as per 
the manufacture’s instructions. Essentially, a 1: 50 BCA working solution was made by 
adding 60μl of solution B into 3ml solution A.  Protein standards were prepared by making 
doubling serial dilutions of bovine serum albumin (BSA) in1x PBS to give the following 
concentrations of protein:  5; 2, 5; 1, 25; 0,625; 0.31; 0,15; 0,08 and 0,04 mg protein. 
Doubling dilutions of the helminth extract were made in PBS as 1:5; 1:10; 1:20; 1:40 and 
1:80. An undiluted sample was also analysed. Two hundred microliters of the BCA working 
solution were pipetted into 5 ml polystyrene tubes labeled with each standard and sample 
dilution. Ten microliters of the diluted standards and helminth extract samples (including an 
undiluted sample) were added to the solution in each corresponding tube and mixed. The 
tubes were incubated at 37ºC for 30 minutes, and then allowed to cool to room temperature. 
Absorbance was then read at 540λ. A standard curve was drawn and the corresponding 
protein concentrations extrapolated.  
  
The endotoxin levels were kindly detected by Ms A. Lynch, University of Cape Town, SA. 
 
5.1.6 Evaluation of antigenecity of the helminth extract : Agarose Gel Diffusion Test 
 
To confirm antigenecity of the extracts, various concentrations (1, 2, 5 and 10ug/ml) of the 
crude antigens were tested on sera obtained from two participants, HIV-1 negative and 
positive, who had elevated levels of serum Ascaris lumbricoides-specific IgE and excreted 
Ascaris lumbricoides eggs in their stools.  
 Agarose A Gel Preparation 
EDTA (0, 03 g) and 0,75g of Agarose (Seravac, Pharmacia) were dissolved in 100ml of 
boiling PBS containing 0,1% Sodium Azide. This was aliquoted in 2ml vials, cooled and 
stored at 4ºC (at which the gel solidified). For the tests, an aliquot of the gel was removed 
and heated until melted. One milliliter was pipetted onto a glass plate and allowed to cool. 
Just before the gel set, a Perspex template (with punched holes) was gently lowered onto 
the agarose gel, sandwiching it between the glass and Perspex surfaces.  The prepared 
plate was left for 4 hours in a humid chamber. For each plate, a central hole, equidistant to 6 
other wells was allocated for antigen addition.  Ten microliters of the different antigens were 
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added to the central well, and ten microliters of sera added to the respective surrounding 
wells. The plate was incubated at room temperature in a humid chamber and allowed to 
diffuse overnight.  Precipitin bands, formed by antigen-antibody binding, were checked for 




5.2 Optimisation of Culture Experiments.  
 
Suitable culture conditions were evaluated for optimal cell activation and cytokine 
production. This was done by varying the culture period from 6, 12, 24, 48, 72 and 120 
hours. The two mitogens were assessed at two concentrations (PHA: 1 and 5 ug/ml) and 
(PMA 50ng/ml /IO 1ug/ml and PMA 20 ng/ml /IO1ug/ml).  Similarly the following recall 
and specific antigen concentrations were evaluated; PPD (1 ug/ml and 5 ug/ml), 
streptokinase (250 IU/ml and 1000IU/ml) HIV-1 p24 antigen (1ug/ml or 5ug/ml) and PBS-
soluble Ascaris lumbricoides extract (5ug/ml and 10ug/ml). For these experiments, 
PBMCs obtained from 6 HIV-1 positive and 1 HIV-1 negative participants and 4 
presumably healthy controls (laboratory workers) were used. Respective totals of 30, 4 
and 19 culture sets were repeated for each of the categories on different days. The 




Six plates were set up, each plate for the specific incubation period. Each sample from 
each donor was designated to 24 wells of a 48-well polypropylene microtiter tissue 
culture plates (Corning, Costar) and two wells were set aside for the unstimulated cells. 
Cell suspensions containing 1x106 cells/ml in complete RPMI 1640 (supplemented with 
50μM β Mercaptoethanol, 100/ml penicillin and 100μg/lml streptomycin) were added to 
the designated wells. One microliter each of the 1mg/ml of α CD28 and αCD49d were 
added to the culture wells. Each stimulant was designated to 4 wells (with each of the 2 
concentrations set in duplicates). The plates were covered, mixed at 1000 rpm for 1 
minute in a plate shaker and incubated at 37ºC in a humidified 5% CO2 incubator for 6, 
12, 24, 48 ,72 and 120 hours. At the end of each incubation period, the respective plate 
was removed from the incubator and supernatants were carefully collected from the 
wells without disturbing the cells. From each well, 4 appropriately labeled Eppendorf 
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vials of 200 μl supernatants were collected and immediately transferred to a -80ºC 
freezer for later analysis. 
 
To compare the different time points and stimulant concentration for optimum 
stimulation, two cytokines Interleukin4 (IL-4) and interferon γ (IFN-γ) were analysed on 
the collected supernatants using the  Quantikine High Sensitivity human IL-4 and IFN γ 
Elisa kits from RDI. The resulting cell pellets were used to optimize the staining for 
lymphocyte proliferation markers. 
For the above experiments, various concentrations of the antigens and mitogens were 
tested for optimal stimulation of cultures at different incubation time points.  
 
5.3 Determination of Cultured PBMC’s Cytokine responses to stimulants  
 
5.3.1 Preliminary experiments 
 
While culture conditions were being optimized, supernatants were collected from 
unstimulated and stimulated cultures and frozen at -80°C. At a later stage, these were 
retrieved and analysed for cytokine [Interferon gamma (IFNγ) and Interleukin 4 (IL-4)] 
production. Eighty two samples were analysed for the production of both IFNγ and IL-4 
after culture with various mitogens and antigens for different periods of time ranging from 
6 hours to 6 days.  The Quantikine human Interferon gamma (IFNγ) and Interleukin 4 (IL-
4) High Sensitivity (HS) Elisa kits purchased from Research Diagnostics Systems 




5.3.2 The Quantikine HS human IL-4 Elisa  
 
The assay employs the quantitative sandwich technique with a monoclonal anti-IL-4 
precoated onto the microplate. Any IL-4 present in samples binds to the immobilized 
antibody. After washing away unbound material, a second enzyme-linked polyconal anti-
IL4 binds to the IL-4 and a substrate added after several washes. The amplifier solution 
is added to develop a colour that is proportional to the amount of bound IL4. Colour 





Reagents and standards were prepared as instructed in the manual. Then serial 
dilutions of the standard were made to produce concentrations of 16pg/ml; 8 pg/ml; 4 
pg/ml; 2 pg/ml; 1 pg/ml; 0, 5 pg/ml and 0, 25 pg/ml. Fifty microliters of assay diluentHD1-
6 was added to each well of the microplate, mixed well and 200μl of each supernatant 
and standard added ( in duplicates). The plate was then covered with the adhesive strip 
and incubated for 3 hours at room temperature (RT). The plate was then washed 4 times 
with the wash buffer using the ComburTip multidispenser and completely removing the 
wash buffer by carefully rapping the inverted plate and blotting in several layers of clean 
paper towels. Two hundred μl of antibody-enzyme conjugate were added to each well 
and the sealed plate incubated for 2 hours at RT. The plate was washed 4 times as 
above and 50μl of substrate solution added. A further 1 hour incubation at room 
temperature preceded the addition of the amplifier solution and 30 minute incubation. 
The absorbance was then read within 30 minutes in the Elisa microplate reader at 
490nm and wavelength correction set to 650nm. A standard curve is drawn by the 
computer using the concentrations vs. absorbance obtained. The concentrations of the 
samples then exported to the Excel software. 
 
5.3.3 IFNγ Elisa.  
 
A sandwich technique employing a polyclonal anti-IFNγ antibody coated onto the plate 
and a secondary, polyclonal antibody conjugate binds to the bound IFNγ molecules, 
which are then quantitated by colorimetry.  
 
Procedure in brief 
 
The instructions for reagents and working standard preparation were adhered to. One 
hundred microliters of assay diluent RD1-51 were added to each well and 100 μl of 
samples and standards added. The plate was covered with adhesive strip and incubated 
for 2 hours at RT in the dark. The well contents were decanted by quickly flicking the 
plate, blotting it onto absorbent paper and then filling it with 400 μl of wash buffer using 
the ComburTip multidispenser. The wash procedure was repeated 4 times. The anti-
IFNγ enzyme conjugate (200μl) was added, the plate covered with adhesive sealer 
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incubated for 2 hours at RT in the dark. The unbound conjugate was decanted and the 
wash procedure repeated 4 times. Two hundred μl of substrate was added and plate 
incubated for 30minutes at RT protected from light. Fifty μl of stop solution was added to 
all wells and absorbance read at 450nm within 30minutes, with wavelength correction at 
540nm in an Elisa plate reader. A standard curve is drawn by the computer using the 
concentrations vs. absorbance obtained. The concentrations of the samples then 
exported to the Excel software. 
Optimization of Ki67 staining procedure. 
The procedure, adapted from BD Biosciences Pharmingen Technical Documents 70-
36624K (http://www.bdbiosciences.com/immunocytometry_systems/) was 
undertaken with various modifications to optimize the method for use in this study.   
First an attempt was made to detect viable, proliferating cells by including  Propidium 
Iodide staining. 
A 5.2.1 Assessment of viable, proliferating lymphocytes: Propidium Iodide / anti-
Ki67 staining  
Samples: Sets of cell cultures of PBMC’s isolated from 19 laboratory controls, 30 HIV 
positives and 4 HIV negatives were established for optimization experiments.  
For each participant, cells were either cultured without stimulants or challenged with the 
various mitogens and antigens to optimize the culture conditions and then to perform the 
actual experiments. Supernatants (800 μl) were carefully removed from cells that had 
been cultured with or without antigens for six days (as described in section 5.2.1.2 
above).The cells were resuspended in the remaining 200 μl of RPMI medium. Ten 
microliters of cell suspension was removed from each well and enumerated using the 
counting chamber. Aliquots containing 1x106 cells/ 100 μl were transferred to 50ml 
polypropylene tubes. Five milliliters of cold 80% ethanol was added dropwise, while 
vortexing the cell suspensions. The cells were then fixed and permeabilised by 
incubation for at least 2 hours at  -20ºC (in most cases were incubated overnight- they 
could be used up to 60 days after fixing). Forty milliliters of wash buffer (1X PBS with 1% 
fetal calf serum and 0,09%  NaN3,  pH 7.2)  was added to the fixed cells and the tubes 
centrifuged at 1000 rpm (with the brake on) for 10 minutes. The supernatant was 
carefully aspirated and discarded.  A further wash-centrifugation step was repeated one 
more time and all supernatant completely removed.  The cells were resuspended in 100 
μl of wash buffer and transferred to designated wells containing 20 μl of anti Ki67-FITC 
conjugate (BD Pharmingen) in 96-well v-bottom microtiter plate. The sample-antibody 
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solutions were mixed in a plate shaker at 1000 rpm for 30 seconds and incubated on ice 
for 45 minutes in the dark. The plates were then centrifuged at 1500 rpm for 3 minutes at 
4ºC with the brake on and the supernatant carefully aspirated by vacuum. (Meticulous 
effort was taken not to disturb the pellets as these fixed cells did not sediment firmly).  
One hundred and eighty microliters of wash buffer was added to each well and the plate 
centrifuged as above. The cells were resuspended in 150 μl of wash buffer and 10 μl of 
1mg/ml Propidium Iodide (Sigma) in water was added. The stained cells were 
transferred to 12x75mm FACS tubes (BD) and analysed on the FACS Calibur TM   Neon- 
Argon dual laser flow cytometer. All experiments contained control wells including 
unstained cells only, unstimulated cells and antiKi67-FITC only; PHA-stimulated cells 
with anti KI67-FITC, PHA-stimulated cells with Propidium Iodide only as well as cells and 
the IgG1κ isotype control).   Unstained cells were used to set the PMT forward and side 
scatter detector voltages as well as the threshold. 
Gating. 
A dual parameter dot plot for side scatter vs forward scatter was set up to distinguish the 
lymphocyte region1 (R1). A second dot plot featuring Propidium Iodide vs anti Ki67-FITC 
staining was used to distinguish viable cells expressing the KI67 antigen in region 2 ( 
R2).  From the two regions R1 and R2, a histogram plot for all viable lymphocytes 
expressing Ki67 was drawn.  
 
A 5.2.2 Discrimination of proliferating lymphocytes by CD3 Staining 
 A second modification of the method aimed at improving the recovery of lymphocytes. It 
included an anti CD3 surface staining step before the antiKi67 staining. 
 Modified Procedure 
Ten microliter aliquots of the cultured cells were enumerated. Twenty microliters of anti-
CD3- PerCP (BD Pharmingen) conjugate were pipetted into designated wells of the 96-
well v-bottom plate. The enumerated cells were adjusted to contain 1x106 cells in 100 μl 
and dispensed into the respective wells containing the antibodies. The plates were 
incubated on ice for 45 minutes in the dark, after which they were centrifuged and 
supernatants aspirated. One hundred and eighty microliters of wash buffer was added to 
resuspend the cells and the plates centrifuged at 1500rpm at 4ºC for 3 minutes.  The 
pelleted cells were resuspended in 100 μl wash buffer, transferred to 50ml polypropylene 
tubes, fixed, and stained for Ki67 as above.   
Flow cytometer setting was done as described earlier 
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 Gating: 
A side scatter vs forward scatter dot plot was drawn to distinguish the lymphocyte region 
R1.  A second dot plot featuring CD3 vs anti Ki67-FITC staining was used to distinguish 
all lymphocytes expressing the Ki67 antigen in region 2 (R2).  A third region (R3) 
differentiating viable lymphocytes positive for Ki67 staining was established on the PI vs 
Ki67 dot plot.  From the three regions R1, R2 and R3, a histogram plot for all viable 
lymphocytes expressing Ki67 (CD 3vs anti K167) was drawn on the gated lymphocytes. 
This gating strategy was found unsuitable because of the broad spectral overlap 
between Propidium Iodide and the flourochromes in FL1, FL2 and FL3 chanels and the 
CD3 light scatter was poor. 
 
A 5.2.3   Improving the side scatter properties: 67% Ethanol/ paraformaldehyde 
fixation 
 The third modification involved substitution of 67% ethanol fixative and a 
paraformaldehyde incubation step to permeabilise the membrane. The aim was to 
improve the quality of the CD3 gate as the light scatter properties were altered on the 
alcohol fixed cells. 
 
Procedure 
 Cell cultures were enumerated and stained for surface expression of CD3 as described 
above.. The stained cells were washed in PBS and transferred into 15 ml polypropylene 
tubes. The cells were fixed by dropwise addition of 0,5ml of 67% ethanol and incubated 
at 4ºC for 30 minutes.  Fixed cells were centrifuged at 1500 rpm at 4ºC with the brake 
on, all supernatant alcohol discarded and 5ml 1XPBS added.   The centrifugation step 
was repeated and supernatant aspirated and discarded. The pelleted cells were 
resuspended in 0,5ml of 1% paraformaldehyde in PBS containing 0.01% Tween 20 
(preparation method in Appendix 1) and incubated for 30 minutes at room temperature. 
Then the tubes were centrifuged at 1500 rpm at 4ºC with the brake on, supernatant 
discarded and washed in PBS with the repeat centrifugation. The cells were 
resuspended in staining wash buffer and stained for intracellular Ki67 expression as 
described above, with the exclusion of Propidium Iodide staining.  The stained cells were 
analysed on the FACS CaliburTM   flow cytometer. After setting the instrument PMT 
voltages, the threshold and isotype controls, spectral overlap was compensated for 
between FL1 and FL2 plus FL2 and FL3. 
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 Gating  
The lymphocyte region 1 (R1) on the side scatter vs forward scatter dot plot was created. 
Region 2 for CD3 positive lymphocytes was set on the side scatter vs CD3 plot. Ki67 
expression was sought on the third histogram plotting all cells expressing Ki67 gated on 
R1 +R2.  
Staining of CD3 staining could not be improved as the side scatter properties were still 
poor. 
A 5.2.4 Anti-Ki67 and anti- CTLA-4 staining 
The final modified staining included staining for the downregulator of T cell stimulation –
CTL-A4. Surface staining for CD3 expression was excluded as this staining proved 
unsuccessful. PBMC’s from 40 HIV-1 positive participants had each been cultured 
unstimulated or in the presence of PHA, HIV-1 p24, Streptokinase and Ascris 
lumbricoides antigens. Control samples from 22 HIV-1 negative participants were 
cultured unstimulated, or challenged with PHA, streptokinase and A. lumbricoides 
antigens. For each sample, 5 wells of a 96 v-bottom plate were designated for the 
respective stimulant. Twenty microliters of each monoclonal antibodies to Ki67 
(conjugated to FITC) and CTLA-4( APC) were carefully pipetted into the bottom of all 
designated wells. After removal of supernatants, the cell cultures (from 2.7.3) were 
enumerated and 100 μl aliquots adjusted to contain 1x106 cells. The 100 μl aliquots were 
pipetted into their corresponding wells containing the antibodies. The solutions were 
mixed by shaking the plates in the shaker at 1000rpm for 30 seconds. Plates were then 
incubated on ice for 45 minutes in the dark. The plates were then centrifuged at 1500 
with the brake on at 4ºC for 3 minutes and supernatant carefully aspirated.  One hundred 
and eighty microliters of wash buffer was dispensed into each well and plates 
centrifuged as above. 
The pellets were resuspended in 180 μl of wash buffer and transferred to FACS tubes 
containing 450μl of wash buffer.  Flow cytometric analysis of the samples then  followed.  
Control samples wells were included: IgG1 κ FITC and IgG2a APC isotype controls, 
unstained cells, stimulated and unstimulated cells stained with anti-Ki67 FITC only, anti-
CTLA-4 APC only and  with both sets of antibodies. The instrument PMT voltages and 
threshold were set. The isotype control samples were run and the negative population 
set using a sample from a HIV-1 negative participant.  
Gating. 
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In the side scatter vs forward scatter dot plot, the lymphocyte region was established. 
For each participant, the unstimulated tube was used to set the gating region and 
was left unchanged for all subsequent tubes of stimulated cells. Dotplots for Ki67 vs 
CTLA-4 were drawn and histogram plots were drawn with markers separating the 
negative and positive cell populations, each for Ki67 and CTLA-4 fluorescence 
intensity as in Figure5.1. 
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